
<html lang="en"     class="pb-page"  data-request-id="f729182f-fd6e-4bb1-8f01-8957cb73a117"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";article:article:10.1021/jm3007799;requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;wgroup:string:ACHS website Group;issue:issue:10.1021/jmcmar.2012.55.issue-21;website:website:acspubs;pageGroup:string:Publication Pages;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="dc.Title" content="Design and Discovery of 6-[(3S,4S)-4-Methyl-1-(pyrimidin-2-ylmethyl)pyrrolidin-3-yl]-1-(tetrahydro-2H-pyran-4-yl)-1,5-dihydro-4H-pyrazolo[3,4-d]pyrimidin-4-one (PF-04447943), a Selective Brain Penetrant PDE9A Inhibitor for the Treatment of Cognitive Disorders" /></meta><meta name="dc.Creator" content="Patrick R.  Verhoest" /></meta><meta name="dc.Creator" content="Kari R.  Fonseca" /></meta><meta name="dc.Creator" content="Xinjun  Hou" /></meta><meta name="dc.Creator" content="Caroline  Proulx-LaFrance" /></meta><meta name="dc.Creator" content="Michael  Corman" /></meta><meta name="dc.Creator" content="Christopher J.  Helal" /></meta><meta name="dc.Creator" content="Michelle M.  Claffey" /></meta><meta name="dc.Creator" content="Jamison B.  Tuttle" /></meta><meta name="dc.Creator" content="Karen J.  Coffman" /></meta><meta name="dc.Creator" content="Shenpinq  Liu" /></meta><meta name="dc.Creator" content="Frederick  Nelson" /></meta><meta name="dc.Creator" content="Robin J.  Kleiman" /></meta><meta name="dc.Creator" content="Frank S.  Menniti" /></meta><meta name="dc.Creator" content="Christopher J.  Schmidt" /></meta><meta name="dc.Creator" content="Michelle  Vanase-Frawley" /></meta><meta name="dc.Creator" content="Spiros  Liras" /></meta><meta name="dc.Description" content="6-[(3S,4S)-4-Methyl-1-(pyrimidin-2-ylmethyl)pyrrolidin-3-yl]-1-(tetrahydro-2H-pyran-4-yl)-1,5-dihydro-4H-pyrazolo[3,4-d]pyrimidin-4-one (PF-04447943) is a novel PDE9A inhibitor identified using par..." /></meta><meta name="Description" content="6-[(3S,4S)-4-Methyl-1-(pyrimidin-2-ylmethyl)pyrrolidin-3-yl]-1-(tetrahydro-2H-pyran-4-yl)-1,5-dihydro-4H-pyrazolo[3,4-d]pyrimidin-4-one (PF-04447943) is a novel PDE9A inhibitor identified using par..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="July 25, 2012" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/jm3007799" /></meta><meta name="dc.Language" content="EN" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="© 2012 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Fjm3007799" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Fjm3007799" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Fjm3007799" /></link>
        
    
    

<title>Design and Discovery of 6-[(3S,4S)-4-Methyl-1-(pyrimidin-2-ylmethyl)pyrrolidin-3-yl]-1-(tetrahydro-2H-pyran-4-yl)-1,5-dihydro-4H-pyrazolo[3,4-d]pyrimidin-4-one (PF-04447943), a Selective Brain Penetrant PDE9A Inhibitor for the Treatment of Cognitive Disorders | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/jm3007799" /></meta><meta property="og:title" content="Design and Discovery of 6-[(3S,4S)-4-Methyl-1-(pyrimidin-2-ylmethyl)pyrrolidin-3-yl]-1-(tetrahydro-2H-pyran-4-yl)-1,5-dihydro-4H-pyrazolo[3,4-d]pyrimidin-4-one (PF-04447943), a Selective Brain Penetrant PDE9A Inhibitor for the Treatment of Cognitive Disorders" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-21/jm3007799/production/images/large/jm-2012-007799_0007.jpeg" /></meta><meta property="og:description" content="6-[(3S,4S)-4-Methyl-1-(pyrimidin-2-ylmethyl)pyrrolidin-3-yl]-1-(tetrahydro-2H-pyran-4-yl)-1,5-dihydro-4H-pyrazolo[3,4-d]pyrimidin-4-one (PF-04447943) is a novel PDE9A inhibitor identified using parallel synthetic chemistry and structure-based drug design (SBDD) and has advanced into clinical trials. Selectivity for PDE9A over other PDE family members was achieved by targeting key residue differences between the PDE9A and PDE1C catalytic site. The physicochemical properties of the series were optimized to provide excellent in vitro and in vivo pharmacokinetics properties in multiple species including humans. It has been reported to elevate central cGMP levels in the brain and CSF of rodents. In addition, it exhibits procognitive activity in several rodent models and synaptic stabilization in an amyloid precursor protein (APP) transgenic mouse model. Recent disclosures from clinical trials confirm that it is well tolerated in humans and elevates cGMP in cerebral spinal fluid of healthy volunteers, confirming that it is a quality pharmacological tool for testing clinical hypotheses in disease states associated with impairment of cGMP signaling or cognition." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/jm3007799"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/jm3007799">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Fjm3007799&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Fjm3007799&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/jm3007799&amp;href=/doi/10.1021/jm3007799" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2012</span><span class="cit-fg-volume">, 55</span><span class="cit-fg-issue">, 21</span><span class="cit-fg-pageRange">, 9045-9054</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/55/21" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/jm300118s" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/jm3009635" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Design and Discovery of 6-[(3<i>S</i>,4<i>S</i>)-4-Methyl-1-(pyrimidin-2-ylmethyl)pyrrolidin-3-yl]-1-(tetrahydro-2<i>H</i>-pyran-4-yl)-1,5-dihydro-4<i>H</i>-pyrazolo[3,4-<i>d</i>]pyrimidin-4-one (PF-04447943), a Selective Brain Penetrant PDE9A Inhibitor for the Treatment of Cognitive Disorders</span></h1><ul class="loa non-jats-loa"><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Patrick+R.++Verhoest">Patrick R. Verhoest</a></span><span class="author-xref-symbol "><sup>*</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Kari+R.++Fonseca">Kari R. Fonseca</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Xinjun++Hou">Xinjun Hou</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Caroline++Proulx-LaFrance">Caroline Proulx-LaFrance</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Michael++Corman">Michael Corman</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Christopher+J.++Helal">Christopher J. Helal</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Michelle+M.++Claffey">Michelle M. Claffey</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Jamison+B.++Tuttle">Jamison B. Tuttle</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Karen+J.++Coffman">Karen J. Coffman</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Shenpinq++Liu">Shenpinq Liu</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Frederick++Nelson">Frederick Nelson</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Robin+J.++Kleiman">Robin J. Kleiman</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Frank+S.++Menniti">Frank S. Menniti</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Christopher+J.++Schmidt">Christopher J. Schmidt</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Michelle++Vanase-Frawley">Michelle Vanase-Frawley</a></span></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Spiros++Liras">Spiros Liras</a></span></span></li><span class="comma-separator"></span></ul><div class="affiliations"><div class="view-affs"><span class="title">View Author Information</span><i class="caret-icon icon-angle-down"></i></div><div class="all-aff-infos hlFld-Affiliation"><div class="aff-info" id="aff1"><span class="aff-text">Neuroscience Medicinal Chemistry, Pfizer World Wide Research and Development, 700 Main Street, Cambridge, Massachusetts 02139, United States</span></div><div class="corresp-info"><strong>*</strong>Phone: 617-395-0708. Fax: 860-686-0013. E-mail: <a href="/cdn-cgi/l/email-protection#13637267617a70783d613d6576617b7c7660675363757a6976613d707c7e"><span class="__cf_email__" data-cfemail="6a1a0b1e180309014418441c0f1802050f191e2a1a0c03100f1844090507">[email protected]</span></a></div></div></div><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Fjm3007799&amp;href=/doi/10.1021%2Fjm3007799" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2012</span></span><span class="cit-volume">, 55</span><span class="cit-issue">, 21</span><span class="cit-pageRange">, 9045–9054</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">July 10, 2012</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>4 June 2012</li><li><span class="item_label"><b>Published</b> online</span>25 July 2012</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 8 November 2012</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/jm3007799" title="DOI URL">https://doi.org/10.1021/jm3007799</a></div><div class="article_header-article-copyright"><strong>Copyright © 2012 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D9045%26pageCount%3D10%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DPatrick%2BR.%2BVerhoest%252C%2BKari%2BR.%2BFonseca%252C%2BXinjun%2BHou%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D55%26issueNum%3D21%26contentID%3Djm3007799%26title%3DDesign%2Band%2BDiscovery%2Bof%2B6-%255B%25283S%252C4S%2529-4-Methyl-1-%2528pyrimidin-2-ylmethyl%2529pyrrolidin-3-yl%255D-1-%2528tetrahydro-2H-pyran-4-yl%2529-1%252C5-dihydro-4H-pyrazolo%255B3%252C4-d%255Dpyrimidin-4-one%2B%2528PF-04447943%2529%252C%2Ba%2BSelective%2BBrain%2BPenetrant%2BPDE9A%2BInhibitor%2Bfor%2Bthe%2BTreatment%2Bof%2BCognitive%2BDisorders%26numPages%3D10%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D9054%26publicationDate%3DNovember%2B2012">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/jm3007799"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">3686</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">51</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/jm3007799" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Design and Discovery of 6-[(3S,4S)-4-Methyl-1-(pyrimidin-2-ylmethyl)pyrrolidin-3-yl]-1-(tetrahydro-2H-pyran-4-yl)-1,5-dihydro-4H-pyrazolo[3,4-d]pyrimidin-4-one (PF-04447943), a Selective Brain Penetrant PDE9A Inhibitor for the Treatment of Cognitive Disorders&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Patrick&quot;,&quot;last_name&quot;:&quot;R. Verhoest&quot;},{&quot;first_name&quot;:&quot;Kari&quot;,&quot;last_name&quot;:&quot;R. Fonseca&quot;},{&quot;first_name&quot;:&quot;Xinjun&quot;,&quot;last_name&quot;:&quot;Hou&quot;},{&quot;first_name&quot;:&quot;Caroline&quot;,&quot;last_name&quot;:&quot;Proulx-LaFrance&quot;},{&quot;first_name&quot;:&quot;Michael&quot;,&quot;last_name&quot;:&quot;Corman&quot;},{&quot;first_name&quot;:&quot;Christopher&quot;,&quot;last_name&quot;:&quot;J. Helal&quot;},{&quot;first_name&quot;:&quot;Michelle&quot;,&quot;last_name&quot;:&quot;M. Claffey&quot;},{&quot;first_name&quot;:&quot;Jamison&quot;,&quot;last_name&quot;:&quot;B. Tuttle&quot;},{&quot;first_name&quot;:&quot;Karen&quot;,&quot;last_name&quot;:&quot;J. Coffman&quot;},{&quot;first_name&quot;:&quot;Shenpinq&quot;,&quot;last_name&quot;:&quot;Liu&quot;},{&quot;first_name&quot;:&quot;Frederick&quot;,&quot;last_name&quot;:&quot;Nelson&quot;},{&quot;first_name&quot;:&quot;Robin&quot;,&quot;last_name&quot;:&quot;J. Kleiman&quot;},{&quot;first_name&quot;:&quot;Frank&quot;,&quot;last_name&quot;:&quot;S. Menniti&quot;},{&quot;first_name&quot;:&quot;Christopher&quot;,&quot;last_name&quot;:&quot;J. Schmidt&quot;},{&quot;first_name&quot;:&quot;Michelle&quot;,&quot;last_name&quot;:&quot;Vanase-Frawley&quot;},{&quot;first_name&quot;:&quot;Spiros&quot;,&quot;last_name&quot;:&quot;Liras&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2012&quot;,&quot;month&quot;:&quot;07&quot;,&quot;day&quot;:&quot;25&quot;,&quot;issue&quot;:&quot;21&quot;,&quot;volume&quot;:&quot;55&quot;,&quot;pages&quot;:&quot;9045-9054&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/jm3007799&quot;},&quot;abstract&quot;:&quot;6-[(3S,4S)-4-Methyl-1-(pyrimidin-2-ylmethyl)pyrrolidin-3-yl]-1-(tetrahydro-2H-pyran-4-yl)-1,5-dihydro-4H-pyrazolo[3,4-d]pyrimidin-4-one (PF-04447943) is a novel PDE9A inhibitor identified using parallel synthetic chemistry and structure-based drug design (SBDD) and has advanced into clinical trials. Selectivity for PDE9A over other PDE family members was achieved by targeting key residue differences between the PDE9A and PDE1C catalytic site. The physicochemical properties of the series were optimized to provide excellent in vitro and in vivo pharmacokinetics properties in multiple species including humans. It has been reported to elevate central cGMP levels in the brain and CSF of rodents. In addition, it exhibits procognitive activity in several rodent models and synaptic stabilization in an amyloid precursor protein (APP) transgenic mouse model. Recent disclosures from clinical trials confirm that it is well tolerated in humans and elevates cGMP in cerebral spinal fluid of healthy volunteers, confirming th&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Fjm3007799&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm3007799" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm3007799&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=jm3007799" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm3007799&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=jm3007799" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Fjm3007799&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm3007799&amp;href=/doi/10.1021/jm3007799" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/jm3007799" /></input><a href="/doi/pdf/10.1021/jm3007799" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (5 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/jm3007799&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Fjm3007799%26sid%3Dliteratum%253Aachs%26pmid%3D22780914%26genre%3Darticle%26aulast%3DVerhoest%26date%3D2012%26atitle%3DDesign%2Band%2BDiscovery%2Bof%2B6-%255B%25283S%252C4S%2529-4-Methyl-1-%2528pyrimidin-2-ylmethyl%2529pyrrolidin-3-yl%255D-1-%2528tetrahydro-2H-pyran-4-yl%2529-1%252C5-dihydro-4H-pyrazolo%255B3%252C4-d%255Dpyrimidin-4-one%2B%2528PF-04447943%2529%252C%2Ba%2BSelective%2BBrain%2BPenetrant%2BPDE9A%2BInhibitor%2Bfor%2Bthe%2BTreatment%2Bof%2BCognitive%2BDisorders%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D55%26issue%3D21%26spage%3D9045%26epage%3D9054%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (1)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=292464" title="Rodent models">Rodent models</a>,</li><li><a href="/action/doSearch?ConceptID=292528" title="Inhibitors">Inhibitors</a>,</li><li><a href="/action/doSearch?ConceptID=292524" title="Peptides and proteins">Peptides and proteins</a>,</li><li><a href="/action/doSearch?ConceptID=292462" title="Central nervous system">Central nervous system</a>,</li><li><a href="/action/doSearch?ConceptID=291711" title="Selectivity">Selectivity</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/55/21" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-21/jmcmar.2012.55.issue-21/production/jmcmar.2012.55.issue-21.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="f_tgr1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-21/jm3007799/production/images/medium/jm-2012-007799_0007.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-21/jm3007799/production/images/large/jm-2012-007799_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm3007799&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">6-[(3<i>S</i>,4<i>S</i>)-4-Methyl-1-(pyrimidin-2-ylmethyl)pyrrolidin-3-yl]-1-(tetrahydro-2<i>H</i>-pyran-4-yl)-1,5-dihydro-4<i>H</i>-pyrazolo[3,4-<i>d</i>]pyrimidin-4-one (PF-04447943) is a novel PDE9A inhibitor identified using parallel synthetic chemistry and structure-based drug design (SBDD) and has advanced into clinical trials. Selectivity for PDE9A over other PDE family members was achieved by targeting key residue differences between the PDE9A and PDE1C catalytic site. The physicochemical properties of the series were optimized to provide excellent in vitro and in vivo pharmacokinetics properties in multiple species including humans. It has been reported to elevate central cGMP levels in the brain and CSF of rodents. In addition, it exhibits procognitive activity in several rodent models and synaptic stabilization in an amyloid precursor protein (APP) transgenic mouse model. Recent disclosures from clinical trials confirm that it is well tolerated in humans and elevates cGMP in cerebral spinal fluid of healthy volunteers, confirming that it is a quality pharmacological tool for testing clinical hypotheses in disease states associated with impairment of cGMP signaling or cognition.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="specialIssueNotice" class="extra-info-sec articleNote"><h4>SPECIAL ISSUE</h4><p class="last">This article is part of the <a href="/toc/jmcmar/55/21"><issue-title>Alzheimer's Disease</issue-title></a> special issue.</p></div><div class="extra-info-sec articleNote withdrawn"><h4><span></span> Accession Codes</h4><p class="last">Coordinates of the PDE9A crystal structures have been deposited in the Protein Data Base for compound <b>16</b> (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4E90">4E90</a>).</p></div><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_17080" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_17080" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Phosphodiesterase (PDE) enzymes catalyze the hydrolysis of cGMP and cAMP, which are ubiquitously utilized second messengers for intracellular signaling cascades invoked by a wide variety of biological stimuli and are of particular functional importance in the central nervous system (CNS).<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> There are 21 PDE genes subclassified into 11 different families (PDE1–11). Each family member is characterized by a unique cellular and subcellular distribution, distinct regulatory domains, enzyme kinetics, and substrate affinity for cGMP, cAMP, or both.<a onclick="showRef(event, 'ref2'); return false;" href="javascript:void(0);" class="ref ref2">(2)</a> cGMP-specific PDEs include PDEs 5, 6, and 9, while cAMP-specific PDEs include 4, 7, and 8 and the PDEs 1, 2, 3, 10, and 11 are dual-substrate PDEs. The ability to potentiate specific cyclic nucleotide cascades by selectively targeting specific PDEs has led to the development of multiple drugs from this class of enzyme inhibitors. To date, inhibitors for PDEs 3, 4, and 5 have been approved for conditions that include congestive heart failure, chronic obstructive pulmonary disease, erectile dysfunction, and pulmonary hypertension.<a onclick="showRef(event, 'ref3 ref4 ref5'); return false;" href="javascript:void(0);" class="ref ref3 ref4 ref5">(3-5)</a></div><div class="NLM_p">Although PDEs have proven to be druggable targets, achieving high selectivity among the gene family can be challenging and is desirable for adequate safety profiles, since unwanted PDE inhibition has been reported to be associated with side effects.<a onclick="showRef(event, 'ref6 ref7'); return false;" href="javascript:void(0);" class="ref ref6 ref7">(6, 7)</a> PDE catalytic domains all share a hydrophobic clamp that binds the “purine”-like core of the cyclic nucleotides and form key hydrogen bonds to the common glutamine. For the dual substrate PDEs, this residue can rotate to form donor–acceptor hydrogen bonds to both cGMP and cAMP.<a onclick="showRef(event, 'ref8'); return false;" href="javascript:void(0);" class="ref ref8">(8)</a></div><div class="NLM_p">The widespread distribution of PDEs in the central nervous system (CNS) and critical role of GPCR signaling in neurotransmission prompted the development of a PDE family initiative to identify potential therapeutic utility for centrally penetrant PDE inhibitors.<a onclick="showRef(event, 'ref9'); return false;" href="javascript:void(0);" class="ref ref9">(9)</a> We have previously reported the discovery of multiple series of PDE10A inhibitors<a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">(10)</a> including a selective PDE10A inhibitor (PF-02545920) that has been administered to patients and completed a phase 2 trial in schizophrenia.<a onclick="showRef(event, 'ref11'); return false;" href="javascript:void(0);" class="ref ref11">(11)</a> We have used the experience gained executing these programs to explore the development of selective brain penetrant PDE9A inhibitors.</div><div class="NLM_p last">It has been reported that cGMP elevation can cause an increase in synaptic transmission and long-term potentiation.<a onclick="showRef(event, 'ref12'); return false;" href="javascript:void(0);" class="ref ref12">(12)</a> In addition it has been shown that cGMP can reverse Aβ induced deficits in long-term potentiation in hippocampal slices.<a onclick="showRef(event, 'ref13'); return false;" href="javascript:void(0);" class="ref ref13">(13)</a> PDE9A is a cGMP specific phosphodiesterase with the highest affinity of all PDEs for cGMP with <i>K</i><sub>m</sub> = 170 nM.<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a> The exquisite potency for cGMP hydrolysis combined with the widespread distribution<a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a> of PDE9A makes it an excellent target for globally elevating cGMP to test this hypothesis in the treatment of cognitive disruption in diseases such as Alzheimer’s disease.<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a></div></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i3">Results and Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_03660" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_03660" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">We have previously described the utilization of parallel medicinal chemistry to enable the potential synthesis of thousands of pyrazolopyrimidines exemplified by HTS hit <b>1</b>. Utilizing prospective physicochemical property based design coupled with the targeting of key residue differences within the PDEs and in particular the residue differences between PDE1C and PDE9A, we developed a brain penetrant in vivo tool <b>2</b> (PF-04181366) that can elevate cGMP in brain tissue (Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>).<a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a></div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-21/jm3007799/production/images/medium/jm-2012-007799_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-21/jm3007799/production/images/large/jm-2012-007799_0009.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Development of in vivo active lead <b>2</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-21/jm3007799/production/images/large/jm-2012-007799_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm3007799&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Although compound <b>2</b> had high potency against PDE9A (1.8 nM) and selectivity over PDE1C (50-fold), it possessed high human liver microsomal clearance (149 mL/min/kg) resulting in a projected large dose and a short half-life.<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a> High selectivity had been achieved with <b>2</b> over all the PDEs except PDE1C. PDE1C is expressed in cardiac tissue, so further selectivity was desired to advance a molecule into clinical trials. Therefore, our goal was to move beyond the development of a centrally penetrant tool to identify a more selective PDE9A inhibitor with improvements in pharmacokinetics and safety that could be taken into clinical trials. Our strategy to improve the pharmacokinetics of our lead molecule <b>2</b> again utilized parallel chemistry to target rapid replacement of the lipophilic cyclopentyl group with more polar functionality. On the basis of the X-ray crystal structure of <b>1</b>, which has been previously cocrystallized in the PDE9A catalytic domain (Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>), we hypothesized that an increase in polarity would also improve our selectivity over PDE1C, since PDE9A has a more polar inhibitor binding environment with the presence of tyrosine-424 versus a corresponding phenyl alanine-441 in PDE1C.</div><figure id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-21/jm3007799/production/images/medium/jm-2012-007799_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-21/jm3007799/production/images/large/jm-2012-007799_0004.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. PDE9A inhibitor <b>1</b> (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3JSI">3JSI</a>) bound and structural differences with PDE1C (pink).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-21/jm3007799/production/images/large/jm-2012-007799_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm3007799&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">In addition, this strategy to design molecules with reduced lipophilicity should improve the P450-mediated clearance of the targeted compounds. The replacement of the cyclopentyl group in compound <b>1</b> was explored by building the pyrazole ring from a variety of commercial and custom hydrazines. This effort identified a 4-tetrahydropyran derivative <b>3</b>, which significantly improved the human liver microsomal clearance from 200 to 14 mL/min/kg without impacting the P-glycoprotein (P-gp) efflux ratio (Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>). Additionally this came with an improvement in lipophilic binding efficiency (LipE)<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a> from 6.75 to 8.5. These characteristics aligned the in vitro ADME properties and binding efficiencies with what is reported for CNS marketed drugs.<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a> By increase of the polarity, a 14-fold improvement in selectivity over PDE1c was established and validated our design strategy. On the basis of the cocrystal structures, the improvement in selectivity appeared to be driven by the pyran oxygen interacting through a water hydrogen bonding network to tyrosine residue 424 in PDE9A, which in PDE1C is a phenylalanine. The loss in potency for PDE1C can be rationalized as being due to an increase in the desolvation penalty to accommodate the more polar tetrahydopyran into the more lipophilic environment in PDE1C formed by the Tyr to Phe mutations (Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>).</div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><p class="first last">Table 1. <a class="ref internalNav" href="#tbl1-fn1" aria-label="a">a</a></p></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-21/jm3007799/production/images/medium/jm-2012-007799_0010.gif" alt="" id="fx1" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-21/jm3007799/production/images/medium/jm-2012-007799_0011.gif" alt="" id="fx2" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-tbl1-fn1"><div class="footnote" id="tbl1-fn1"><sup>Table a</sup><p class="last">PDE9A and PDE1C: potency reported in nM as average of <i>n</i> = 4. HLM human liver microsomal clearance is in mL/min/kg. MDR is the efflux ratio BA/AB. LipE= −log <i>K</i><sub>i</sub> – ClogP.</p></div></div><div></div></div><div class="NLM_p">Incorporating the tetrahydropyran group with the benzylpyrrolidine motif in compound <b>2</b> was paramount to identifying compounds with further improvements in PDE1C selectivity. Condensing 4-hydrazinetetrahydropyran with the 2-(ethoxymethylene)malononitrile with base provided the cyanopyrazole (Scheme <a class="ref internalNav" href="#sch1" aria-label="1">1</a>). Oxidation of the cyano to the carboxamide was achieved with aqueous hydrogen peroxide. Pyrrolidine esters were then coupled with the pyrazoloaminoamide to provide the benzyl analogues. The benzylpyrrolidine is an enabled monomer that can rapidly be deprotected and functionalized via reductive amination or alkylation to afford the fully functionalized products.</div><figure id="sch1" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-21/jm3007799/production/images/medium/jm-2012-007799_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-21/jm3007799/production/images/large/jm-2012-007799_0012.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 1. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-21/jm3007799/production/images/large/jm-2012-007799_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm3007799&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>(a) Step 1: 2-(ethoxymethylene)malononitrile (1 equiv), triethylamine (4 equiv), ethanol (0.3 M), reflux 2 h. Step 2: 35% aq H<sub>2</sub>O<sub>2</sub>, aq ammonia, ethanol, 48 h. Step 3: pyrolidine ester (2 equiv), THF (0.1 M), 1.0 M <i>t</i>-BuOK (in THF, 2 equiv), reflux 16 h. Step 4: PdOH<sub>2</sub> (10%), conc HCl (1 equiv), methanol, 40 psi of H<sub>2</sub> 18 h. Step 5: reductive amination, aldehyde, 1,2-dichloroethane, sodium triacetoxyborohydride, 50 °C, 18 h; or alkylation, 2-(chloromethyl)pyrimidine–HCl, cesium carbonate, iron triflate, DMF, 60 °C, 24 h.</p></p></figure><div class="NLM_p">As we had hypothesized, the combination of the pyran and the pyrolidine moiety afforded a highly potent 4.9 nM and selective PDE9 inhibitor with improved pharmacokinetic properties. Significant improvements from compound <b>2</b> included increased selectivity (>200× over PDE1C) and a 5-fold reduction in clearance measured by human liver microsomes. It was determined that most of the activity resided in the enantiomer exemplified by compound <b>8</b>, which was 30-fold more potent than the less active enantiomer <b>9</b>.</div><div class="NLM_p">Structure-based design identified an opportunity to improve potency by completely filling the pocket that the methyl on pyrrolidine compound <b>8</b> accessed. Modeling of an ethyl group analogue into the crystal structure was projected to optimize the space filling of the lipophilic pocket in PDE9A (see Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a>).</div><figure id="fig3" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-21/jm3007799/production/images/medium/jm-2012-007799_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-21/jm3007799/production/images/large/jm-2012-007799_0005.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. The methyl group on the pyrrolidine does not completely fill the lipophilic pocket of PDE9A (circled area) (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3JSW">3JSW</a>).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-21/jm3007799/production/images/large/jm-2012-007799_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm3007799&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Addition of an ethyl group in compound <b>10</b> did enhance potency (3-fold) but did not show an improvement in LipE or selectivity and displayed a higher human liver microsomal clearance (Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>), rendering this avenue less appealing. Removal of the benzyl moiety in <b>11</b> afforded a compound that had low human liver microsomal clearance but with a significant loss in potency.<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a></div><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><p class="first last">Table 2. <a class="ref internalNav" href="#tbl2-fn1" aria-label="a">a</a></p></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-21/jm3007799/production/images/medium/jm-2012-007799_0013.gif" alt="" id="fx3" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-21/jm3007799/production/images/medium/jm-2012-007799_0001.gif" alt="" id="fx4" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-tbl2-fn1"><div class="footnote" id="tbl2-fn1"><sup>Table a</sup><p class="last">PDE9A and PDE1C: potency reported in nM as average of <i>n</i> = 4. HLM human liver microsomal clearance is in mL/min/kg. MDR is the efflux ratio BA/AB. LipE= −log <i>K</i><sub>i</sub> – ClogP. NA = unable to measure flux in MDR potentially because of poor permeability.</p></div></div><div></div></div><div class="NLM_p">While compound <b>8</b> displayed many desirable attributes to advance as a candidate molecule into clinical trials, the human liver microsomal clearance was still moderate. Compound <b>8</b> has a significant plasma protein binding free fraction of 40% due to the polarity of the molecule ClogP = 0.97. While plasma protein binding does not impact the dose, high free fractions can lead to a decreased half-life projection in humans, since a large amount of free drug is available to metabolize.<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a> To ensure that a clinical compound from this series with low plasma protein binding and a moderate volume of distribution could be dosed once or twice a day, it was necessary to have a compound with very low human liver microsomal clearance to achieve an acceptable half-life in humans. Lowering the clearance of the molecule would also have a positive impact on the dose projection in humans. The enabled pyrrolidine monomer rapidly allowed for SAR generation to identify either substituents on the phenyl ring or incorporation of heterocycles to drive down P450-mediated clearance.</div><div class="NLM_p">Fluorination of the phenyl ring did not reduce the clearance of the molecules, and only the para-fluoro substituent had equivalent clearance to the unsubstituted phenyl ring. This suggested that utilizing a blocking strategy with a fluorine to deactivate the phenyl ring to reduce P450-mediated oxidation was not likely to improve the dose or half-life projection. The increased clearance in these fluorinated analogues is probably driven through the increase in lipophilicity. Alternatively, lowering lipophilicity by incorporation of a heteroatom into the phenyl ring proved to be fruitful on multiple fronts. As expected, human liver microsomal clearance tracked with the lipophilicity of the compounds. Incorporation of one heteroatom into the ring decreased the microsomal clearance by half for compounds <b>16</b> and <b>17</b>. Subsequently, pyrimidines and pyrazines were incorporated to determine if the clearance could be lowered further with addition of another heteroatom and concomitant lowering of the lipophilicity. It was determined that the pyrimidine compounds <b>19</b> and <b>20</b> could effectively render the compounds completely stable to P450-mediated oxidation in the in vitro human liver microsomal system.</div><div class="NLM_p">While these heteroaryl compounds were highly polar with negative ClogP values, compounds within this series still maintained brain penetration. Interesting trends were seen with the P-gp MDR efflux ratios, which are predictive of brain penetration in humans. CNS compounds that exhibit no central penetration impairment typically have an efflux ratio of <2.5. The 2-pyridyl substitution <b>16</b> provided significantly less P-gp efflux liability than the 3-substituted pyridine <b>17</b> (1.44 vs 4.49) (Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a>). To further explore this trend, the 2,6-pyrimidine was compared to the 3,5-pyrimidine, and this effect was even more pronounced. The 2,6-pyrimidine 6-[(3<i>S</i>,4<i>S</i>)-4-methyl-1-(pyrimidin-2-ylmethyl)pyrrolidin-3-yl]-1-(tetrahydro-2<i>H</i>-pyran-4-yl)-1,5-dihydro-4<i>H</i>-pyrazolo[3,4-<i>d</i>]pyrimidin-4-one (PF-04447943)<a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a><b>20</b> with a ClogP of −1.5 displayed an MDR ratio of 1.23, while the 3,5-pyrimidine showed an efflux ratio of 15.8. This ratio proved highly predictive in that compound <b>20</b> displayed good brain penetration in the rat and compound <b>19</b> showed a very low brain to plasma ratio (<0.05). The differential brain penetration and P-gp efflux liability cannot be explained by traditional physicochemical properties, since the differences in molecular weight, basic p<i>K</i><sub>a</sub>, lipophilicity, and polar surface area are negligible. Future publications will explore the cause and generality of these findings.</div><div class="NLM_table-wrap" id="tbl3"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><p class="first last">Table 3. <a class="ref internalNav" href="#tbl3-fn1" aria-label="a">a</a></p></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-21/jm3007799/production/images/medium/jm-2012-007799_0002.gif" alt="" id="fx5" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-21/jm3007799/production/images/medium/jm-2012-007799_0003.gif" alt="" id="fx6" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-tbl3-fn1"><div class="footnote" id="tbl3-fn1"><sup>Table a</sup><p class="last">PDE9A and PDE1C: potency reported in nM as average of <i>n</i> = 4. HLM human liver microsomal clearance is in mL/min/kg. MDR is the efflux ratio BA/AB. LipE= −log <i>K</i><sub>i</sub> – ClogP.</p></div></div><div></div></div><div class="NLM_p">Alignment of the desired in vitro ADME properties was achieved with compound <b>20</b>, and just as importantly potency for PDE9A inhibition was maintained as lipophilicity was decreased. This is demonstrated with the heterocyclic compounds exhibiting improved LipE over the phenyl compounds. The LipE was further improved via incorporation of the pyrimidines, culminating in compound <b>20</b> with a LipE of 9.58. LipE for <b>20</b> is exquisitely high when compared to typical enzyme inhibitors and marketed CNS drugs.</div><div class="NLM_p">The X-ray structure of <b>20</b> cocrystallized in the catalytic domain of PDE9A (Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a>) shows that unique features of interaction with PDE9A. While the traditional interactions with Gln-453 are maintained, the pyrimidine ring is stacking with the Phe-441. It appears that this stacking is not driven by lipophilicity in that the heterocyclic analogues are essentially equipotent to the phenyl ring. An edge on interaction with Phe-456 is also observed. The water molecule mediating the ligand Tyr-424 interaction is also observed and could potentially donate a hydrogen bond to the nitrogen of the pyrimidine ring of <b>20</b> at a distance of 2.9 Å. Compound <b>20</b> possessed all of the desired in vitro attributes that were targeted to advance into candidate selection including potency (8 nM), selectivity (>10 μM versus all the PDEs except PDE1C at >1 μM), low human liver microsomal clearance (<8), and no P-gp liability. Evaluation of <b>20</b> in the CEREP panel screen showed less than 50% activity against a 75+ panel of GPCRs, enzymes, and ion channels when tested at 10 μM. This selectivity was achieved by optimizing the physicochemical properties of the molecule and by interacting with two unique residues in PDE9A vs PDE1C. As was designed, polar interactions with tyrosine-424 in PDE9A (vs phenylalanine in PDE1C) by the pyrrolidine and incorporation of a more polar pyran provided significant selectivity. Additionally selectivity was gained via a π-stacking interaction between the 2,6-pyrimidine and phenylalanine 441 in PDE9A, which is an isoleucine in PDE1C.</div><figure id="fig4" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-21/jm3007799/production/images/medium/jm-2012-007799_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-21/jm3007799/production/images/large/jm-2012-007799_0006.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. X-ray crystral structure of PDE9A inhibitor <b>20</b> (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4E90">4E90</a>) bound in PDE9A making key interaction with the phenylalanine and tyrosine to provide selectivity over PDE1C.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-21/jm3007799/production/images/large/jm-2012-007799_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm3007799&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Compound <b>20</b> was centrally penetrant in rodents as evidenced by brain to plasma ratios ranging from 0.59 to 0.88 in rats and mice, respectively. There was a slight disequilibrium in free drug concentrations across the central compartment, as evidenced by free brain/free plasma ratios ranging from 0.32 to 0.52 (rats and mice, respectively) and by a cerebrospinal fluid (CSF)/free plasma equal to 0.19 (rat). These findings indicate some impairment in the compound’s ability to cross the rodent blood–brain barrier. The disequilibrium in free drug concentrations was further evaluated to determine species specificity and potential human translation and was predicted to be a rodent-specific finding mediated by efflux via P-gp (cross-species in vitro transporter evaluation). Additional experiments examining CSF and plasma concentration–time profiles in the dog resulted in no evidence of disequilibrium (AUC<sub>csf</sub>/AUC<sub>p,u</sub> equal to 0.93) in this higher species.</div><div class="NLM_p">The pharmacokinetic properties of compound <b>20</b> were determined in both the rat and dog. The in vivo clearance of compound <b>20</b> was moderate in the rat and low in the dog, in agreement with in vitro clearance estimates generated using liver microsomes (Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a>). The volume of distribution was determined to be moderate across species (∼2 L/kg), and the bioavailability ranged from 73% to 91% in rats and dogs, respectively. In humans, compound <b>20</b> was projected to have a low systemic clearance through the use of preclinical/in vitro clearance prediction methodology.<a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a> Additional information on the preclinical and clinical pharmacokinetics and exposure–response relationships will be reported in a future publication.</div><div class="NLM_table-wrap" id="tbl4"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 4. Summary of Preclinical Pharmacokinetic Parameters of Compound <b>20</b><a class="ref internalNav" href="#tbl4-fn1" aria-label="a">a</a></div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center">rat</th><th class="colsep0 rowsep0" align="center">dog</th><th class="colsep0 rowsep0" align="center">human</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">microsomal CL<sub>b</sub> <a class="ref internalNav" href="#t4fn1" aria-label="b">b</a>(mL/min/kg)</td><td class="colsep0 rowsep0" align="left"><22.1</td><td class="colsep0 rowsep0" align="left"><17.4</td><td class="colsep0 rowsep0" align="left"><5.3</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">in vivo CL<sub>b</sub>(mL/min/kg)</td><td class="colsep0 rowsep0" align="left">32.1</td><td class="colsep0 rowsep0" align="left">11.7</td><td class="colsep0 rowsep0" align="left">NA</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">ivivc</td><td class="colsep0 rowsep0" align="left">1.5×</td><td class="colsep0 rowsep0" align="left">1.5×</td><td class="colsep0 rowsep0" align="left">NA</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-tbl4-fn1"><div class="footnote" id="tbl4-fn1"><sup>a</sup><p class="last">CL<sub>b</sub> determined from rat and dog following iv administration at 1 and 0.3 mg/kg, respectively. NA = not applicable. ivivc = in vitro to in vivo correlation.</p></div><div class="footnote" id="t4fn1"><sup>b</sup><p class="last">Calculated using the well-stirred model with the inclusion of all binding factors.</p></div></div></div><div class="NLM_p last">With desirable potency, selectivity, and pharmacokinetic properties, compound <b>20</b> has been the subject of extensive biological profiling using models of CNS function and dysfunction. It has been shown to elevate cGMP in multiple brain regions and in cerebral spinal fluid (CSF), which provided the opportunity for a translatable biomarker to assess target engagement. Electrophysiological evaluation of compound <b>20</b> under select conditions has revealed an impact on hippocampal synaptic plasticity, as represented by long-term potentiation. In vivo studies demonstrate that auditory gating deficits produced by amphetamine can be reversed in a dose-dependent fashion with <b>20</b>, suggesting the potential for utility in a variety of human disease states that exhibit a disrupted P50-gating response including schizophrenia, Huntington’s disease, and Alzheimer’s disease.<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a> Procognitive activity in a variety of rodent models has been demonstrated by multiple groups. Compound <b>20</b> was efficacious in both a spatial recognition memory model and a novel object recognition model, which both rely on time-dependent disruption of episodic memory.<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a> In addition, compound <b>20</b> was able to reverse scopolamine-induced deficits in both the Morris water maze and novel object recognition, suggesting potential therapeutic utility in patients with slight impairments of the cholinergic system, such as mild cognitive impairment or early Alzheimer’s disease. Evidence that <b>20</b> can reverse deficits produced by the NMDA receptor antagonist ketamine, at doses expected to produce moderate inhibition of the PDE9A enzyme, in a spatial memory task using an eight-arm radial maze suggests the potential for remediation of cognitive deficits across a variety of disease states exhibiting impaired glutamate neurotransmission.<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a> Finally, preliminary evidence of synaptic stabilization in the Tg2576 mouse model of amyloid precursor protein (APP) overexpression is suggested by data showing that chronic exposure to <b>20</b> prevented the loss in hippocampal dendritic spine density that normally occurs in this transgenic model between 4 and 5 months of age.<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a> Efficacy in this potential synaptoprotective model occurred with chronic exposures equivalent to efficacy seen in the cognition models and correlated with a CSF cGMP elevation of ∼125–150%</div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i5">Conclusion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_85674" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_85674" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p last">Through parallel chemistry and structure-based design, clinical candidate <b>20</b> was identified to answer biological questions for a centrally penetrant PDE9A inhibitor in humans. In particular, PDE9A inhibition may improve cognition in multiple disease states. Compound <b>20</b> shows excellent selectivity within the PDE family and in broad ligand profiling. The physicochemical properties of the molecule show that a highly polar molecule (ClogP < 0) can still have CNS penetration if other physicochemical properties are balanced such as limiting the number of hydrogen bond donors, lowering the basic p<i>K</i><sub>a</sub>, and minimizing the molecular weight.<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a> The broad efficacy in multiple preclinical cognition models including the potential for synaptic stabilization in the Tg2576 mouse model has supported the advancement of <b>20</b> into clinical trials. The promising preclinical pharmacokinetic properties has translated to phase 1 clinical trials. In humans, <b>20</b> has excellent tolerability, exposure, and a half-life of 19–31 h.<a onclick="showRef(event, 'ref29'); return false;" href="javascript:void(0);" class="ref ref29">(29)</a> The preclinical CSF elevation of cGMP has translated to humans, and it has been reported that a single dose of 40 mg elevated CSF cGMP by ∼300%.<a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a> The translation of the central preclinical cGMP response to humans is proof that <b>20</b> is a viable clinical compound to test in multiple clinical populations that display cognitive deficits.</div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i6">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_33767" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_33767" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">All reagents and solvents were used as purchased from commercial sources. Reactions were carried out under a blanket of nitrogen. Silica gel chromatography was done using the appropriate size Biotage prepacked silica filled cartridges. Mass spectral data were collected on a Micromass ADM atmospheric pressure chemical ionization instrument (LRMS APCI). NMR spectra were generated on a Varian 400 MHz instrument. Chemical shifts were recorded in ppm relative to tetramethylsilane (TMS) with multiplicities given as s (singlet), bs (broad singlet), d (doublet), t (triplet), dt (doublet of triplets), m (multiplet). Compound purity is determined by combustion analysis (Quantitative Technologies, Inc.) or high pressure liquid chromatography (HPLC). The purity of title compounds used in pharmacology testing was verified by HPLC–MS using the following method: 12 min gradient on a HP1100C pump of increasing concentrations of acetonitrile in water (5% → 95%) containing 0.1% formic acid with a flow rate of 1 mL/min and UV detection at λ 220 and 254 nm on a Gemini C18 150 mm × 4.6 mm, 5 μm column (Phenomenex, Torrance, CA). All final compounds either met combustion analysis within ±0.4% or were >95% pure by HPLC by one of the methods above.</div><div id="sec4_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i7" class="anchor-spacer"></div><h3 class="article-section__title" id="_i7"> 6-Benzyl-1-(tetrahydro-2<i>H</i>-pyran-4-yl)-1<i>H</i>-pyrazole[3,4-<i>d</i>]pyrimidin-4(5<i>H</i>)-one (<b>3</b>)</h3><div class="NLM_p last">To a solution of 5-amino-1-(tetrahydro-2<i>H</i>-pyran-4-yl)-1<i>H</i>-pyrazole-4-carboxamide <b>6</b> (100 mg, 0.476 mmol) in 4.8 mL of absolute ethanol was added ethyl 2-phenylacetate (352 mg, 2.14 mmol, 4.5 equiv) and then NaH (99 mg, 2.48 mmol, 5.2 equiv). The resulting heterogeneous mixture was heated in a microwave at 150 °C for 30 min. After cooling to ambient temperature, the resulting mixture was concentrated. The crude material was purified with a 0–10% NH<sub>4</sub>OH in methanol/ethyl acetate gradient to afford the desired material (130 mg, 88% yield) as a white solid. 400 MHz <sup>1</sup>H NMR (CDCl<sub>3</sub>) δ 11.32 (s, 1H), 8.10 (s, 1H), 7.46–7.29 (m, 5H), 4.92 (m, 1H), 4.19 (dd, <i>J</i> = 11.5, 3.8 Hz, 2H), 4.11 (s, 2H), 3.67 (t, <i>J</i> = 11.4 Hz, 2H), 2.49–2.38 (m, 2H), 2.00–1.96 (m, 2H). MS: M<sup>+</sup>H <i>m</i>/<i>z</i> = 311.3.</div></div><div id="sec4_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i8" class="anchor-spacer"></div><h3 class="article-section__title" id="_i8"> 1-(Tetrahydro-2<i>H</i>-pyran-4-yl)hydrazine (<b>4</b>)</h3><div class="NLM_p last">To a solution of tetrahydropyran-4-one (71.6 g, 715 mmol) in methanol (2 L) was added <i>tert</i>-butylcarbazate (100 g, 758 mmol) at ambient temperature. The mixture was stirred at ambient temperature for 20 h. The reaction mixture was concentrated under reduced pressure to dryness to afford a white solid (154 g). To a suspension of the white solid (154 g, 715 mmol) in water (1 L) was added acetic acid (500 mL, 8.73 mol), and the mixture was stirred for 30 min to get a clear solution. To this solution, solid NaCNBH<sub>3</sub> (44.5 g, 708 mmol) was added portionwise. The mixture was stirred at ambient temperature for 2 h. The mixture was then transferred to a 12 L flask, cooled to 0 °C, and quenched with 1 N NaOH (8.73 L, 8.73 mol). The mixture was extracted with CH<sub>2</sub>Cl<sub>2</sub> (3 × 3 L) and dried over Na<sub>2</sub>SO<sub>4</sub>. The organic layer was filtered and concentrated to afford a white solid (164 g, contains ∼15% of <i>N</i>-acetyl-<i>N</i>′-Boc-hydrazine derivative). Chromatography [silica, ethyl acetate/MeOH (95:5)] gave 94 g of 90% pure Boc-hydrazine. A solution of Boc-hydrazine (50 g, 231 mmol) in methanol (500 mL) was added to a solution of HCl in dioxane (462 mL, 1.85 mol, 4.0 M). The mixture was stirred at ambient temperature overnight. Concentration of the reaction mixture under reduced pressure afforded the title compound as a white solid (43 g, 98%). 400 MHz <sup>1</sup>H NMR (DMSO) δ 3.85–3.82 (m, 2H), 3.27–3.21 (m, 2H), 3.13–3.05 (m, 1H), 1.88–1.84 (m, 2H), 1.48–1.38 (m, 2H). MS: M + H <i>m</i>/<i>z</i> = 117.2.</div></div><div id="sec4_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i9" class="anchor-spacer"></div><h3 class="article-section__title" id="_i9"> 5-Amino-1-(tetrahydro-2<i>H</i>-pyran-4-yl)-1<i>H</i>-pyrazole-4-carbonitrile (<b>5</b>)</h3><div class="NLM_p last">To a mixture of 1-(tetrahydro-2<i>H</i>-pyran-4-yl)hydrazine dihydrogen chloride <b>4</b> (18 g, 96 mmol) in 200 mL of ethanol was added triethylamine (30 g, 40 mL, 288 mmol) at 0 °C (ice bath). The resulting mixture was stirred for 1 h. Then a solution of 2-(ethoxymethylene)malononitrile (12 g, 96 mmol) in 100 mL of ethanol was added slowly to keep the reaction temperature below 5 °C. This mixture was stirred at ambient temperature overnight and then heated to reflux for 2 h. After removal of the solvent under vacuum, the residue was washed with 300 mL of water. The solid was collected, washed with additional 200 mL of water and 200 mL of 1:1 of hexane and ether, and dried to give 17 g of yellow solid. 400 MHz <sup>1</sup>H NMR (CD<sub>3</sub>OD) δ 7.71 (s, 1H), 4.29–4.21 (m, 1H), 4.02 (dd, <i>J</i> = 11.6, 4.6 Hz, 2H), 3.28 (t, <i>J</i> = 1.7 Hz, 2H), 2.12–2.02 (m, 2H), 1.80–1.76 (m, 2H). MS: M<sup>+</sup>H <i>m</i>/<i>z</i> = 193.1.</div></div><div id="sec4_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i10" class="anchor-spacer"></div><h3 class="article-section__title" id="_i10"> 5-Amino-1-(tetrahydro-2<i>H</i>-pyran-4-yl)-1<i>H</i>-pyrazole-4-carboxamide (<b>6</b>)</h3><div class="NLM_p last">A stirred solution of 5-amino-1-(tetrahydro-2<i>H</i>-pyran-4-yl)-1<i>H</i>-pyrazole-4-carbonitrile <b>5</b> (228 mmol) in ethanol (300 mL) was treated with 35% aqueous H<sub>2</sub>O<sub>2</sub> (100 mL) followed by aqueous ammonia (300 mL). The reaction mixture was stirred for 48 h at ambient temperature and then quenched with saturated sodium thiosulfate (800 mL) and concentrated under reduced pressure to remove most of the ethanol. The resulting solid was removed by filtration and washed with water (2 × 200 mL) and ether (2 × 150 mL). The solid was dried in vacuo to constant weight (31 g, 65% yield for two steps). 400 MHz <sup>1</sup>H NMR (CD<sub>3</sub>OD) δ 7.67 (s, 1H), 4.27–4.21 (m, 1H), 4.03 (dd, <i>J</i> = 11.6, 4.6 Hz, 2H), 3.28 (t, <i>J</i> = 1.7 Hz, 2H), 2.14–2.04 (m, 2H), 1.81–1.78 (m, 2H). MS: M<sup>+</sup>H <i>m</i>/<i>z</i> = 211.2.</div></div><div id="sec4_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i11" class="anchor-spacer"></div><h3 class="article-section__title" id="_i11"> 6-[(3<i>S</i>,4<i>S</i>)-1-Benzyl-4-methylpyrrolidin-3-yl]-1-(tetrahydro-2<i>H</i>-pyran-4-yl)-1,5-dihydro-4<i>H</i>-pyrazolo[3,4-<i>d</i>]pyrimidin-4-one (<b>8</b>)</h3><div class="NLM_p last">To a mixture of 5-amino-1-(tetrahydro-2<i>H</i>-pyran-4-yl)-1<i>H</i>-pyrazole-4-carboxamide (5.0 g, 23.78 mmol) and (3,4-<i>trans</i>)-methyl 1-benzyl-4-methylpyrrolidine-3-carboxylate (11.7 g, 47.57 mmol) in tetrahydrofuran (0.1 M) were added molecular sieves (pellets). To the stirred mixture was added a 1.0 M solution of <i>t</i>-BuOK in THF (48.0 mL, 47.57 mmol), and the resulting mixture was heated at reflux under an atmosphere of nitrogen with vigorous stirring overnight. The reaction mixture was cooled to ambient temperature, and solids were removed by filtration. The solids were washed with EtOAc (2×), and the combined filtrates were concentrated under reduced pressure. The remainder was partitioned between CH<sub>2</sub>Cl<sub>2</sub> and H<sub>2</sub>O, and the aqueous and organic layers were separated. The aqueous phase was extracted with CH<sub>2</sub>Cl<sub>2</sub> (1×), and the combined organic extracts were dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated under reduced pressure. The crude material was purified by chromatography (silica gel, 1% Et<sub>3</sub>N in EtOAc) to produce (6.6 g, 68% yield) as a white solid. The enantiomers were separated utilizing chiral chromatography with Chiralcel OD-H, mobile phase 70/30 heptane/EtOH, <i>t</i><sub>R</sub> = 11.465 (more active enantiomer <b>3</b>), to provide the two enantiomers in >98% ee. 400 MHz <sup>1</sup>H NMR (CDCl<sub>3</sub>) δ 8.02 (s, 1H), 7.39–7.25 (m, 6H), 4.83–4.75 (m, 1H), 4.14–4.09 (m, 2H), 3.82 (m, 1H), 3.62–3.54 (m, 3H), 3.39–3.37 (m, 1H), 3.00 (m, 1H), 2.83 (m, 1H), 2.66–2.27 (m, 4H), 2.10–1.83 (m, 3H), 1.20 (d, <i>J</i> = 6.6 Hz, 3H). MS: M<sup>+</sup>H <i>m</i>/<i>z</i> = 394.2.</div></div><div id="sec4_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i12" class="anchor-spacer"></div><h3 class="article-section__title" id="_i12"> 6-[(3<i>R</i>,4<i>R</i>)-1-Benzyl-4-methylpyrrolidin-3-yl]-1-(tetrahydro-2<i>H</i>-pyran-4-yl)-1,5-dihydro-4<i>H</i>-pyrazolo[3,4-<i>d</i>]pyrimidin-4-one (<b>9</b>)</h3><div class="NLM_p last">400 MHz <sup>1</sup>H NMR (CDCl<sub>3</sub>) δ 8.02 (s, 1H), 7.39–7.25 (m, 6H), 4.82–4.76 (m, 1H), 4.14–4.09 (m, 2H), 3.82–3.79 (m, 1H), 3.62–3.54 (m, 3H), 3.37 (d, <i>J</i> = 8.7 Hz, 1H), 3.00 (d, <i>J</i> = 9.9 Hz, 1H), 2.79 (dd, <i>J</i> = 6.3, 2.5 Hz, 1H), 2.52–2.48 (m, 1H), 2.42–2.30 (m, 3H), 1.94–1.82 (m, 3H), 1.20 (d, <i>J</i> = 6.6 Hz, 3H). MS: M<sup>+</sup>H <i>m</i>/<i>z</i> = 394.2.</div></div><div id="sec4_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i13" class="anchor-spacer"></div><h3 class="article-section__title" id="_i13"> 6-[(3,4-<i>trans</i>)-1-Benzyl-4-ethylpyrrolidin-3-yl]-1-(tetrahydro-2<i>H</i>-pyran-4-yl)-1,5-dihydro-4<i>H</i>-pyrazolo[3,4-<i>d</i>]pyrimidin-4-one (<b>10</b>)</h3><div class="NLM_p last">Following the procedure for the preparation of 6-[(3<i>S</i>,4<i>S</i>)-1-benzyl-4-methylpyrrolidin-3-yl]-1-(tetrahydro-2<i>H</i>-pyran-4-yl)-15-dihydro-4<i>H</i>-pyrazolo[3,4-<i>d</i>]pyrimidin-4-one (<b>8</b>) but substituting <i>trans</i>-methyl 1-benzyl-4-ethylpyrolidine-3-carboxylate provided the title compound. Preparative conditions: Chiralcel OJ-H, mobile phase 80/20 CO<sub>2</sub>/MeOH, <i>t</i><sub>R</sub> = 3.27. Analytical: AD column, mobile phase 85/15 heptane/EtOH, <i>t</i><sub>R</sub> = 12.896. 400 MHz <sup>1</sup>H NMR (CDCl<sub>3</sub>) δ 8.02 (s, 1H), 7.40–7.26 (m, 5H), 4.78 (m, 1H), 4.12–4.09 (m, 2H), 3.82–3.804 (m, 1H), 3.65–3.54 (m, 3H), 3.35 (t, <i>J</i> = 8.3 Hz, 1H), 2.98 (d, <i>J</i> = 9.9 Hz, 1H), 2.89–2.86 (m, 1H), 2.48–2.32 (m, 3H), 2.20 (m, 1H), 1.95–1.87 (m, 2H), 1.63–1.58 (m, 2H), 1.50–1.49 (m, 1H), 0.93 (t, <i>J</i> = 7.1 Hz, 3H). MS: M + H <i>m</i>/<i>z</i> = 408.1.</div></div><div id="sec4_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i14" class="anchor-spacer"></div><h3 class="article-section__title" id="_i14"> 6-[(3<i>S</i>,4<i>S</i>)-4-Methylpyrrolidin-3-yl]-1-(tetrahydro-2<i>H</i>-pyran-4-yl)-1<i>H</i>-pyrazolo[3,4-<i>d</i>]pyrimidin-4(5<i>H</i>)-one (<b>11</b>)</h3><div class="NLM_p last">6-[(3<i>S</i>,4<i>S</i>)-1-Benzyl-4-methylpyrrolidin-3-yl]-1-(tetrahydro-2<i>H</i>-pyran-4-yl)-15-dihydro-4<i>H</i>-pyrazolo[3,4-<i>d</i>]pyrimidin-4-one (5.6 g) was dissolved in 100 mL of methanol, and the mixture was added to a Parr bottle. Palladium hydroxide (3.76 g) was added along with 3.56 mL of concentrated hydrochloric acid. The reaction mixture was placed on a hydrogenator under 40 psi of H<sub>2</sub> for 18 h. The reaction mixture was filtered through Celite and concentrated to provide 4.47 g of the title compound as the hydrogen chloride salt. 400 MHz <sup>1</sup>H NMR (CD<sub>3</sub>OD) δ 8.03 (s, 1H), 4.49 (m, 1H), 4.09–4.06 (m, 2H), 3.74–3.57 (m, 4H), 3.24 (m, 1H), 3.05 (m, 1H), 2.89 (m, 1H), 2.77 (m, 1H), 2.30 (m, 2H), 1.90 (m, 2H), 1.22 (d, <i>J</i> = 6.6 Hz, 3H). MS: M<sup>+</sup>H <i>m</i>/<i>z</i> = 304.2.</div></div><div id="sec4_9" class="NLM_sec NLM_sec_level_2"><div id="ac_i15" class="anchor-spacer"></div><h3 class="article-section__title" id="_i15"> 6-[(3<i>S</i>,4<i>S</i>)-1-(2-Fluorobenzyl)-4-methylpyrrolidin-3-yl]-1-(tetrahydro-2<i>H</i>-pyran-4-yl)-1,5-dihydro-4<i>H</i>-pyrazolo[3,4-<i>d</i>]pyrimidin-4-one (<b>12</b>)</h3><div class="NLM_p last">Following the procedure for the preparation of 6-{(3<i>S</i>,4<i>S</i>)-4-methyl-1-[(2-methylpyrimidin-5-yl)methyl]pyrrolidin-3-yl}-1-(tetrahydro-2<i>H</i>-pyran-4-yl)-15-dihydro-4<i>H</i>-pyrazolo[3,4-<i>d</i>]pyrimidin-4-one (<b>19</b>) but substituting 2-fluorobenzaldehyde provided the title compound. 400 MHz <sup>1</sup>H NMR (CD<sub>3</sub>OD) δ 7.98 (s, 1H), 7.47–7.42 (m, 1H), 7.33–7.26 (m, 2H), 7.18–7.07 (m, 1H), 4.08–4.04 (m, 2H), 3.85 (s, 2H), 3.69–3.56 (m, 3H), 3.20–2.93 (m, 4H), 2.69–2.62 (m, 1H), 2.40–2.19 (m, 3H), 1.88–1.85 (m, 2H), 1.14 (d, <i>J</i> = 6.6 Hz, 3H). MS: M + H <i>m</i>/<i>z</i> = 412.1.</div></div><div id="sec4_10" class="NLM_sec NLM_sec_level_2"><div id="ac_i16" class="anchor-spacer"></div><h3 class="article-section__title" id="_i16"> 6-[(3<i>S</i>,4<i>S</i>)-1-(3-Fluorobenzyl)-4-methylpyrrolidin-3-yl]-1-(tetrahydro-2<i>H</i>-pyran-4-yl)-1,5-dihydro-4<i>H</i>-pyrazolo[3,4-<i>d</i>]pyrimidin-4-one (<b>13</b>)</h3><div class="NLM_p last">Following the procedure for the preparation of 6-{(3<i>S</i>,4<i>S</i>)-4-methyl-1-[(2-methylpyrimidin-5-yl)methyl]pyrrolidin-3-yl}-1-(tetrahydro-2<i>H</i>-pyran-4-yl)-15-dihydro-4<i>H</i>-pyrazolo[3,4-<i>d</i>]pyrimidin-4-one (<b>19</b>) but substituting 3-fluorobenzaldehyde provided the title compound. 400 MHz <sup>1</sup>H NMR (CDCl<sub>3</sub>) δ 8.02 (s, 1H), 7.35–7.30 (m, 1H), 7.21–7.20 (m, 1H), 7.05 (d, <i>J</i> = 9.5 Hz, 1H), 6.98–6.93 (m, 1H), 4.83–4.77 (m, 1H), 4.14–4.08 (m, 2H), 3.80–3.77 (m, 1H), 3.64–3.54 (m, 3H), 3.36 (t, <i>J</i> = 8.8 Hz, 1H), 3.01 (d, <i>J</i> = 9.9 Hz, 1H), 2.84–2.83 (m, 1H), 2.57 (m, 1H), 2.44–2.27 (m, 3H), 1.95–1.83 (m, 3H), 1.20 (d, <i>J</i> = 7.1 Hz, 3H). MS: M + H <i>m</i>/<i>z</i> = 412.4.</div></div><div id="sec4_11" class="NLM_sec NLM_sec_level_2"><div id="ac_i17" class="anchor-spacer"></div><h3 class="article-section__title" id="_i17"> 6-[(3<i>S</i>,4<i>S</i>)-1-(4-Fluorobenzyl)-4-methylpyrrolidin-3-yl]-1-(tetrahydro-2<i>H</i>-pyran-4-yl)-1,5-dihydro-4<i>H</i>-pyrazolo[3,4-<i>d</i>]pyrimidin-4-one (<b>14</b>)</h3><div class="NLM_p last">Following the procedure for the preparation of 6-{(3<i>S</i>,4<i>S</i>)-4-methyl-1-[(2-methylpyrimidin-5-yl)methyl]pyrrolidin-3-yl}-1-(tetrahydro-2<i>H</i>-pyran-4-yl)-15-dihydro-4<i>H</i>-pyrazolo[3,4-<i>d</i>]pyrimidin-4-one <b>19</b> but substituting 4-fluorobenzaldehyde provided the title compound. 400 MHz <sup>1</sup>H NMR (CDCl<sub>3</sub>) δ 8.02 (s, 1H), 7.36–7.33 (m, 2H), 7.05–7.01 (m, 2H), 4.82–4.77 (m, 1H), 4.14–4.09 (m, 2H), 3.79–3.76 (m, 1H), 3.62–3.54 (m, 3H), 3.34 (t, <i>J</i> = 8.3 Hz, 1H), 2.99 (d, <i>J</i> = 9.9 Hz, 1H), 2.85–2.83 (m, 1H), 2.60–2.55 (m, 1H), 2.45–2.30 (m, 3H), 1.99–1.82 (m, 3H), 1.20 (d, <i>J</i> = 7.1 Hz, 3H). MS: M + H <i>m</i>/<i>z</i> = 412.1.</div></div><div id="sec4_12" class="NLM_sec NLM_sec_level_2"><div id="ac_i18" class="anchor-spacer"></div><h3 class="article-section__title" id="_i18"> 6-[(3<i>S</i>,4<i>S</i>)-1-(4-Methoxybenzyl)-4-methylpyrrolidin-3-yl]-1-(tetrahydro-2<i>H</i>-pyran-4-yl)-1,5-dihydro-4<i>H</i>-pyrazolo[3,4-<i>d</i>]pyrimidin-4-one (<b>15</b>)</h3><div class="NLM_p last">Following the procedure for the preparation of 6-{(3<i>S</i>,4<i>S</i>)-4-methyl-1-[(2-methylpyrimidin-5-yl)methyl]pyrrolidin-3-yl}-1-(tetrahydro-2<i>H</i>-pyran-4-yl)-15-dihydro-4<i>H</i>-pyrazolo[3,4-<i>d</i>]pyrimidin-4-one <b>19</b> but substituting 4-methoxybenzaldehyde provided the title compound. 400 MHz <sup>1</sup>H NMR (CDCl<sub>3</sub>) δ 8.01 (s, 1H), 7.29 (d, <i>J</i> = 8.3 Hz, 2H), 6.87 (d, <i>J</i> = 8.7 Hz, 2H), 4.82–4.08 (m, 1H), 4.13–4.08 (m, 2H), 3.84–3.75 (m, 4H), 3.61–3.51 (m, 3H), 3.35 (t, <i>J</i> = 8.7 Hz, 1H), 2.97 (d, <i>J</i> = 9.9 Hz, 1H), 2.82–2.80 (m, 1H), 2.53–2.49 (m, 1H), 2.42–2.30 (m, 3H), 1.95–1.82 (m, 3H), 1.18 (d, <i>J</i> = 7.1 Hz, 3H). MS: M + H <i>m</i>/<i>z</i> = 424.5.</div></div><div id="sec4_13" class="NLM_sec NLM_sec_level_2"><div id="ac_i19" class="anchor-spacer"></div><h3 class="article-section__title" id="_i19"> 6-{(3<i>S</i>,4<i>S</i>)-4-Methyl-1-[(6-methylpyridin-3-yl)methyl]pyrrolidin-3-yl}-1-(tetrahydro-2<i>H</i>-pyran-4-yl)-1,5-dihydro-4<i>H</i>-pyrazolo[3,4-<i>d</i>]pyrimidin-4-one (<b>16</b>)</h3><div class="NLM_p last">Following the procedure for the preparation of 6-{(3<i>S</i>,4<i>S</i>)-4-methyl-1-[(2-methylpyrimidin-5-yl)methyl]pyrrolidin-3-yl}-1-(tetrahydro-2<i>H</i>-pyran-4-yl)-15-dihydro-4<i>H</i>-pyrazolo[3,4-<i>d</i>]pyrimidin-4-one <b>19</b> but substituting 6-methylnicotinaldehyde provided the title compound. 400 MHz <sup>1</sup>H NMR (CD<sub>3</sub>OD) δ 8.38 (d, <i>J</i> = 2.1 Hz, 1H), 7.99 (s, 1H), 7.77 (d, <i>J</i> = 2.07 Hz, 1H), 7.75 (d, <i>J</i> = 2.07 Hz, 1H), 4.94–4.83 (m, 1H), 4.09–4.05 (m, 2H), 3.78–3.57 (m, 4H), 3.31–3.28 (m, 1H), 3.11–3.06 (m, 1H), 3.01–2.91 (m, 2H), 2.72–2.65 (m, 1H), 2.50 (s, 3H), 2.33–2.23 (m, 3H), 1.90–1.86 (m, 2H), 1.14 (d, <i>J</i> = 7.1 Hz, 3H). MS: M + H <i>m</i>/<i>z</i> = 409.2.</div></div><div id="sec4_14" class="NLM_sec NLM_sec_level_2"><div id="ac_i20" class="anchor-spacer"></div><h3 class="article-section__title" id="_i20"> 6-{(3<i>S</i>,4<i>S</i>)-4-Methyl-1-[(6-methylpyridin-3-yl)methyl]pyrrolidin-3-yl}-1-(tetrahydro-2<i>H</i>-pyran-4-yl)-1,5-dihydro-4<i>H</i>-pyrazolo[3,4-<i>d</i>]pyrimidin-4-one (<b>17</b>)</h3><div class="NLM_p last">Following the procedure for the preparation of 6-{(3<i>S</i>,4<i>S</i>)-4-methyl-1-[(2-methylpyrimidin-5-yl)methyl]pyrrolidin-3-yl}-1-(tetrahydro-2<i>H</i>-pyran-4-yl)-15-dihydro-4<i>H</i>-pyrazolo[3,4-<i>d</i>]pyrimidin-4-one <b>19</b> but substituting 6-methylnicotinaldehyde provided the title compound. 400 MHz <sup>1</sup>H NMR (CD<sub>3</sub>OD) δ 8.38 (d, <i>J</i> = 2.1 Hz, 1H), 7.99 (s, 1H), 7.77 (d, <i>J</i> = 2.07 Hz, 1H), 7.75 (d, <i>J</i> = 2.07 Hz, 1H), 4.94–4.83 (m, 1H), 4.09–4.05 (m, 2H), 3.78–3.57 (m, 4H), 3.31–3.28 (m, 1H), 3.11–3.06 (m, 1H), 3.01–2.91 (m, 2H), 2.72–2.65 (m, 1H), 2.50 (s, 3H), 2.33–2.23 (m, 3H), 1.90–1.86 (m, 2H), 1.14 (d, <i>J</i> = 7.1 Hz, 3H). MS: M + H <i>m</i>/<i>z</i> = 409.2.</div></div><div id="sec4_15" class="NLM_sec NLM_sec_level_2"><div id="ac_i21" class="anchor-spacer"></div><h3 class="article-section__title" id="_i21"> 6-{(3<i>S</i>,4<i>S</i>)-4-Methyl-1-[(5-methylpyrazin-2-yl)methyl]pyrrolidin-3-yl}-1-(tetrahydro-2<i>H</i>-pyran-4-yl)-1,5-dihydro-4<i>H</i>-pyrazolo[3,4-<i>d</i>]pyrimidin-4-one (<b>18</b>)</h3><div class="NLM_p last">Following the procedure for the preparation of 6-{(3<i>S</i>,4<i>S</i>)-4-methyl-1-[(2-methylpyrimidin-5-yl)methyl]pyrrolidin-3-yl}-1-(tetrahydro-2<i>H</i>-pyran-4-yl)-15-dihydro-4<i>H</i>-pyrazolo[3,4-<i>d</i>]pyrimidin-4-one <b>19</b> but substituting 5-methylpyrazine-2-carbaldehyde provided the title compound. 400 MHz <sup>1</sup>H NMR (CDCl<sub>3</sub>) δ 8.53 (s, 1H), 8.47 (s, 1H), 8.03 (s, 1H), 4.83–4.79 (m, 1H), 4.12–4.03 (m, 2H), 3.78–3.75 (m, 1H), 3.61–3.55 (m, 2H), 3.46–3.40 (m, 1H), 3.12–3.09 (m, 1H), 2.87 (m, 1H), 2.64 (m, 1H), 2.53 (m, 2H), 2.47–2.28 (m, 4H), 2.16 (m, 2H), 1.91–1.84 (m, 2H), 1.23–1.20 (m, 3H). MS: M + H <i>m</i>/<i>z</i> = 410.3.</div></div><div id="sec4_16" class="NLM_sec NLM_sec_level_2"><div id="ac_i22" class="anchor-spacer"></div><h3 class="article-section__title" id="_i22"> 6-{(3<i>S</i>,4<i>S</i>)-4-Methyl-1-[(2-methylpyrimidin-5-yl)methyl]pyrrolidin-3-yl}-1-(tetrahydro-2<i>H</i>-pyran-4-yl)-1,5-dihydro-4<i>H</i>-pyrazolo[3,4-<i>d</i>]pyrimidin-4-one (<b>19</b>)</h3><div class="NLM_p last">To a solution of 6-[(3<i>S</i>,4<i>S</i>)-4-methylpyrrolidin-3-yl]-1-(tetrahydro-2<i>H</i>-pyran-4-yl)-1<i>H</i>-pyrazolo[3,4-<i>d</i>]pyrimidin-4(5<i>H</i>)-one hydrogen chloride (493 mg) in 1,2-dichloroethane (10 mL) were added acetic acid (174 mg), 2-methylpyrimidine-5-carbaldehyde (236 mg), and sodium triacetoxyborohydride (635 mg). The reaction mixture was heated at 50 °C overnight. The reaction mixture was concentrated onto silica gel and purified by CombiFlash chromatography to provide the title compound (146 mg). 400 MHz <sup>1</sup>H NMR (CDCl<sub>3</sub>) δ 8.63 (s, 2H), 8.01 (s, 1H), 4.82–4.76 (m, 1H), 4.12–4.08 (m, 2H), 3.68 (d, <i>J</i> = 5.0 Hz, 3H), 3.64–3.54 (m, 2H), 3.28 (t, <i>J</i> = 8.3 Hz, 1H), 3.04 (d, <i>J</i> = 9.9 Hz, 1H), 2.89–2.86 (m, 1H), 2.71 (s, 3H), 2.66–2.62 (m, 1H), 2.49–2.27 (m, 3H), 1.97 (t, <i>J</i> = 7.9 Hz, 1H), 1.91–1.83 (m, 2H), 1.19 (d, <i>J</i> = 7.05 Hz, 3H). MS: M + H <i>m</i>/<i>z</i> = 410.2.</div></div><div id="sec4_17" class="NLM_sec NLM_sec_level_2"><div id="ac_i23" class="anchor-spacer"></div><h3 class="article-section__title" id="_i23"> 6-[(3<i>S</i>,4<i>S</i>)-4-Methyl-1-(pyrimidin-2-ylmethyl)pyrrolidin-3-yl]-1-(tetrahydro-2<i>H</i>-pyran-4-yl)-1,5-dihydro-4<i>H</i>-pyrazolo[3,4-<i>d</i>]pyrimidin-4-one (<b>20</b>)</h3><div class="NLM_p last">To a solution of 6-[(3<i>S</i>,4<i>S</i>)-4-methylpyrrolidin-3-yl]-1-(tetrahydro-2<i>H</i>-pyran-4-yl)-1<i>H</i>-pyrazolo[3,4-<i>d</i>]pyrimidin-4(5<i>H</i>)-one hydrogen chloride (7.75 g) in dimethylformamide (115 mL) were added iron triflate (900 mg), 2-(chloromethyl)pyrimidine hydrogen chloride (4.5 g), and cesium carbonate (22.2 g), and the reaction mixture was heated at 60 °C for 24 h. The reaction mixture was concentrated onto silica gel and purified by flash chromatography, eluting with 0–15% methanol/ethyl acetate/1% saturated ammonium hydroxide to provide the title compound (6 g). 400 MHz <sup>1</sup>H NMR (CDCl<sub>3</sub>) δ 12.30 (s, 1H), 8.63 (d, <i>J</i> = 5.0, Hz, 2H), 8.03 (s, 1H), 7.20 (d, <i>J</i> = 5.0, Hz, 1H), 4.84–4.79 (m, 1H), 4.30–4.27 (m, 1H), 4.14–4.08 (m, 2H), 3.87–3.82 (m, 1H), 3.63–3.55 (m, 2H), 3.47 (t, <i>J</i> = 7.9 Hz, 1H), 3.29 (d, <i>J</i> = 9.9 Hz, 1H), 2.88–2.86 (m, 1H), 2.60–2.56 (m, 1H), 2.46–2.24 (m, 4H), 1.93–1.84 (m, 2H), 1.24 (t, <i>J</i> = 7.1 Hz, 3H). MS: M + H <i>m</i>/<i>z</i> = 396.2. Anal. Calcd for C<sub>20</sub>H<sub>25</sub>N<sub>7</sub>O<sub>2</sub>: C, 60.74%; H, 6.37%; N, 24.79%. Found: C, 60.56%; H, 6.43%; N, 24.61%.</div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i24"><a href="/doi/suppl/10.1021/jm3007799">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_16831" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_16831" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">Experimental procedures for the enzyme assays and pharmacokinetic experiments. This material is available free of charge via the Internet at <a href="http://pubs.acs.org" class="extLink">http://pubs.acs.org</a>.</p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/jm3007799/suppl_file/jm3007799_si_001.pdf">jm3007799_si_001.pdf (174.01 kb)</a></li></ul></div></div></div><div class="testing" data-doi="10.1021/jm3007799" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_85767" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_85767" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Author</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Patrick R. Verhoest</span> - <span class="hlFld-Affiliation affiliation">Neuroscience
Medicinal Chemistry, Pfizer
World Wide Research and Development, 700 Main Street,
Cambridge, Massachusetts 02139, United States</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#a7d7c6d3d5cec4cc89d589d1c2d5cfc8c2d4d3e7d7c1ceddc2d589c4c8ca"><span class="__cf_email__" data-cfemail="3b4b5a4f495258501549154d5e4953545e484f7b4b5d52415e4915585456">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Kari R. Fonseca</span> - <span class="hlFld-Affiliation affiliation">Neuroscience
Medicinal Chemistry, Pfizer
World Wide Research and Development, 700 Main Street,
Cambridge, Massachusetts 02139, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Xinjun Hou</span> - <span class="hlFld-Affiliation affiliation">Neuroscience
Medicinal Chemistry, Pfizer
World Wide Research and Development, 700 Main Street,
Cambridge, Massachusetts 02139, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Caroline Proulx-LaFrance</span> - <span class="hlFld-Affiliation affiliation">Neuroscience
Medicinal Chemistry, Pfizer
World Wide Research and Development, 700 Main Street,
Cambridge, Massachusetts 02139, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Michael Corman</span> - <span class="hlFld-Affiliation affiliation">Neuroscience
Medicinal Chemistry, Pfizer
World Wide Research and Development, 700 Main Street,
Cambridge, Massachusetts 02139, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Christopher J. Helal</span> - <span class="hlFld-Affiliation affiliation">Neuroscience
Medicinal Chemistry, Pfizer
World Wide Research and Development, 700 Main Street,
Cambridge, Massachusetts 02139, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Michelle M. Claffey</span> - <span class="hlFld-Affiliation affiliation">Neuroscience
Medicinal Chemistry, Pfizer
World Wide Research and Development, 700 Main Street,
Cambridge, Massachusetts 02139, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jamison B. Tuttle</span> - <span class="hlFld-Affiliation affiliation">Neuroscience
Medicinal Chemistry, Pfizer
World Wide Research and Development, 700 Main Street,
Cambridge, Massachusetts 02139, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Karen J. Coffman</span> - <span class="hlFld-Affiliation affiliation">Neuroscience
Medicinal Chemistry, Pfizer
World Wide Research and Development, 700 Main Street,
Cambridge, Massachusetts 02139, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Shenpinq Liu</span> - <span class="hlFld-Affiliation affiliation">Neuroscience
Medicinal Chemistry, Pfizer
World Wide Research and Development, 700 Main Street,
Cambridge, Massachusetts 02139, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Frederick Nelson</span> - <span class="hlFld-Affiliation affiliation">Neuroscience
Medicinal Chemistry, Pfizer
World Wide Research and Development, 700 Main Street,
Cambridge, Massachusetts 02139, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Robin J. Kleiman</span> - <span class="hlFld-Affiliation affiliation">Neuroscience
Medicinal Chemistry, Pfizer
World Wide Research and Development, 700 Main Street,
Cambridge, Massachusetts 02139, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Frank S. Menniti</span> - <span class="hlFld-Affiliation affiliation">Neuroscience
Medicinal Chemistry, Pfizer
World Wide Research and Development, 700 Main Street,
Cambridge, Massachusetts 02139, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Christopher J. Schmidt</span> - <span class="hlFld-Affiliation affiliation">Neuroscience
Medicinal Chemistry, Pfizer
World Wide Research and Development, 700 Main Street,
Cambridge, Massachusetts 02139, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Michelle Vanase-Frawley</span> - <span class="hlFld-Affiliation affiliation">Neuroscience
Medicinal Chemistry, Pfizer
World Wide Research and Development, 700 Main Street,
Cambridge, Massachusetts 02139, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Spiros Liras</span> - <span class="hlFld-Affiliation affiliation">Neuroscience
Medicinal Chemistry, Pfizer
World Wide Research and Development, 700 Main Street,
Cambridge, Massachusetts 02139, United States</span></div></li></ul></li><li></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare no competing financial interest.<br /></br></div></li></ul></div><div id="" class="NLM_sec NLM_sec_level_1"><div id="ac_i25" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i25"> </h2><div class="NLM_p last"><table summary="" class="NLM_def-list" id="dl1"><div id="ac_i26" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i26"> Abbreviations Used</h2><tr><td class="NLM_term">PDE</td><td class="NLM_def"><p class="first last">phosphodiesterase</p></td></tr><tr><td class="NLM_term">cGMP</td><td class="NLM_def"><p class="first last">cyclic guanosine monophosphate</p></td></tr><tr><td class="NLM_term">CNS</td><td class="NLM_def"><p class="first last">central nervous system</p></td></tr><tr><td class="NLM_term">SBDD</td><td class="NLM_def"><p class="first last">structure-based drug design</p></td></tr><tr><td class="NLM_term">P-gp</td><td class="NLM_def"><p class="first last">P-glycoprotein</p></td></tr><tr><td class="NLM_term">LipE</td><td class="NLM_def"><p class="first last">lipophilic ligand efficiency</p></td></tr><tr><td class="NLM_term">LE</td><td class="NLM_def"><p class="first last">ligand efficiency</p></td></tr><tr><td class="NLM_term">CSF</td><td class="NLM_def"><p class="first last">cerebral spinal fluid</p></td></tr><tr><td class="NLM_term">LTP</td><td class="NLM_def"><p class="first last">long-term potentiation</p></td></tr></table></div></div><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i27">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_88550" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_88550" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 30 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group">Schmidt, C. J.</span><span> </span><span class="NLM_article-title">Phosphodiesterase Inhibitors as Potential Cognition Enhancing Agents</span> <span class="citation_source-journal">Curr. Top. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">222</span><span class="NLM_x">–</span> <span class="NLM_lpage">230</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Fjm3007799&amp;key=10.2174%2F156802610790411009" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Fjm3007799&amp;key=20166957" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Fjm3007799&amp;key=1%3ACAS%3A528%3ADC%252BC3cXjtFajsrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2010&pages=222-230&author=C.+J.+Schmidt&title=Phosphodiesterase+Inhibitors+as+Potential+Cognition+Enhancing+Agents"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Phosphodiesterase inhibitors as potential cognition enhancing agents</span></div><div class="casAuthors">Schmidt, Christopher J.</div><div class="citationInfo"><span class="NLM_cas:title">Current Topics in Medicinal Chemistry (Sharjah, United Arab Emirates)</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">222-230</span>CODEN:
                <span class="NLM_cas:coden">CTMCCL</span>;
        ISSN:<span class="NLM_cas:issn">1568-0266</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  As might be predicted for an organ designed for cell to cell communication, cyclic nucleotide signaling in the brain is highly organized and regulated.  Augmentation of cyclic nucleotide signaling by means of phosphodiesterase inhibition appears to be a viable and tractable means of enhancing neuronal communication.  Of the various CNS disorders that have been considered as target indications for phosphodiesterase inhibitors, no condition has received more attention than cognitive dysfunction.  This review provides a background for understanding the expanding literature in this field as well as a brief update on the rationale driving the search for selective inhibitors of targets such as PDE1B, PDE2, PDE5 and PDE9.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqBVYtnViej97Vg90H21EOLACvtfcHk0lhqf5aghWVStw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXjtFajsrY%253D&md5=47e8397d9f69207c27940575411bbe12</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.2174%2F156802610790411009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F156802610790411009%26sid%3Dliteratum%253Aachs%26aulast%3DSchmidt%26aufirst%3DC.%2BJ.%26atitle%3DPhosphodiesterase%2520Inhibitors%2520as%2520Potential%2520Cognition%2520Enhancing%2520Agents%26jtitle%3DCurr.%2520Top.%2520Med.%2520Chem.%26date%3D2010%26volume%3D10%26spage%3D222%26epage%3D230" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group">Beavo, J. A.</span><span> </span><span class="NLM_article-title">Cyclic Nucleotide Phosphodiesterases: Functional Implications of Multiple Isoforms</span> <span class="citation_source-journal">Phys. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">75</span><span class="NLM_x">, </span> <span class="NLM_fpage">725</span><span class="NLM_x">–</span> <span class="NLM_lpage">748</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=75&publication_year=1995&pages=725-748&author=J.+A.+Beavo&title=Cyclic+Nucleotide+Phosphodiesterases%3A+Functional+Implications+of+Multiple+Isoforms"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBeavo%26aufirst%3DJ.%2BA.%26atitle%3DCyclic%2520Nucleotide%2520Phosphodiesterases%253A%2520Functional%2520Implications%2520of%2520Multiple%2520Isoforms%26jtitle%3DPhys.%2520Rev.%26date%3D1995%26volume%3D75%26spage%3D725%26epage%3D748" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group">Setter, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iltz, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fincham, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Campbell, R. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baker, D. E.</span><span> </span><span class="NLM_article-title">Phosphodiesterase 5 Inhibitors for Erectile Dysfunction</span> <span class="citation_source-journal">Ann. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">39</span><span class="NLM_x">, </span> <span class="NLM_fpage">1286</span><span class="NLM_x">–</span> <span class="NLM_lpage">1295</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Fjm3007799&amp;key=10.1345%2Faph.1E487" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Fjm3007799&amp;key=1%3ACAS%3A528%3ADC%252BD2MXms12gsrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=39&publication_year=2005&pages=1286-1295&author=S.+M.+Setterauthor=J.+L.+Iltzauthor=J.+E.+Finchamauthor=R.+K.+Campbellauthor=D.+E.+Baker&title=Phosphodiesterase+5+Inhibitors+for+Erectile+Dysfunction"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Phosphodiesterase 5 inhibitors for erectile dysfunction</span></div><div class="casAuthors">Setter, Stephen M.; Iltz, Jason L.; Fincham, Jack E.; Campbell, R. Keith; Baker, Danial E.</div><div class="citationInfo"><span class="NLM_cas:title">Annals of Pharmacotherapy</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">39</span>
        (<span class="NLM_cas:issue">7/8</span>),
    <span class="NLM_cas:pages">1286-1295</span>CODEN:
                <span class="NLM_cas:coden">APHRER</span>;
        ISSN:<span class="NLM_cas:issn">1060-0280</span>.
    
            (<span class="NLM_cas:orgname">Harvey Whitney Books Co.</span>)
        </div><div class="casAbstract">Objective: To review the pharmacol. and clin. trial data of the Food and Drug Administration-approved phosphodiesterase 5 (PDE5) inhibitors for the treatment of erectile dysfunction (ED).  Data Sources: Primary research and review articles were identified through a search of ScienceDirect, PubMed/MEDLINE, and International Pharmaceutical Abstrs. (1990-August 2004).  The following search terms were used in the Medicine Dentistry and Pharmacol., Toxicol., and Pharmaceutical Sciences subcategories: phosphodiesterase 5 inhibitor, PDE5 inhibitor, erectile dysfunction, sildenafil, vardenafil, tadalafil, prostatectomy, and diabetes.  Web of Science (1990-August 2004) was used to search for addnl. abstrs. using the same search terms as above.  The package inserts for sildenafil, vardenafil, and tadalafil were also consulted.  Study Selection And Data Extn.: All identified research, review articles, and abstrs. were assessed for relevance, and all relevant information was included.  Priority was given to the primary medical literature and clin. trial reports.  Data Synthesis: ED is a common disorder in males with increased prevalence assocd. with age and presence of cardiovascular disease, prostatectomy, or diabetes mellitus.  Sildenafil, vardenafil, and tadalafil are selective PDE5 inhibitors currently available for treatment of ED.  Their pharmacol. and pharmacokinetics vary slightly, but with potentially important clin. differences in duration of activity; all have similar clin. efficacy and adverse effect profiles in patients with ED of various causes.  Conclusions: Sildenafil, vardenafil, and tadalafil are safe and effective PDE5 inhibitors for the treatment of ED.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqYGVq6PfMu3LVg90H21EOLACvtfcHk0lgOdCP4yNWgKg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXms12gsrk%253D&md5=ba8f6a681eee4e96832e4e98df7be0c3</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1345%2Faph.1E487&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1345%252Faph.1E487%26sid%3Dliteratum%253Aachs%26aulast%3DSetter%26aufirst%3DS.%2BM.%26aulast%3DIltz%26aufirst%3DJ.%2BL.%26aulast%3DFincham%26aufirst%3DJ.%2BE.%26aulast%3DCampbell%26aufirst%3DR.%2BK.%26aulast%3DBaker%26aufirst%3DD.%2BE.%26atitle%3DPhosphodiesterase%25205%2520Inhibitors%2520for%2520Erectile%2520Dysfunction%26jtitle%3DAnn.%2520Pharmacol.%26date%3D2005%26volume%3D39%26spage%3D1286%26epage%3D1295" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group">Zewail, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Newar, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vrtovec, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eastwood, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Biswajit, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Delgado, R. M.</span><span> </span><span class="NLM_article-title">Intravenous Milrinone in Treatment of Advanced Congestive Heart Failure</span> <span class="citation_source-journal">Tex. Heart Inst. J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">30</span><span class="NLM_x">, </span> <span class="NLM_fpage">109</span><span class="NLM_x">–</span> <span class="NLM_lpage">113</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Fjm3007799&amp;key=12809251" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Fjm3007799&amp;key=1%3ACAS%3A280%3ADC%252BD3s3otFyjtA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=2003&pages=109-113&author=A.+M.+Zewailauthor=M.+Newarauthor=B.+Vrtovecauthor=C.+Eastwoodauthor=K.+Biswajitauthor=R.+M.+Delgado&title=Intravenous+Milrinone+in+Treatment+of+Advanced+Congestive+Heart+Failure"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Intravenous milrinone in treatment of advanced congestive heart failure</span></div><div class="casAuthors">Zewail Aly M; Nawar Mohammad; Vrtovec Bojan; Eastwood Cathy; Kar M N Biswajit; Delgado Reynolds M 3rd</div><div class="citationInfo"><span class="NLM_cas:title">Texas Heart Institute journal / from the Texas Heart Institute of St. Luke's Episcopal Hospital, Texas Children's Hospital</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">30</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">109-13</span>
        ISSN:<span class="NLM_cas:issn">0730-2347</span>.
    </div><div class="casAbstract">Phosphodiesterase inhibitors such as milrinone can relieve symptoms and improve hemodynamics in patients with advanced congestive heart failure.  We retrospectively evaluated the hemodynamic and clinical outcomes of long-term combination therapy with intravenous milrinone and oral beta-blockers in 65 patients with severe congestive heart failure (New York Heart Association class IV function and ejection fraction <25%) refractory to oral medical therapy.  Fifty-one patients successfully began beta-blocker therapy while on intravenous milrinone.  Oral medical therapy was maximized when possible.  The mean duration of milrinone treatment in this combination-treatment group was 269 days (range, 14-1,026 days).  Functional class improved from IV to II-III with milrinone therapy.  Twenty-four such patients tolerated beta-blocker up-titration and were successfully weaned from milrinone.  Sixteen patients (31%) died while receiving combination therapy; one died of sudden cardiac death (on treatment day 116); the other 15 died of progressive heart failure or other complications.  Hospital admissions during the previous 6 months and admissions within 6 months after milrinone initiation stayed the same.  Meanwhile, the total number of hospital days decreased from 450 to 380 (a 15.6% reduction), and the mean length of stay decreased by 1.4 days (a 14.7% reduction).  We conclude that 1) milrinone plus beta-blocker combination therapy is an effective treatment for heart failure even with beta-blocker up-titration, 2) weaning from milrinone may be possible once medications are maximized, 3) patients' functional status improves on the combination regimen, and 4) treatment-related sudden death is relatively infrequent during the combination regimen.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSlTNY8KKijnO98rul4nhSdfW6udTcc2eZOOoEc8V7zArntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD3s3otFyjtA%253D%253D&md5=a5cdc3c0d36b4b3d13baecf7ac0b7a62</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DZewail%26aufirst%3DA.%2BM.%26aulast%3DNewar%26aufirst%3DM.%26aulast%3DVrtovec%26aufirst%3DB.%26aulast%3DEastwood%26aufirst%3DC.%26aulast%3DBiswajit%26aufirst%3DK.%26aulast%3DDelgado%26aufirst%3DR.%2BM.%26atitle%3DIntravenous%2520Milrinone%2520in%2520Treatment%2520of%2520Advanced%2520Congestive%2520Heart%2520Failure%26jtitle%3DTex.%2520Heart%2520Inst.%2520J.%26date%3D2003%26volume%3D30%26spage%3D109%26epage%3D113" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group">Boswell-Smith, V</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spina, D.</span><span> </span><span class="NLM_article-title">PDE4 Inhibitors as Potential Therapeutic Agents in the Treatment of COPD-Focus on Roflumilast</span> <span class="citation_source-journal">Int. J. Chronic Obstruct. Pulm. Dis.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">121</span><span class="NLM_x">–</span> <span class="NLM_lpage">129</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Fjm3007799&amp;key=18044684" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Fjm3007799&amp;key=1%3ACAS%3A528%3ADC%252BD2sXpsFKgu78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2007&pages=121-129&author=V+Boswell-Smithauthor=D.+Spina&title=PDE4+Inhibitors+as+Potential+Therapeutic+Agents+in+the+Treatment+of+COPD-Focus+on+Roflumilast"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">PDE4 inhibitors as potential therapeutic agents in the treatment of COPD-focus on roflumilast</span></div><div class="casAuthors">Boswell-Smith, Victoria; Spina, Domenico</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Chronic Obstructive Pulmonary Disease</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">121-129</span>CODEN:
                <span class="NLM_cas:coden">IJCOC3</span>;
        ISSN:<span class="NLM_cas:issn">1176-9106</span>.
    
            (<span class="NLM_cas:orgname">Dove Medical Press (NZ) Ltd.</span>)
        </div><div class="casAbstract">A review.  Chronic obstructive pulmonary disease is characterized by a rapid decline in lung function due to small airway fibrosis, mucus hypersecretion and emphysema.  The major causative factor for COPD is cigarette smoking that drives an inflammatory process that gives rise to leukocyte recruitment, imbalance in protease levels and consequently matrix remodeling resulting in small airway fibrosis and loss of alveolar tissue.  Current drug treatment improves symptoms but do not alter the underlying progression of this disease.  The failure of anti-inflammatory drugs like glucocorticosteroids to have a major impact in this disease has hastened the need to develop novel therapeutic strategies.  Phosphodiesterase (PDE)4 inhibitors are novel anti-inflammatory drugs that have recently been show to document clin. efficacy in this disease, although their utility is hampered by class related side-effects of nausea, emesis and diarrhea.  While it is not yet clear whether such drugs will prevent emphysema, this is a distinct possibility provided exptl. observations from preclin. studies translate to man.  This review will discuss the current standing of PDE4 inhibitors like roflumilast as novel treatments for COPD and the potential for developing nonemetic anti-inflammatory drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq2kjDBEjY5yrVg90H21EOLACvtfcHk0lhtXRoOWuOZKQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXpsFKgu78%253D&md5=98a80944248eb8649145a33d6229def0</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBoswell-Smith%26aufirst%3DV%26aulast%3DSpina%26aufirst%3DD.%26atitle%3DPDE4%2520Inhibitors%2520as%2520Potential%2520Therapeutic%2520Agents%2520in%2520the%2520Treatment%2520of%2520COPD-Focus%2520on%2520Roflumilast%26jtitle%3DInt.%2520J.%2520Chronic%2520Obstruct.%2520Pulm.%2520Dis.%26date%3D2007%26volume%3D2%26spage%3D121%26epage%3D129" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group">Cote, R. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feng, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Valeriani, B. A.</span><span> </span><span class="NLM_article-title">Relative Potency of Various Classes of Phosphodiesterase (PDE) Inhibitors for Rod and Cone Photoreceptor PDE6</span> <span class="citation_source-journal">Invest. Ophthalmol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">44</span><span class="NLM_x">, </span> <span class="NLM_fpage">1524</span><span class="NLM_x">–</span> <span class="NLM_lpage">1527</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=2003&pages=1524-1527&author=R.+H.+Coteauthor=Q.+Fengauthor=B.+A.+Valeriani&title=Relative+Potency+of+Various+Classes+of+Phosphodiesterase+%28PDE%29+Inhibitors+for+Rod+and+Cone+Photoreceptor+PDE6"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCote%26aufirst%3DR.%2BH.%26aulast%3DFeng%26aufirst%3DQ.%26aulast%3DValeriani%26aufirst%3DB.%2BA.%26atitle%3DRelative%2520Potency%2520of%2520Various%2520Classes%2520of%2520Phosphodiesterase%2520%2528PDE%2529%2520Inhibitors%2520for%2520Rod%2520and%2520Cone%2520Photoreceptor%2520PDE6%26jtitle%3DInvest.%2520Ophthalmol.%26date%3D2003%26volume%3D44%26spage%3D1524%26epage%3D1527" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group">Young, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ward, A.</span><span> </span><span class="NLM_article-title">Milrinone. A Preliminary Review of Its Pharmacological Properties and Therapeutic Use</span> <span class="citation_source-journal">Drugs</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1988</span><span class="NLM_x">, </span> <span class="NLM_volume">36</span><span class="NLM_x">, </span> <span class="NLM_fpage">158</span><span class="NLM_x">–</span> <span class="NLM_lpage">192</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=36&publication_year=1988&pages=158-192&author=R.+A.+Youngauthor=A.+Ward&title=Milrinone.+A+Preliminary+Review+of+Its+Pharmacological+Properties+and+Therapeutic+Use"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DYoung%26aufirst%3DR.%2BA.%26aulast%3DWard%26aufirst%3DA.%26atitle%3DMilrinone.%2520A%2520Preliminary%2520Review%2520of%2520Its%2520Pharmacological%2520Properties%2520and%2520Therapeutic%2520Use%26jtitle%3DDrugs%26date%3D1988%26volume%3D36%26spage%3D158%26epage%3D192" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group">Card, G. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">England, B. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suzuki, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fong, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Powell, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luu, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tabrizizad, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gillete, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ibrahim, P. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Artis, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bollag, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Milburn, M. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schlessinger, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zang, K. Y. J.</span><span> </span><span class="NLM_article-title">Structural Basis for the Activity of Drugs That Inhibit Phosphodiesterases</span> <span class="citation_source-journal">Structure</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">2233</span><span class="NLM_x">–</span> <span class="NLM_lpage">2247</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Fjm3007799&amp;key=10.1016%2Fj.str.2004.10.004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Fjm3007799&amp;key=15576036" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Fjm3007799&amp;key=1%3ACAS%3A528%3ADC%252BD2cXhtVClur3K" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2004&pages=2233-2247&author=G.+L.+Cardauthor=B.+P.+Englandauthor=Y.+Suzukiauthor=D.+Fongauthor=B.+Powellauthor=B.+Leeauthor=C.+Luuauthor=M.+Tabrizizadauthor=S.+Gilleteauthor=P.+N.+Ibrahimauthor=D.+R.+Artisauthor=G.+Bollagauthor=M.+V.+Milburnauthor=S.+Kimauthor=J.+Schlessingerauthor=K.+Y.+J.+Zang&title=Structural+Basis+for+the+Activity+of+Drugs+That+Inhibit+Phosphodiesterases"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Structural Basis for the Activity of Drugs that Inhibit Phosphodiesterases</span></div><div class="casAuthors">Card, Graeme L.; England, Bruce P.; Suzuki, Yoshihisa; Fong, Daniel; Powell, Ben; Lee, Byunghun; Luu, Catherine; Tabrizizad, Maryam; Gillette, Sam; Ibrahim, Prabha N.; Artis, Dean R.; Bollag, Gideon; Milburn, Michael V.; Kim, Sung-Hou; Schlessinger, Joseph; Zhang, Kam Y. J.</div><div class="citationInfo"><span class="NLM_cas:title">Structure (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">2233-2247</span>CODEN:
                <span class="NLM_cas:coden">STRUE6</span>;
        ISSN:<span class="NLM_cas:issn">0969-2126</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Phosphodiesterases (PDEs) comprise a large family of enzymes that catalyze the hydrolysis of cAMP or cGMP and are implicated in various diseases.  The authors describe the high-resoln. crystal structures of the catalytic domains of PDE4B, PDE4D, and PDE5A with ten different inhibitors, including the drug candidates cilomilast and roflumilast, for respiratory diseases.  These cocrystal structures reveal a common scheme of inhibitor binding to the PDEs: (i) a hydrophobic clamp formed by highly conserved hydrophobic residues that sandwich the inhibitor in the active site; (ii) hydrogen bonding to an invariant glutamine that controls the orientation of inhibitor binding.  A scaffold can be readily identified for any given inhibitor based on the formation of these two types of conserved interactions.  These structural insights will enable the design of isoform-selective inhibitors with improved binding affinity and should facilitate the discovery of more potent and selective PDE inhibitors for the treatment of a variety of diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr8l4KWCohSy7Vg90H21EOLACvtfcHk0lhzmOssAZUq9Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXhtVClur3K&md5=0fa91e4b9047e3df3946c526592be396</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1016%2Fj.str.2004.10.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.str.2004.10.004%26sid%3Dliteratum%253Aachs%26aulast%3DCard%26aufirst%3DG.%2BL.%26aulast%3DEngland%26aufirst%3DB.%2BP.%26aulast%3DSuzuki%26aufirst%3DY.%26aulast%3DFong%26aufirst%3DD.%26aulast%3DPowell%26aufirst%3DB.%26aulast%3DLee%26aufirst%3DB.%26aulast%3DLuu%26aufirst%3DC.%26aulast%3DTabrizizad%26aufirst%3DM.%26aulast%3DGillete%26aufirst%3DS.%26aulast%3DIbrahim%26aufirst%3DP.%2BN.%26aulast%3DArtis%26aufirst%3DD.%2BR.%26aulast%3DBollag%26aufirst%3DG.%26aulast%3DMilburn%26aufirst%3DM.%2BV.%26aulast%3DKim%26aufirst%3DS.%26aulast%3DSchlessinger%26aufirst%3DJ.%26aulast%3DZang%26aufirst%3DK.%2BY.%2BJ.%26atitle%3DStructural%2520Basis%2520for%2520the%2520Activity%2520of%2520Drugs%2520That%2520Inhibit%2520Phosphodiesterases%26jtitle%3DStructure%26date%3D2004%26volume%3D12%26spage%3D2233%26epage%3D2247" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group">Menniti, F. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Faraci, S. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schmidt, C. J.</span><span> </span><span class="NLM_article-title">Phosphodiesterases in the CNS: Targets for Drug Development</span> <span class="citation_source-journal">Nat. Rev. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">660</span><span class="NLM_x">–</span> <span class="NLM_lpage">670</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Fjm3007799&amp;key=10.1038%2Fnrd2058" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Fjm3007799&amp;key=16883304" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Fjm3007799&amp;key=1%3ACAS%3A528%3ADC%252BD28XnsFCkurg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2006&pages=660-670&author=F.+S.+Mennitiauthor=S.+W.+Faraciauthor=C.+J.+Schmidt&title=Phosphodiesterases+in+the+CNS%3A+Targets+for+Drug+Development"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Phosphodiesterases in the CNS: targets for drug development</span></div><div class="casAuthors">Menniti, Frank S.; Faraci, W. Stephen; Schmidt, Christopher J.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">660-670</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  The therapeutic and com. success of phosphodiesterase 5 inhibitors such as Viagra, Levitra and Cialis has sparked renewed interest in the phosphodiesterases as drug discovery targets.  Virtually all the phosphodiesterases are expressed in the CNS, making this gene family a particularly attractive source of new targets for the treatment of psychiatric and neurodegenerative disorders.  Significantly, all neurons express multiple phosphodiesterases, which differ in cyclic nucleotide specificity, affinity, regulatory control and subcellular compartmentalization.  Therefore, phosphodiesterase inhibition represents a mechanism through which it could be possible to precisely modulate neuronal activity.  In this article, we review the current state of the art in the burgeoning field of phosphodiesterase pharmacol. in the CNS.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpa2I3t5o1HibVg90H21EOLACvtfcHk0lhzmOssAZUq9Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XnsFCkurg%253D&md5=7c2b421b629efe9ee73999098322e811</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1038%2Fnrd2058&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd2058%26sid%3Dliteratum%253Aachs%26aulast%3DMenniti%26aufirst%3DF.%2BS.%26aulast%3DFaraci%26aufirst%3DS.%2BW.%26aulast%3DSchmidt%26aufirst%3DC.%2BJ.%26atitle%3DPhosphodiesterases%2520in%2520the%2520CNS%253A%2520Targets%2520for%2520Drug%2520Development%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2006%26volume%3D5%26spage%3D660%26epage%3D670" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group">Chappie, T. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Humphrey, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Allen, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Estep, K. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fox, C. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lebel, L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liras, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marr, E. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Menniti, F. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pandit, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schmidt, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tu, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, R. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, F. V.</span><span> </span><span class="NLM_article-title">Discovery of a Series of 6,7-Dimethoxy-4-pyrrolidylquinazoline PDE10A Inhibitors</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x">, </span> <span class="NLM_fpage">182</span><span class="NLM_x">–</span> <span class="NLM_lpage">185</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm060653b" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2007&pages=182-185&author=T.+A.+Chappieauthor=J.+M.+Humphreyauthor=M.+P.+Allenauthor=K.+G.+Estepauthor=C.+B.+Foxauthor=L.+A.+Lebelauthor=S.+Lirasauthor=E.+S.+Marrauthor=F.+S.+Mennitiauthor=J.+Panditauthor=C.+J.+Schmidtauthor=M.+Tuauthor=R.+D.+Williamsauthor=F.+V.+Yang&title=Discovery+of+a+Series+of+6%2C7-Dimethoxy-4-pyrrolidylquinazoline+PDE10A+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1021%2Fjm060653b&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm060653b%26sid%3Dliteratum%253Aachs%26aulast%3DChappie%26aufirst%3DT.%2BA.%26aulast%3DHumphrey%26aufirst%3DJ.%2BM.%26aulast%3DAllen%26aufirst%3DM.%2BP.%26aulast%3DEstep%26aufirst%3DK.%2BG.%26aulast%3DFox%26aufirst%3DC.%2BB.%26aulast%3DLebel%26aufirst%3DL.%2BA.%26aulast%3DLiras%26aufirst%3DS.%26aulast%3DMarr%26aufirst%3DE.%2BS.%26aulast%3DMenniti%26aufirst%3DF.%2BS.%26aulast%3DPandit%26aufirst%3DJ.%26aulast%3DSchmidt%26aufirst%3DC.%2BJ.%26aulast%3DTu%26aufirst%3DM.%26aulast%3DWilliams%26aufirst%3DR.%2BD.%26aulast%3DYang%26aufirst%3DF.%2BV.%26atitle%3DDiscovery%2520of%2520a%2520Series%2520of%25206%252C7-Dimethoxy-4-pyrrolidylquinazoline%2520PDE10A%2520Inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2007%26volume%3D50%26spage%3D182%26epage%3D185" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group">Verhoest, P. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chapin, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Corman, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fonseca, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harms, J. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hou, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marr, E. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Menniti, F. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nelson, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Connor, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pandit, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Proulx-LaFrance, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schmidt, A. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schmidt, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suiciak, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liras, S.</span><span> </span><span class="NLM_article-title">Discovery of a Novel Class of PDE10A Inhibitors and Identification of Clinical Candidate 2-[4-(1-Methyl-4-pyridin-4-yl-1<i>H</i>-pyrazol-3-yl)phenoxylmethyl]quinoline (PF-2545920) for the Treatment of Schizophrenia</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">5188</span><span class="NLM_x">–</span> <span class="NLM_lpage">5196</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm900521k" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=5188-5196&author=P.+R.+Verhoestauthor=D.+S.+Chapinauthor=M.+Cormanauthor=K.+Fonsecaauthor=J.+F.+Harmsauthor=X.+Houauthor=E.+S.+Marrauthor=F.+S.+Mennitiauthor=F.+Nelsonauthor=R.+O%E2%80%99Connorauthor=J.+Panditauthor=C.+Proulx-LaFranceauthor=A.+W.+Schmidtauthor=C.+J.+Schmidtauthor=J.+A.+Suiciakauthor=S.+Liras&title=Discovery+of+a+Novel+Class+of+PDE10A+Inhibitors+and+Identification+of+Clinical+Candidate+2-%5B4-%281-Methyl-4-pyridin-4-yl-1H-pyrazol-3-yl%29phenoxylmethyl%5Dquinoline+%28PF-2545920%29+for+the+Treatment+of+Schizophrenia"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1021%2Fjm900521k&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm900521k%26sid%3Dliteratum%253Aachs%26aulast%3DVerhoest%26aufirst%3DP.%2BR.%26aulast%3DChapin%26aufirst%3DD.%2BS.%26aulast%3DCorman%26aufirst%3DM.%26aulast%3DFonseca%26aufirst%3DK.%26aulast%3DHarms%26aufirst%3DJ.%2BF.%26aulast%3DHou%26aufirst%3DX.%26aulast%3DMarr%26aufirst%3DE.%2BS.%26aulast%3DMenniti%26aufirst%3DF.%2BS.%26aulast%3DNelson%26aufirst%3DF.%26aulast%3DO%25E2%2580%2599Connor%26aufirst%3DR.%26aulast%3DPandit%26aufirst%3DJ.%26aulast%3DProulx-LaFrance%26aufirst%3DC.%26aulast%3DSchmidt%26aufirst%3DA.%2BW.%26aulast%3DSchmidt%26aufirst%3DC.%2BJ.%26aulast%3DSuiciak%26aufirst%3DJ.%2BA.%26aulast%3DLiras%26aufirst%3DS.%26atitle%3DDiscovery%2520of%2520a%2520Novel%2520Class%2520of%2520PDE10A%2520Inhibitors%2520and%2520Identification%2520of%2520Clinical%2520Candidate%25202-%255B4-%25281-Methyl-4-pyridin-4-yl-1H-pyrazol-3-yl%2529phenoxylmethyl%255Dquinoline%2520%2528PF-2545920%2529%2520for%2520the%2520Treatment%2520of%2520Schizophrenia%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26spage%3D5188%26epage%3D5196" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group">Lu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kandel, E., R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hawkins, R. D.</span><span> </span><span class="NLM_article-title">Nitric Oxide Signaling Contributes to Late-Phase LTP and CREB Phosphorylation in the Hippocampus</span> <span class="citation_source-journal">J. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">10250</span><span class="NLM_x">–</span> <span class="NLM_lpage">10261</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Fjm3007799&amp;key=10.1523%2FJNEUROSCI.19-23-10250.1999" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Fjm3007799&amp;key=10575022" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Fjm3007799&amp;key=1%3ACAS%3A528%3ADyaK1MXnslyrt70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=1999&pages=10250-10261&author=Y.+Luauthor=E.%2C+R.+Kandelauthor=R.+D.+Hawkins&title=Nitric+Oxide+Signaling+Contributes+to+Late-Phase+LTP+and+CREB+Phosphorylation+in+the+Hippocampus"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Nitric oxide signaling contributes to late-phase LTP and CREB phosphorylation in the hippocampus</span></div><div class="casAuthors">Lu, Yun-Fei; Kandel, Eric R.; Hawkins, Robert D.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroscience</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">10250-10261</span>CODEN:
                <span class="NLM_cas:coden">JNRSDS</span>;
        ISSN:<span class="NLM_cas:issn">0270-6474</span>.
    
            (<span class="NLM_cas:orgname">Society for Neuroscience</span>)
        </div><div class="casAbstract">Long-term potentiation (LTP) in the hippocampus has an early phase (E-LTP) that can be induced by 1- or 2-train tetanization, lasts ∼1 h, and is cAMP-dependent protein kinase A (PKA)- and protein synthesis-independent and a late phase (L-LTP) that can be induced by 3- or 4-train tetanization, lasts >3 h, and is reduced by inhibitors of PKA and of protein or RNA synthesis.  NO is thought to be involved in E-LTP, but until now there has been no information about the role of the NO-signaling pathway in L-LTP.  Here, the authors examd. this question at the Schaffer collateral-CA1 synapses in slices of mouse hippocampus.  An inhibitor of nitric oxide synthase blocked L-LTP induced by 3-train tetanization and reduced L-LTP induced by 4-train tetanization, whereas an inhibitor of PKA was more effective in blocking 4-train L-LTP than 3-train L-LTP.  Three-train L-LTP was also blocked by inhibitors of guanylyl cyclase or cGMP-dependent protein kinase G (PKG).  Conversely, either NO or cGMP analogs paired with 1-train tetanization produced late-phase potentiation, and the cGMP-induced potentiation was blocked by inhibitors of protein or RNA synthesis and an inhibitor of PKG, but not by an inhibitor of PKA.  To test a possible downstream target of PKG, the authors examd. changes in phospho-CRE-binding protein (phospho-CREB) immunofluorescence in the CA1 cell body area and obtained results similar to those of the electrophysiol. expts.  The results suggested that NO contributes to L-LTP by stimulating guanylyl cyclase and PKG, which acts in parallel with PKA to increase phosphorylation of transcription factor CREB.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqY0i0LYOPf7LVg90H21EOLACvtfcHk0li0fE-BRsQeNg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXnslyrt70%253D&md5=6d09b68560c09b81e38354826f7c21b6</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1523%2FJNEUROSCI.19-23-10250.1999&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1523%252FJNEUROSCI.19-23-10250.1999%26sid%3Dliteratum%253Aachs%26aulast%3DLu%26aufirst%3DY.%26aulast%3DKandel%26aufirst%3DE.%252C%2BR.%26aulast%3DHawkins%26aufirst%3DR.%2BD.%26atitle%3DNitric%2520Oxide%2520Signaling%2520Contributes%2520to%2520Late-Phase%2520LTP%2520and%2520CREB%2520Phosphorylation%2520in%2520the%2520Hippocampus%26jtitle%3DJ.%2520Neurosci.%26date%3D1999%26volume%3D19%26spage%3D10250%26epage%3D10261" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group">Puzzo, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vitolo, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fabrizio, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jacob, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Palmeri, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arancio, O.</span><span> </span><span class="NLM_article-title">Amyloid-beta Peptide Inhibits Activation of the Nitric Oxide/cGMP/cAMP Responsive Element-Binding Protein Pathway during Hippocampal Synaptic Plasticity</span> <span class="citation_source-journal">J. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">25</span><span class="NLM_x">, </span> <span class="NLM_fpage">6887</span><span class="NLM_x">–</span> <span class="NLM_lpage">6897</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Fjm3007799&amp;key=10.1523%2FJNEUROSCI.5291-04.2005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Fjm3007799&amp;key=16033898" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Fjm3007799&amp;key=1%3ACAS%3A528%3ADC%252BD2MXmslClt78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2005&pages=6887-6897&author=D.+Puzzoauthor=O.+Vitoloauthor=T.+Fabrizioauthor=J.+P.+Jacobauthor=A.+Palmeriauthor=O.+Arancio&title=Amyloid-beta+Peptide+Inhibits+Activation+of+the+Nitric+Oxide%2FcGMP%2FcAMP+Responsive+Element-Binding+Protein+Pathway+during+Hippocampal+Synaptic+Plasticity"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Amyloid-β peptide inhibits activation of the nitric oxide/cGMP/cAMP-responsive element-binding protein pathway during hippocampal synaptic plasticity</span></div><div class="casAuthors">Puzzo, Daniela; Vitolo, Ottavio; Trinchese, Fabrizio; Jacob, Joel P.; Palmeri, Agostino; Arancio, Ottavio</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroscience</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">29</span>),
    <span class="NLM_cas:pages">6887-6897</span>CODEN:
                <span class="NLM_cas:coden">JNRSDS</span>;
        ISSN:<span class="NLM_cas:issn">0270-6474</span>.
    
            (<span class="NLM_cas:orgname">Society for Neuroscience</span>)
        </div><div class="casAbstract">Amyloid-β (Aβ), a peptide thought to play a crucial role in Alzheimer's disease (AD), has many targets that, in turn, activate different 2nd-messenger cascades.  Interestingly, Aβ was found to markedly impair hippocampal long-term potentiation (LTP).  To identify a new pathway that might be responsible for such impairment, the authors analyzed the role of the NO/sol. guanylyl cyclase (sGC)/cGMP/cGMP-dependent protein kinase (cGK)/cAMP-responsive element-binding protein (CREB) cascade because of its involvement in LTP.  The use of the NO donor 2-(N,N-dethylamino)-diazenolate-2-oxide diethylammonium salt (DEA/NO), the sGC stimulator 3-(4-amino-5-cyclopropylpyrimidine-2-yl)-1-(2-fluorobenzyl)-1H-pyrazolo[3,4-b]pyridine, or the cGMP-analogs 8-bromo-cGMP and 8-(4-chlorophenylthio)-cGMP reversed the Aβ-induced impairment of CA1-LTP through cGK activation.  Furthermore, these compds. reestablished the enhancement of CREB phosphorylation occurring during LTP in slices exposed to Aβ.  We also found that Aβ blocks the increase in cGMP immunoreactivity occurring immediately after LTP and that DEA/NO counteracts the effect of Aβ.  These results strongly suggest that, when modulating hippocampal synaptic plasticity, Aβ downregulates the NO/cGMP/cGK/CREB pathway; thus, enhancement of the NO/cGMP signaling may provide a novel approach to the treatment of AD and other neurodegenerative diseases with elevated prodn. of Aβ.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpT_M3WUlYelLVg90H21EOLACvtfcHk0liI1H9pNtUg_g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXmslClt78%253D&md5=448717d56147ceb9665d8c1ce8136c98</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1523%2FJNEUROSCI.5291-04.2005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1523%252FJNEUROSCI.5291-04.2005%26sid%3Dliteratum%253Aachs%26aulast%3DPuzzo%26aufirst%3DD.%26aulast%3DVitolo%26aufirst%3DO.%26aulast%3DFabrizio%26aufirst%3DT.%26aulast%3DJacob%26aufirst%3DJ.%2BP.%26aulast%3DPalmeri%26aufirst%3DA.%26aulast%3DArancio%26aufirst%3DO.%26atitle%3DAmyloid-beta%2520Peptide%2520Inhibits%2520Activation%2520of%2520the%2520Nitric%2520Oxide%252FcGMP%252FcAMP%2520Responsive%2520Element-Binding%2520Protein%2520Pathway%2520during%2520Hippocampal%2520Synaptic%2520Plasticity%26jtitle%3DJ.%2520Neurosci.%26date%3D2005%26volume%3D25%26spage%3D6887%26epage%3D6897" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group">Fisher, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, J. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pillar, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Denis, S. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheng, J. B.</span><span> </span><span class="NLM_article-title">Isolation and Characterization of PDE9A, a Novel Human cGMP-Specific Phosphodiesterase</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">25</span><span class="NLM_x">, </span> <span class="NLM_fpage">15559</span><span class="NLM_x">–</span> <span class="NLM_lpage">15564</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=1998&pages=15559-15564&author=D.+A.+Fisherauthor=J.+F.+Smithauthor=J.+S.+Pillarauthor=S.+H.+Denisauthor=J.+B.+Cheng&title=Isolation+and+Characterization+of+PDE9A%2C+a+Novel+Human+cGMP-Specific+Phosphodiesterase"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFisher%26aufirst%3DD.%2BA.%26aulast%3DSmith%26aufirst%3DJ.%2BF.%26aulast%3DPillar%26aufirst%3DJ.%2BS.%26aulast%3DDenis%26aufirst%3DS.%2BH.%26aulast%3DCheng%26aufirst%3DJ.%2BB.%26atitle%3DIsolation%2520and%2520Characterization%2520of%2520PDE9A%252C%2520a%2520Novel%2520Human%2520cGMP-Specific%2520Phosphodiesterase%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1998%26volume%3D25%26spage%3D15559%26epage%3D15564" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group">Andreeva, S. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dikkes, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Epstein, P. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosenberg, P. A.</span><span> </span><span class="NLM_article-title">Expression of cGMP-Specific Phosphodiesterase 9A mRNA in the Rat Brain</span> <span class="citation_source-journal">J. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">9068</span><span class="NLM_x">–</span> <span class="NLM_lpage">9076</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2001&pages=9068-9076&author=S.+G.+Andreevaauthor=P.+Dikkesauthor=P.+M.+Epsteinauthor=P.+A.+Rosenberg&title=Expression+of+cGMP-Specific+Phosphodiesterase+9A+mRNA+in+the+Rat+Brain"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAndreeva%26aufirst%3DS.%2BG.%26aulast%3DDikkes%26aufirst%3DP.%26aulast%3DEpstein%26aufirst%3DP.%2BM.%26aulast%3DRosenberg%26aufirst%3DP.%2BA.%26atitle%3DExpression%2520of%2520cGMP-Specific%2520Phosphodiesterase%25209A%2520mRNA%2520in%2520the%2520Rat%2520Brain%26jtitle%3DJ.%2520Neurosci.%26date%3D2001%26volume%3D15%26spage%3D9068%26epage%3D9076" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group">Van Der Staay, F. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rutten, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barfacker, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DeVry, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Erb, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schroder, H. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hendrix, M.</span><span> </span><span class="NLM_article-title">The Novel Selective PDE9 Inhibitor BAY 73-6691 Improves Learning and Memory in Rodents</span> <span class="citation_source-journal">Neuropharmacology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">908</span><span class="NLM_x">–</span> <span class="NLM_lpage">918</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2008&pages=908-918&author=F.+J.+Van+Der+Staayauthor=K.+Ruttenauthor=L.+Barfackerauthor=J.+DeVryauthor=C.+Erbauthor=H.+H.+Schroderauthor=M.+Hendrix&title=The+Novel+Selective+PDE9+Inhibitor+BAY+73-6691+Improves+Learning+and+Memory+in+Rodents"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DVan%2BDer%2BStaay%26aufirst%3DF.%2BJ.%26aulast%3DRutten%26aufirst%3DK.%26aulast%3DBarfacker%26aufirst%3DL.%26aulast%3DDeVry%26aufirst%3DJ.%26aulast%3DErb%26aufirst%3DC.%26aulast%3DSchroder%26aufirst%3DH.%2BH.%26aulast%3DHendrix%26aufirst%3DM.%26atitle%3DThe%2520Novel%2520Selective%2520PDE9%2520Inhibitor%2520BAY%252073-6691%2520Improves%2520Learning%2520and%2520Memory%2520in%2520Rodents%26jtitle%3DNeuropharmacology%26date%3D2008%26volume%3D55%26spage%3D908%26epage%3D918" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group">Verhoest, P. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Proulx-Lafrance, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Corman, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chenard, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Helal, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hou, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kleiman, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marr, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Menniti, F. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schmidt, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vanase-Frawley, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schmidt, A. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, R. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nelson, F. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fonseca, K. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liras, S.</span><span> </span><span class="NLM_article-title">Identification of a Brain Penetrant PDE9A Inhibitor Utilizing Prospective Design and Chemical Enablement as a Rapid Lead Optimization Strategy</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">7946</span><span class="NLM_x">–</span> <span class="NLM_lpage">7949</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm9015334" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Fjm3007799&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhsValtbzI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=7946-7949&author=P.+R.+Verhoestauthor=C.+Proulx-Lafranceauthor=M.+Cormanauthor=L.+Chenardauthor=C.+J.+Helalauthor=X.+Houauthor=R.+Kleimanauthor=S.+Liuauthor=E.+Marrauthor=F.+S.+Mennitiauthor=C.+J.+Schmidtauthor=M.+Vanase-Frawleyauthor=A.+W.+Schmidtauthor=R.+D.+Williamsauthor=F.+R.+Nelsonauthor=K.+R.+Fonsecaauthor=S.+Liras&title=Identification+of+a+Brain+Penetrant+PDE9A+Inhibitor+Utilizing+Prospective+Design+and+Chemical+Enablement+as+a+Rapid+Lead+Optimization+Strategy"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of a Brain Penetrant PDE9A Inhibitor Utilizing Prospective Design and Chemical Enablement as a Rapid Lead Optimization Strategy</span></div><div class="casAuthors">Verhoest, Patrick R.; Proulx-Lafrance, Caroline; Corman, Michael; Chenard, Lois; Helal, Christopher J.; Hou, Xinjun; Kleiman, Robin; Liu, Shenping; Marr, Eric; Menniti, Frank S.; Schmidt, Christopher J.; Vanase-Frawley, Michelle; Schmidt, Anne W.; Williams, Robert D.; Nelson, Frederick R.; Fonseca, Kari R.; Liras, Spiros</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">52</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">7946-7949</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A novel series of selective, brain penetrant PDE9A inhibitors I (R1 = i-Pr, i-Bu, cyclopentyl, R2 = Ph; R1 = cyclopentyl, R2 = 3-MeC6H4, 2-pyridyl, 6-quinoxalinyl, etc.) has been identified that are capable of producing in vivo elevations of brain cGMP.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGou_Q49qDJV3bVg90H21EOLACvtfcHk0lgSthCDTnKvlw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhsValtbzI&md5=4e1a67684031737596a83d1feb4bee08</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1021%2Fjm9015334&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm9015334%26sid%3Dliteratum%253Aachs%26aulast%3DVerhoest%26aufirst%3DP.%2BR.%26aulast%3DProulx-Lafrance%26aufirst%3DC.%26aulast%3DCorman%26aufirst%3DM.%26aulast%3DChenard%26aufirst%3DL.%26aulast%3DHelal%26aufirst%3DC.%2BJ.%26aulast%3DHou%26aufirst%3DX.%26aulast%3DKleiman%26aufirst%3DR.%26aulast%3DLiu%26aufirst%3DS.%26aulast%3DMarr%26aufirst%3DE.%26aulast%3DMenniti%26aufirst%3DF.%2BS.%26aulast%3DSchmidt%26aufirst%3DC.%2BJ.%26aulast%3DVanase-Frawley%26aufirst%3DM.%26aulast%3DSchmidt%26aufirst%3DA.%2BW.%26aulast%3DWilliams%26aufirst%3DR.%2BD.%26aulast%3DNelson%26aufirst%3DF.%2BR.%26aulast%3DFonseca%26aufirst%3DK.%2BR.%26aulast%3DLiras%26aufirst%3DS.%26atitle%3DIdentification%2520of%2520a%2520Brain%2520Penetrant%2520PDE9A%2520Inhibitor%2520Utilizing%2520Prospective%2520Design%2520and%2520Chemical%2520Enablement%2520as%2520a%2520Rapid%2520Lead%2520Optimization%2520Strategy%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26spage%3D7946%26epage%3D7949" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group">Whalen, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gobey, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Janiszewski, J. A.</span><span> </span><span class="NLM_article-title">Centralized Approach to Tandem Mass Spectrometry Method Development for High-Throughput ADME Screening</span> <span class="citation_source-journal">Rapid Commun. Mass Spectrom.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">1497</span><span class="NLM_x">–</span> <span class="NLM_lpage">1503</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Fjm3007799&amp;key=10.1002%2Frcm.2469" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Fjm3007799&amp;key=16628559" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Fjm3007799&amp;key=1%3ACAS%3A528%3ADC%252BD28XltVartLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2006&pages=1497-1503&author=K.+Whalenauthor=J.+Gobeyauthor=J.+A.+Janiszewski&title=Centralized+Approach+to+Tandem+Mass+Spectrometry+Method+Development+for+High-Throughput+ADME+Screening"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">A centralized approach to tandem mass spectrometry method development for high-throughput ADME screening</span></div><div class="casAuthors">Whalen, Kevin; Gobey, Jason; Janiszewski, John</div><div class="citationInfo"><span class="NLM_cas:title">Rapid Communications in Mass Spectrometry</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1497-1503</span>CODEN:
                <span class="NLM_cas:coden">RCMSEF</span>;
        ISSN:<span class="NLM_cas:issn">0951-4198</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons Ltd.</span>)
        </div><div class="casAbstract">A centralized approach to acquisition and dissemination of tandem mass spectrometry (MS/MS) conditions within an ADME-screening bioanal. mass spectrometry group was developed.  The method development process uses 2 automated software products (Autoscan and Automaton) specifically designed for mass spectrometers manufd. by MDS Sciex.  Both provide the ability to quickly det. selected reaction monitoring (SRM) transitions for hundreds of compds. per day.  Autoscan dets. optimal polarity and collision energy (CE).  Automaton also dets. the optimal declustering potential (DP) as well as the CE.  The resulting optimized conditions are loaded into a central database for access by LC/MS/MS bioanal. workstations in the group.  The effect of DP and CE on the sensitivity was studied.  Optimization of DP improved signal response ∼27% on av.  For ∼10% of compds., signal enhancement was >50% compared to the generic setting.  A generic setting of DP = 25 V can be used for the majority of ADME-screening applications.  Optimization of CE can have a much larger impact on signal intensity and a min. of 3 CE settings should be tested.  CE values of 1, 30 and 45 V provide adequate coverage for most small mol. drug discovery analytes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpjYhEOAvOWB7Vg90H21EOLACvtfcHk0lgSthCDTnKvlw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XltVartLk%253D&md5=6e57b4b490527b98931bc58aa871d48c</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1002%2Frcm.2469&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Frcm.2469%26sid%3Dliteratum%253Aachs%26aulast%3DWhalen%26aufirst%3DK.%26aulast%3DGobey%26aufirst%3DJ.%26aulast%3DJaniszewski%26aufirst%3DJ.%2BA.%26atitle%3DCentralized%2520Approach%2520to%2520Tandem%2520Mass%2520Spectrometry%2520Method%2520Development%2520for%2520High-Throughput%2520ADME%2520Screening%26jtitle%3DRapid%2520Commun.%2520Mass%2520Spectrom.%26date%3D2006%26volume%3D20%26spage%3D1497%26epage%3D1503" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group">Kuntz, I. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sharp, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kollman, P. A.</span><span> </span><span class="NLM_article-title">The Maximal Affinity of Ligands</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U.S.A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">96</span><span class="NLM_x">, </span> <span class="NLM_fpage">9997</span><span class="NLM_x">–</span> <span class="NLM_lpage">10002</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Fjm3007799&amp;key=10.1073%2Fpnas.96.18.9997" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Fjm3007799&amp;key=10468550" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Fjm3007799&amp;key=1%3ACAS%3A528%3ADyaK1MXlvFehu7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=96&publication_year=1999&pages=9997-10002&author=I.+D.+Kuntzauthor=K.+Chenauthor=K.+A.+Sharpauthor=P.+A.+Kollman&title=The+Maximal+Affinity+of+Ligands"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">The maximal affinity of ligands</span></div><div class="casAuthors">Kuntz, I. D.; Chen, K.; Sharp, K. A.; Kollman, P. A.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">96</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">9997-10002</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">We explore the question of what are the best ligands for macromol. targets.  A survey of exptl. data on a large no. of the strongest-binding ligands indicates that the free energy of binding increases with the no. of nonhydrogen atoms with an initial slope of ≈-1.5 kcal/mol (1 cal = 4.18 J) per atom.  For ligands that contain more than 15 nonhydrogen atoms, the free energy of binding increases very little with relative mol. mass.  This nonlinearity is largely ascribed to nonthermodynamic factors.  An anal. of the dominant interactions suggests that van der Waals interactions and hydrophobic effects provide a reasonable basis for understanding binding affinities across the entire set of ligands.  Interesting outliers that bind unusually strongly on a per atom basis include metal ions, covalently attached ligands, and a few well known complexes such as biotin-avidin.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq0L6KZhR0TxbVg90H21EOLACvtfcHk0liotp0IZho1RA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXlvFehu7s%253D&md5=46fe894b016f3041831a2f0b71f812b1</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1073%2Fpnas.96.18.9997&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.96.18.9997%26sid%3Dliteratum%253Aachs%26aulast%3DKuntz%26aufirst%3DI.%2BD.%26aulast%3DChen%26aufirst%3DK.%26aulast%3DSharp%26aufirst%3DK.%2BA.%26aulast%3DKollman%26aufirst%3DP.%2BA.%26atitle%3DThe%2520Maximal%2520Affinity%2520of%2520Ligands%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D1999%26volume%3D96%26spage%3D9997%26epage%3D10002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group">Wager, T. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chandrasekaran, R. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hou, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Troutman, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Verhoest, P. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Villalobos, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Will, Y.</span><span> </span><span class="NLM_article-title">Defining Desirable Central Nervous System Drug Space through the Alignment of Molecular Properties, in Vitro ADME, and Safety Attributes</span> <span class="citation_source-journal">ACS Chem. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">1</span><span class="NLM_x">, </span> <span class="NLM_fpage">420</span><span class="NLM_x">–</span> <span class="NLM_lpage">434</span></span><div class="citationLinks">[<a href="/doi/10.1021/cn100007x" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Fjm3007799&amp;key=1%3ACAS%3A528%3ADC%252BC3cXjvVaqtbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2010&pages=420-434&author=T.+T.+Wagerauthor=R.+Y.+Chandrasekaranauthor=X.+Houauthor=M.+D.+Troutmanauthor=P.+R.+Verhoestauthor=A.+Villalobosauthor=Y.+Will&title=Defining+Desirable+Central+Nervous+System+Drug+Space+through+the+Alignment+of+Molecular+Properties%2C+in+Vitro+ADME%2C+and+Safety+Attributes"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Defining Desirable Central Nervous System Drug Space through the Alignment of Molecular Properties, in Vitro ADME, and Safety Attributes</span></div><div class="casAuthors">Wager, Travis T.; Chandrasekaran, Ramalakshmi Y.; Hou, Xinjun; Troutman, Matthew D.; Verhoest, Patrick R.; Villalobos, Anabella; Will, Yvonne</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Neuroscience</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">420-434</span>CODEN:
                <span class="NLM_cas:coden">ACNCDM</span>;
        ISSN:<span class="NLM_cas:issn">1948-7193</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">As part of our effort to increase survival of drug candidates and to move our medicinal chem. design to higher probability space for success in the Neuroscience therapeutic area, we embarked on a detailed study of the property space for a collection of central nervous system (CNS) mols.  We carried out a thorough anal. of properties for 119 marketed CNS drugs and a set of 108 Pfizer CNS candidates.  In particular, we focused on understanding the relationships between physicochem. properties, in vitro ADME (absorption, distribution, metab., and elimination) attributes, primary pharmacol. binding efficiencies, and in vitro safety data for these two sets of compds.  This scholarship provides guidance for the design of CNS mols. in a property space with increased probability of success and may lead to the identification of druglike candidates with favorable safety profiles that can successfully test hypotheses in the clinic.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqvEMBo2f34BrVg90H21EOLACvtfcHk0liotp0IZho1RA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXjvVaqtbk%253D&md5=85716be86290fd85e93c6b8d5621683c</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1021%2Fcn100007x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcn100007x%26sid%3Dliteratum%253Aachs%26aulast%3DWager%26aufirst%3DT.%2BT.%26aulast%3DChandrasekaran%26aufirst%3DR.%2BY.%26aulast%3DHou%26aufirst%3DX.%26aulast%3DTroutman%26aufirst%3DM.%2BD.%26aulast%3DVerhoest%26aufirst%3DP.%2BR.%26aulast%3DVillalobos%26aufirst%3DA.%26aulast%3DWill%26aufirst%3DY.%26atitle%3DDefining%2520Desirable%2520Central%2520Nervous%2520System%2520Drug%2520Space%2520through%2520the%2520Alignment%2520of%2520Molecular%2520Properties%252C%2520in%2520Vitro%2520ADME%252C%2520and%2520Safety%2520Attributes%26jtitle%3DACS%2520Chem.%2520Neurosci.%26date%3D2010%26volume%3D1%26spage%3D420%26epage%3D434" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group">Feng, B</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mills, J. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davidson, R. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mireles, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Janiszewski, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Troutman, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Morais, S. M.</span><span> </span><span class="NLM_article-title">In Vitro P-Glycoprotein Assays To Predict the in Vivo Interactions of P-Glycoprotein with Drugs in the Central Nervous System</span> <span class="citation_source-journal">Drug Metab. Dispos.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">36</span><span class="NLM_x">, </span> <span class="NLM_fpage">268</span><span class="NLM_x">–</span> <span class="NLM_lpage">275</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Fjm3007799&amp;key=10.1124%2Fdmd.107.017434" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Fjm3007799&amp;key=17962372" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Fjm3007799&amp;key=1%3ACAS%3A528%3ADC%252BD1cXht1yktbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=36&publication_year=2008&pages=268-275&author=B+Fengauthor=J.+B.+Millsauthor=R.+E.+Davidsonauthor=R.+J.+Mirelesauthor=J.+S.+Janiszewskiauthor=M.+D.+Troutmanauthor=S.+M.+de+Morais&title=In+Vitro+P-Glycoprotein+Assays+To+Predict+the+in+Vivo+Interactions+of+P-Glycoprotein+with+Drugs+in+the+Central+Nervous+System"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">In vitro P-glycoprotein assays to predict the in vivo interactions of P-glycoprotein with drugs in the central nervous system</span></div><div class="casAuthors">Feng, Bo; Mills, Jessica B.; Davidson, Ralph E.; Mireles, Rouchelle J.; Janiszewski, John S.; Troutman, Matthew D.; de Morais, Sonia M.</div><div class="citationInfo"><span class="NLM_cas:title">Drug Metabolism and Disposition</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">36</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">268-275</span>CODEN:
                <span class="NLM_cas:coden">DMDSAI</span>;
        ISSN:<span class="NLM_cas:issn">0090-9556</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Thirty-one structurally diverse marketed central nervous system (CNS)-active drugs, one active metabolite, and seven non-CNS-active compds. were tested in three P-glycoprotein (P-gp) in vitro assays: transwell assays using MDCK, human MDR1-MDCK, and mouse Mdr1a-MDCK cells, ATPase, and calcein AM inhibition.  Addnl., the permeability for these compds. was measured in two in vitro models: parallel artificial membrane permeation assay and apical-to-basolateral apparent permeability in MDCK.  The exposure of the same set of compds. in brain and plasma was measured in P-gp knockout (KO) and wild-type (WT) mice after s.c. administration.  One drug and its metabolite, risperidone and 9-hydroxyrisperidone, of the 32 CNS compds., and 6 of the 7 non-CNS drugs were detd. to have pos. efflux using ratio of ratios in MDR1-MDCK vs. MDCK transwell assays.  Data from transwell studies correlated well with the brain-to-plasma area under the curve ratios between P-gp KO and WT mice for the 32 CNS compds.  In addn., 3300 Pfizer compds. were tested in MDR1-MDCK and Mdr1a-MDCK transwell assays, with a good correlation (R2 = 0.92) between the efflux ratios in human MDR1-MDCK and mouse Mdr1a-MDCK cells.  Permeability data showed that the majority of the 32 CNS compds. have moderate to high passive permeability.  This work has demonstrated that in vitro transporter assays help in understanding the role of P-gp-mediated efflux activity in detg. the disposition of CNS drugs in vivo, and the transwell assay is a valuable in vitro assay to evaluate human P-gp interaction with compds. for assessing brain penetration of new chem. entities to treat CNS disorders.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqsQyRSOySyGLVg90H21EOLACvtfcHk0ljwGCGl7KNJ7Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXht1yktbc%253D&md5=bbf8b6969bd6d6b3d741b6ef9e7853f3</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1124%2Fdmd.107.017434&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fdmd.107.017434%26sid%3Dliteratum%253Aachs%26aulast%3DFeng%26aufirst%3DB%26aulast%3DMills%26aufirst%3DJ.%2BB.%26aulast%3DDavidson%26aufirst%3DR.%2BE.%26aulast%3DMireles%26aufirst%3DR.%2BJ.%26aulast%3DJaniszewski%26aufirst%3DJ.%2BS.%26aulast%3DTroutman%26aufirst%3DM.%2BD.%26aulast%3Dde%2BMorais%26aufirst%3DS.%2BM.%26atitle%3DIn%2520Vitro%2520P-Glycoprotein%2520Assays%2520To%2520Predict%2520the%2520in%2520Vivo%2520Interactions%2520of%2520P-Glycoprotein%2520with%2520Drugs%2520in%2520the%2520Central%2520Nervous%2520System%26jtitle%3DDrug%2520Metab.%2520Dispos.%26date%3D2008%26volume%3D36%26spage%3D268%26epage%3D275" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group">Obach, R. S.</span><span> </span><span class="NLM_article-title">Prediction of Human Clearance of Twenty-Nine Drugs from Hepatic Microsomal Intrinsic Clearance Data: An Examination of in Vitro Half-Life Approach and Nonspecific Binding to Microsomes</span> <span class="citation_source-journal">Drug. Metab. Dispos.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">27</span><span class="NLM_x">, </span> <span class="NLM_fpage">1350</span><span class="NLM_x">–</span> <span class="NLM_lpage">1359</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Fjm3007799&amp;key=10534321" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Fjm3007799&amp;key=1%3ACAS%3A528%3ADyaK1MXntFSht7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=1999&pages=1350-1359&author=R.+S.+Obach&title=Prediction+of+Human+Clearance+of+Twenty-Nine+Drugs+from+Hepatic+Microsomal+Intrinsic+Clearance+Data%3A+An+Examination+of+in+Vitro+Half-Life+Approach+and+Nonspecific+Binding+to+Microsomes"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Prediction of human clearance of twenty-nine drugs from hepatic microsomal intrinsic clearance data: an examination of in vitro half-life approach and nonspecific binding to microsomes</span></div><div class="casAuthors">Obach, R. Scott</div><div class="citationInfo"><span class="NLM_cas:title">Drug Metabolism and Disposition</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1350-1359</span>CODEN:
                <span class="NLM_cas:coden">DMDSAI</span>;
        ISSN:<span class="NLM_cas:issn">0090-9556</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Twenty-nine drugs of disparate structures and physicochem. properties were used in an examn. of the capability of human liver microsomal lability data ("in vitro T1/2" approach) to be useful in the prediction of human clearance.  Addnl., the potential importance of nonspecific binding to microsomes in the in vitro incubation milieu for the accurate prediction of human clearance was investigated.  The compds. examd. demonstrated a wide range of microsomal metabolic labilities with scaled intrinsic clearance values ranging from less than 0.5 mL/min/kg to 189 mL/min/kg.  Microsomal binding was detd. at microsomal protein concns. used in the lability incubations.  For the 29 compds. studied, unbound fractions in microsomes ranged from 0.11 to 1.0.  Generally, basic compds. demonstrated the greatest extent of binding and neutral and acidic compds. the least extent of binding.  In the projection of human clearance values, basic and neutral compds. were well predicted when all binding considerations (blood and microsome) were disregarded, however, including both binding considerations also yielded reasonable predictions.  Including only blood binding yielded very poor projections of human clearance for these two types of compds.  However, for acidic compds., disregarding all binding considerations yielded poor predictions of human clearance.  It was generally most difficult to accurately predict clearance for this class of compds.; however the accuracy was best when all binding considerations were included.  Overall, inclusion of both blood and microsome binding values gave the best agreement between in vivo clearance values and clearance values projected from in vitro intrinsic clearance data.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpWp2hUTOxyubVg90H21EOLACvtfcHk0ljwGCGl7KNJ7Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXntFSht7c%253D&md5=7804cd4dfb131caac45aff9b7a1df901</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DObach%26aufirst%3DR.%2BS.%26atitle%3DPrediction%2520of%2520Human%2520Clearance%2520of%2520Twenty-Nine%2520Drugs%2520from%2520Hepatic%2520Microsomal%2520Intrinsic%2520Clearance%2520Data%253A%2520An%2520Examination%2520of%2520in%2520Vitro%2520Half-Life%2520Approach%2520and%2520Nonspecific%2520Binding%2520to%2520Microsomes%26jtitle%3DDrug.%2520Metab.%2520Dispos.%26date%3D1999%26volume%3D27%26spage%3D1350%26epage%3D1359" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group">Obach, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baxter, J. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liston, T. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Silber, B. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, B. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">MacIntyre, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rance, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wastall, P.</span><span> </span><span class="NLM_article-title">The Prediction of Human Pharmacokinetic Parameters from Preclinical and in Vitro Metabolism Data</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">283</span><span class="NLM_x">, </span> <span class="NLM_fpage">46</span><span class="NLM_x">–</span> <span class="NLM_lpage">58</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Fjm3007799&amp;key=9336307" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Fjm3007799&amp;key=1%3ACAS%3A528%3ADyaK2sXmslCltr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=283&publication_year=1997&pages=46-58&author=S.+R.+Obachauthor=J.+G.+Baxterauthor=T.+E.+Listonauthor=B.+M.+Silberauthor=B.+C.+Jonesauthor=F.+MacIntyreauthor=D.+J.+Ranceauthor=P.+Wastall&title=The+Prediction+of+Human+Pharmacokinetic+Parameters+from+Preclinical+and+in+Vitro+Metabolism+Data"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">The prediction of human pharmacokinetic parameters from preclinical and in vitro metabolism data</span></div><div class="casAuthors">Obach, R. Scott; Baxter, James G.; Liston, Theodore E.; Silber, B. Michael; Jones, Barry C.; Macintyre, Flona; Rance, David J.; Wastall, Philip</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">283</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">46-58</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">Williams & Wilkins</span>)
        </div><div class="casAbstract">A review with 35 refs.  We describe a comprehensive retrospective anal. in which the abilities of several methods by which human pharmacokinetic parameters are predicted from preclin. pharmacokinetic data and/or in vitro metab. data were assessed.  The prediction methods examd. included both methods from the scientific literature as well as some described in this report for the first time.  Four methods were examd. for their ability to predict human vol. of distribution.  Three were highly predictive, yielding, on av., predictions that were within 60% to 90% of actual values.  Twelve methods were assessed for their utility in predicting clearance.  The most successful allometric scaling method yielded clearance predictions that were, on av., within 80% of actual values.  The best methods in which in vitro metab. data from human liver microsomes were scaled to in vivo clearance values yielded predicted clearance values that were, on av., within 70% to 80% of actual values.  Human t1/2 was predicted by combining predictions of human vol. of distribution and clearance.  The best t1/2 prediction methods successfully assigned compds. to appropriate dosing regimen categories (e.g., once daily, twice daily and so forth) 70% to 80% of the time.  In addn., correlations between human t1/2 and t1/2 values from preclin. species were also generally successful (72-87%) when used to predict human dosing regimens.  In summary, this retrospective anal. has identified several approaches by which human pharmacokinetic data can be predicted from preclin. data.  Such approaches should find utility in the drug discovery and development processes in the identification and selection of compds. that will possess appropriate pharmacokinetic characteristics in humans for progression to clin. trials.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGppAngniZ4izLVg90H21EOLACvtfcHk0liIuoCDYINLdw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXmslCltr0%253D&md5=68d1910d925e26ec4a8ef23043ffb1ed</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DObach%26aufirst%3DS.%2BR.%26aulast%3DBaxter%26aufirst%3DJ.%2BG.%26aulast%3DListon%26aufirst%3DT.%2BE.%26aulast%3DSilber%26aufirst%3DB.%2BM.%26aulast%3DJones%26aufirst%3DB.%2BC.%26aulast%3DMacIntyre%26aufirst%3DF.%26aulast%3DRance%26aufirst%3DD.%2BJ.%26aulast%3DWastall%26aufirst%3DP.%26atitle%3DThe%2520Prediction%2520of%2520Human%2520Pharmacokinetic%2520Parameters%2520from%2520Preclinical%2520and%2520in%2520Vitro%2520Metabolism%2520Data%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D1997%26volume%3D283%26spage%3D46%26epage%3D58" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group">Kleiman, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chapin, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Christoffersen, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Freeman, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fonseca, K. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Geoghegan, K. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grimwood, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guanowsky, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hajos, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harms, J. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Helal, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoffman, W. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kocan, G. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Majchrzak, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McGinnis, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McLean, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Menniti, F. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nelson, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roof, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schmidt, A. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seymour, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stephenson, D. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tingley, F. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vanase-Frawley, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Verhoest, P. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schmidt, C. J.</span><span> </span><span class="NLM_article-title">Phosphodiesterase 9A Regulates Central cGMP and Modulates Responses to Cholinergic and Monoaminergic Perturbation in Vivo</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">341</span><span class="NLM_x">, </span> <span class="NLM_fpage">1</span><span class="NLM_x">–</span> <span class="NLM_lpage">14</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Fjm3007799&amp;key=10.1124%2Fjpet.111.191353" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=341&publication_year=2012&pages=1-14&author=R.+J.+Kleimanauthor=D.+S.+Chapinauthor=C.+Christoffersenauthor=J.+Freemanauthor=K.+R.+Fonsecaauthor=K.+F.+Geogheganauthor=S.+Grimwoodauthor=V.+Guanowskyauthor=M.+Hajosauthor=J.+F.+Harmsauthor=C.+J.+Helalauthor=W.+E.+Hoffmanauthor=G.+P.+Kocanauthor=M.+Majchrzakauthor=D.+McGinnisauthor=S.+McLeanauthor=F.+S.+Mennitiauthor=F.+Nelsonauthor=R.+Roofauthor=A.+W.+Schmidtauthor=P.+A.+Seymourauthor=D.+T.+Stephensonauthor=F.+D.+Tingleyauthor=M.+Vanase-Frawleyauthor=P.+R.+Verhoestauthor=C.+J.+Schmidt&title=Phosphodiesterase+9A+Regulates+Central+cGMP+and+Modulates+Responses+to+Cholinergic+and+Monoaminergic+Perturbation+in+Vivo"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1124%2Fjpet.111.191353&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.111.191353%26sid%3Dliteratum%253Aachs%26aulast%3DKleiman%26aufirst%3DR.%2BJ.%26aulast%3DChapin%26aufirst%3DD.%2BS.%26aulast%3DChristoffersen%26aufirst%3DC.%26aulast%3DFreeman%26aufirst%3DJ.%26aulast%3DFonseca%26aufirst%3DK.%2BR.%26aulast%3DGeoghegan%26aufirst%3DK.%2BF.%26aulast%3DGrimwood%26aufirst%3DS.%26aulast%3DGuanowsky%26aufirst%3DV.%26aulast%3DHajos%26aufirst%3DM.%26aulast%3DHarms%26aufirst%3DJ.%2BF.%26aulast%3DHelal%26aufirst%3DC.%2BJ.%26aulast%3DHoffman%26aufirst%3DW.%2BE.%26aulast%3DKocan%26aufirst%3DG.%2BP.%26aulast%3DMajchrzak%26aufirst%3DM.%26aulast%3DMcGinnis%26aufirst%3DD.%26aulast%3DMcLean%26aufirst%3DS.%26aulast%3DMenniti%26aufirst%3DF.%2BS.%26aulast%3DNelson%26aufirst%3DF.%26aulast%3DRoof%26aufirst%3DR.%26aulast%3DSchmidt%26aufirst%3DA.%2BW.%26aulast%3DSeymour%26aufirst%3DP.%2BA.%26aulast%3DStephenson%26aufirst%3DD.%2BT.%26aulast%3DTingley%26aufirst%3DF.%2BD.%26aulast%3DVanase-Frawley%26aufirst%3DM.%26aulast%3DVerhoest%26aufirst%3DP.%2BR.%26aulast%3DSchmidt%26aufirst%3DC.%2BJ.%26atitle%3DPhosphodiesterase%25209A%2520Regulates%2520Central%2520cGMP%2520and%2520Modulates%2520Responses%2520to%2520Cholinergic%2520and%2520Monoaminergic%2520Perturbation%2520in%2520Vivo%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2012%26volume%3D341%26spage%3D1%26epage%3D14" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group">Vardigan, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Convero, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hutson, P. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Uslaner, J. M.</span><span> </span><span class="NLM_article-title">Selective Phosphodiesterase 9 Inhibitor PF-04447943 Attenuates a Scapolamine-Induced Deficits in a Novel Rodent Attenuation Task</span> <span class="citation_source-journal">J. Neurogenet.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">25</span><span class="NLM_x">, </span> <span class="NLM_fpage">120</span><span class="NLM_x">–</span> <span class="NLM_lpage">126</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Fjm3007799&amp;key=10.3109%2F01677063.2011.630494" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Fjm3007799&amp;key=22070409" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Fjm3007799&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhsV2hs7bF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2011&pages=120-126&author=J.+D.+Vardiganauthor=A.+Converoauthor=P.+H.+Hutsonauthor=J.+M.+Uslaner&title=Selective+Phosphodiesterase+9+Inhibitor+PF-04447943+Attenuates+a+Scapolamine-Induced+Deficits+in+a+Novel+Rodent+Attenuation+Task"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">The Selective Phosphodiesterase 9 (PDE9) Inhibitor PF-04447943 Attenuates a Scopolamine-Induced Deficit in a Novel Rodent Attention Task</span></div><div class="casAuthors">Vardigan, Joshua D.; Converso, Antonella; Hutson, Pete H.; Uslaner, Jason M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neurogenetics</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">120-126</span>CODEN:
                <span class="NLM_cas:coden">JLNEDK</span>;
        ISSN:<span class="NLM_cas:issn">0167-7063</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">Numerous changes occur during aging and Alzheimer's disease (AD) progression, including a decline in cholinergic functioning and cognition, as well as alterations in gene expression and activity in the nitric oxide/cyclic guanosine monophosphate (NO/cGMP) pathway.  Donepezil, the current std. of care for Alzheimer's disease, improves cholinergic functioning and has demonstrated effects on multiple domains of cognition, including memory and attention in both preclin. species and patients.  We previously found that increasing activation of the NO/cGMP pathway via phosphodiesterase 9 (PDE9) inhibition also improves memory in rodents and suggested that PDE9 might be a promising target for novel treatments for AD.  Here we investigated whether PDE9 inhibition also enhances attention using a novel attention task in rats.  We validated this task using several pharmacol. manipulations and showed that the selective PDE9 inhibitor PF-04447943 produced effects similar to those of donepezil.  These data confirm and extend the hypothesis that PDE9 inhibition might serve as a novel treatment for AD and age-related cognitive decline.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqJa-1clww9LrVg90H21EOLACvtfcHk0lj35Jbu0dCF4Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhsV2hs7bF&md5=1d03e024134e690d1765bd4ee8576aad</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.3109%2F01677063.2011.630494&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3109%252F01677063.2011.630494%26sid%3Dliteratum%253Aachs%26aulast%3DVardigan%26aufirst%3DJ.%2BD.%26aulast%3DConvero%26aufirst%3DA.%26aulast%3DHutson%26aufirst%3DP.%2BH.%26aulast%3DUslaner%26aufirst%3DJ.%2BM.%26atitle%3DSelective%2520Phosphodiesterase%25209%2520Inhibitor%2520PF-04447943%2520Attenuates%2520a%2520Scapolamine-Induced%2520Deficits%2520in%2520a%2520Novel%2520Rodent%2520Attenuation%2520Task%26jtitle%3DJ.%2520Neurogenet.%26date%3D2011%26volume%3D25%26spage%3D120%26epage%3D126" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group">Hutson, P. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Finger, E. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Magliaro, B. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Converso, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sanderson, P. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mullins, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hyde, L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eschle, B. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Turnbull, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sloan, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guzzi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rindgen, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mazzola, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vivian, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eddins, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Uslaner, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bednar, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gambone, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Le-Mari, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marino, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sachs, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parmentier-Batteur, S.</span><span> </span><span class="NLM_article-title">The Selective Phosphodiesterase 9 (PDE9) Inhibitor PF-04447943 (6-[(3<i>S</i>,4<i>S</i>)-4-methyl-1-(pyrimidin-2-ylmethyl)pyrrolidin-3-yl]-1-(tetrahydro-2<i>H</i>-pyran-4-yl)-1,5-dihydro-4<i>H</i>-pyrazolo[3,4-<i>d</i>]pyrimidin-4-one) Enhances Synaptic Plasticity and Cognitive Function in Rodents</span> <span class="citation_source-journal">Neuropharmacology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">61</span><span class="NLM_x">, </span> <span class="NLM_fpage">665</span><span class="NLM_x">–</span> <span class="NLM_lpage">667</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2011&pages=665-667&author=P.+H.+Hutsonauthor=E.+N.+Fingerauthor=B.+C.+Magliaroauthor=S.+M.+Smithauthor=A.+Conversoauthor=P.+E.+Sandersonauthor=D.+Mullinsauthor=L.+A.+Hydeauthor=B.+K.+Eschleauthor=Z.+Turnbullauthor=H.+Sloanauthor=M.+Guzziauthor=X.+Zhangauthor=A.+Wangauthor=D.+Rindgenauthor=R.+Mazzolaauthor=J.+A.+Vivianauthor=D.+Eddinsauthor=J.+M.+Uslanerauthor=R.+Bednarauthor=C.+Gamboneauthor=W.+Le-Mariauthor=M.+J.+Marinoauthor=N.+Sachsauthor=G.+Xuauthor=S.+Parmentier-Batteur&title=The+Selective+Phosphodiesterase+9+%28PDE9%29+Inhibitor+PF-04447943+%286-%5B%283S%2C4S%29-4-methyl-1-%28pyrimidin-2-ylmethyl%29pyrrolidin-3-yl%5D-1-%28tetrahydro-2H-pyran-4-yl%29-1%2C5-dihydro-4H-pyrazolo%5B3%2C4-d%5Dpyrimidin-4-one%29+Enhances+Synaptic+Plasticity+and+Cognitive+Function+in+Rodents"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHutson%26aufirst%3DP.%2BH.%26aulast%3DFinger%26aufirst%3DE.%2BN.%26aulast%3DMagliaro%26aufirst%3DB.%2BC.%26aulast%3DSmith%26aufirst%3DS.%2BM.%26aulast%3DConverso%26aufirst%3DA.%26aulast%3DSanderson%26aufirst%3DP.%2BE.%26aulast%3DMullins%26aufirst%3DD.%26aulast%3DHyde%26aufirst%3DL.%2BA.%26aulast%3DEschle%26aufirst%3DB.%2BK.%26aulast%3DTurnbull%26aufirst%3DZ.%26aulast%3DSloan%26aufirst%3DH.%26aulast%3DGuzzi%26aufirst%3DM.%26aulast%3DZhang%26aufirst%3DX.%26aulast%3DWang%26aufirst%3DA.%26aulast%3DRindgen%26aufirst%3DD.%26aulast%3DMazzola%26aufirst%3DR.%26aulast%3DVivian%26aufirst%3DJ.%2BA.%26aulast%3DEddins%26aufirst%3DD.%26aulast%3DUslaner%26aufirst%3DJ.%2BM.%26aulast%3DBednar%26aufirst%3DR.%26aulast%3DGambone%26aufirst%3DC.%26aulast%3DLe-Mari%26aufirst%3DW.%26aulast%3DMarino%26aufirst%3DM.%2BJ.%26aulast%3DSachs%26aufirst%3DN.%26aulast%3DXu%26aufirst%3DG.%26aulast%3DParmentier-Batteur%26aufirst%3DS.%26atitle%3DThe%2520Selective%2520Phosphodiesterase%25209%2520%2528PDE9%2529%2520Inhibitor%2520PF-04447943%2520%25286-%255B%25283S%252C4S%2529-4-methyl-1-%2528pyrimidin-2-ylmethyl%2529pyrrolidin-3-yl%255D-1-%2528tetrahydro-2H-pyran-4-yl%2529-1%252C5-dihydro-4H-pyrazolo%255B3%252C4-d%255Dpyrimidin-4-one%2529%2520Enhances%2520Synaptic%2520Plasticity%2520and%2520Cognitive%2520Function%2520in%2520Rodents%26jtitle%3DNeuropharmacology%26date%3D2011%26volume%3D61%26spage%3D665%26epage%3D667" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group">Kleiman, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lanz, T. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Finley, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bove, S. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Majchrzak, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Becker, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carvajal-Gonzales, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuhn, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wood, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mariga, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nelson, F. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Verhoest, P. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seymour, P. A</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stephenson, D. T.</span><span> </span><span class="NLM_article-title">Dendritic Spine Density Deficits in the Hippocampal CA1 Region of Young Tg2576 Mice Are Ameliorated with the PDE9A Inhibitor PF-04447943</span> <span class="citation_source-journal">Alzheimer’s Dementia</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">S563</span><span class="NLM_x">–</span> <span class="NLM_lpage">S564</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2010&pages=S563-S564&author=R.+J.+Kleimanauthor=T.+A.+Lanzauthor=J.+E.+Finleyauthor=S.+E.+Boveauthor=M.+J.+Majchrzakauthor=S.+L.+Beckerauthor=S.+Carvajal-Gonzalesauthor=A.+M.+Kuhnauthor=K.+M.+Woodauthor=A.+Marigaauthor=F.+R.+Nelsonauthor=P.+R.+Verhoestauthor=P.+A+Seymourauthor=D.+T.+Stephenson&title=Dendritic+Spine+Density+Deficits+in+the+Hippocampal+CA1+Region+of+Young+Tg2576+Mice+Are+Ameliorated+with+the+PDE9A+Inhibitor+PF-04447943"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKleiman%26aufirst%3DR.%2BJ.%26aulast%3DLanz%26aufirst%3DT.%2BA.%26aulast%3DFinley%26aufirst%3DJ.%2BE.%26aulast%3DBove%26aufirst%3DS.%2BE.%26aulast%3DMajchrzak%26aufirst%3DM.%2BJ.%26aulast%3DBecker%26aufirst%3DS.%2BL.%26aulast%3DCarvajal-Gonzales%26aufirst%3DS.%26aulast%3DKuhn%26aufirst%3DA.%2BM.%26aulast%3DWood%26aufirst%3DK.%2BM.%26aulast%3DMariga%26aufirst%3DA.%26aulast%3DNelson%26aufirst%3DF.%2BR.%26aulast%3DVerhoest%26aufirst%3DP.%2BR.%26aulast%3DSeymour%26aufirst%3DP.%2BA%26aulast%3DStephenson%26aufirst%3DD.%2BT.%26atitle%3DDendritic%2520Spine%2520Density%2520Deficits%2520in%2520the%2520Hippocampal%2520CA1%2520Region%2520of%2520Young%2520Tg2576%2520Mice%2520Are%2520Ameliorated%2520with%2520the%2520PDE9A%2520Inhibitor%2520PF-04447943%26jtitle%3DAlzheimer%25E2%2580%2599s%2520Dementia%26date%3D2010%26volume%3D6%26spage%3DS563%26epage%3DS564" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group">Wager, T. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hou, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Verhoest, P. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Villalobos, A.</span><span> </span><span class="NLM_article-title">Moving beyond Rules: The Development of a Central Nervous System Multiparameter Optimization (CNS MPO) Approach To Enable Alignment of Druglike Properties</span> <span class="citation_source-journal">ACS Chem. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">1</span><span class="NLM_x">, </span> <span class="NLM_fpage">435</span><span class="NLM_x">–</span> <span class="NLM_lpage">449</span></span><div class="citationLinks">[<a href="/doi/10.1021/cn100008c" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Fjm3007799&amp;key=1%3ACAS%3A528%3ADC%252BC3cXjvVejtr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2010&pages=435-449&author=T.+T.+Wagerauthor=X.+Houauthor=P.+R.+Verhoestauthor=A.+Villalobos&title=Moving+beyond+Rules%3A+The+Development+of+a+Central+Nervous+System+Multiparameter+Optimization+%28CNS+MPO%29+Approach+To+Enable+Alignment+of+Druglike+Properties"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Moving beyond Rules: The Development of a Central Nervous System Multiparameter Optimization (CNS MPO) Approach To Enable Alignment of Druglike Properties</span></div><div class="casAuthors">Wager, Travis T.; Hou, Xinjun; Verhoest, Patrick R.; Villalobos, Anabella</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Neuroscience</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">435-449</span>CODEN:
                <span class="NLM_cas:coden">ACNCDM</span>;
        ISSN:<span class="NLM_cas:issn">1948-7193</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The interplay among commonly used physicochem. properties in drug design was examd. and utilized to create a prospective design tool focused on the alignment of key druglike attributes.  Using a set of six physicochem. parameters ((a) lipophilicity, calcd. partition coeff. (ClogP); (b) calcd. distribution coeff. at pH = 7.4 (ClogD); (c) mol. wt. (MW); (d) topol. polar surface area (TPSA); (e) no. of hydrogen bond donors (HBD); (f) most basic center (pKa)), a druglikeness central nervous system multiparameter optimization (CNS MPO) algorithm was built and applied to a set of marketed CNS drugs (N = 119) and Pfizer CNS candidates (N = 108), as well as to a large diversity set of Pfizer proprietary compds. (N = 11 303).  The novel CNS MPO algorithm showed that 74% of marketed CNS drugs displayed a high CNS MPO score (MPO desirability score ≥ 4, using a scale of 0-6), in comparison to 60% of the Pfizer CNS candidates.  This anal. suggests that this algorithm could potentially be used to identify compds. with a higher probability of successfully testing hypotheses in the clinic.  In addn., a relationship between an increasing CNS MPO score and alignment of key in vitro attributes of drug discovery (favorable permeability, P-glycoprotein (P-gp) efflux, metabolic stability, and safety) was seen in the marketed CNS drug set, the Pfizer candidate set, and the Pfizer proprietary diversity set.  The CNS MPO scoring function offers advantages over hard cutoffs or utilization of single parameters to optimize structure-activity relationships (SAR) by expanding medicinal chem. design space through a holistic assessment approach.  Based on six physicochem. properties commonly used by medicinal chemists, the CNS MPO function may be used prospectively at the design stage to accelerate the identification of compds. with increased probability of success.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqB3Mvkgm_X5bVg90H21EOLACvtfcHk0lgdupzzjbCYsg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXjvVejtr8%253D&md5=e94998f65a420be6ee4dec4a987cb983</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1021%2Fcn100008c&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcn100008c%26sid%3Dliteratum%253Aachs%26aulast%3DWager%26aufirst%3DT.%2BT.%26aulast%3DHou%26aufirst%3DX.%26aulast%3DVerhoest%26aufirst%3DP.%2BR.%26aulast%3DVillalobos%26aufirst%3DA.%26atitle%3DMoving%2520beyond%2520Rules%253A%2520The%2520Development%2520of%2520a%2520Central%2520Nervous%2520System%2520Multiparameter%2520Optimization%2520%2528CNS%2520MPO%2529%2520Approach%2520To%2520Enable%2520Alignment%2520of%2520Druglike%2520Properties%26jtitle%3DACS%2520Chem.%2520Neurosci.%26date%3D2010%26volume%3D1%26spage%3D435%26epage%3D449" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group">Evans, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nicholas, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Le, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qiu, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martin, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martin, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Styren, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fullerton, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schwam, E.</span><span> </span><span class="NLM_article-title">Safety and Pharmacokinetics of PF-04447943, a PDE9A Inhibitor, in Single and Mulitple Dose Phase 1 Studies in Healthy Volunteers</span> <span class="citation_source-journal">Alzheimer’s Dementia</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">S135</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2010&pages=S135&author=R.+M.+Evansauthor=T.+Nicholasauthor=V.+Leauthor=R.+Qiuauthor=W.+Martinauthor=D.+Martinauthor=S.+Styrenauthor=T.+Fullertonauthor=E.+Schwam&title=Safety+and+Pharmacokinetics+of+PF-04447943%2C+a+PDE9A+Inhibitor%2C+in+Single+and+Mulitple+Dose+Phase+1+Studies+in+Healthy+Volunteers"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DEvans%26aufirst%3DR.%2BM.%26aulast%3DNicholas%26aufirst%3DT.%26aulast%3DLe%26aufirst%3DV.%26aulast%3DQiu%26aufirst%3DR.%26aulast%3DMartin%26aufirst%3DW.%26aulast%3DMartin%26aufirst%3DD.%26aulast%3DStyren%26aufirst%3DS.%26aulast%3DFullerton%26aufirst%3DT.%26aulast%3DSchwam%26aufirst%3DE.%26atitle%3DSafety%2520and%2520Pharmacokinetics%2520of%2520PF-04447943%252C%2520a%2520PDE9A%2520Inhibitor%252C%2520in%2520Single%2520and%2520Mulitple%2520Dose%2520Phase%25201%2520Studies%2520in%2520Healthy%2520Volunteers%26jtitle%3DAlzheimer%25E2%2580%2599s%2520Dementia%26date%3D2010%26volume%3D6%26spage%3DS135" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group">Nicholas, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Evans, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Styren, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qui, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, E. Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nelson, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Le, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grimwood, S</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Christoffersen, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Banerjee, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Corrigan, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kocan, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Geoghegan, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carrieri, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raha, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Verhoest, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Soares, H.</span><span> </span><span class="NLM_article-title">PF-04447943, a Novel PDE9A Inhibitor, Increases cGMP Levels in Cerebrospinal Fluid: Translation from Non-Clinical Species to Healthy Human Volunteers</span> <span class="citation_source-journal">Alzheimer’s Dementia</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">P330</span><span class="NLM_x">–</span> <span class="NLM_lpage">P331</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2009&pages=P330-P331&author=T.+Nicholasauthor=R.+Evansauthor=S.+Styrenauthor=R.+Quiauthor=E.+Q.+Wangauthor=F.+Nelsonauthor=V.+Leauthor=S+Grimwoodauthor=C.+Christoffersenauthor=S.+Banerjeeauthor=B.+Corriganauthor=G.+Kocanauthor=K.+Geogheganauthor=C.+Carrieriauthor=N.+Rahaauthor=P.+Verhoestauthor=H.+Soares&title=PF-04447943%2C+a+Novel+PDE9A+Inhibitor%2C+Increases+cGMP+Levels+in+Cerebrospinal+Fluid%3A+Translation+from+Non-Clinical+Species+to+Healthy+Human+Volunteers"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DNicholas%26aufirst%3DT.%26aulast%3DEvans%26aufirst%3DR.%26aulast%3DStyren%26aufirst%3DS.%26aulast%3DQui%26aufirst%3DR.%26aulast%3DWang%26aufirst%3DE.%2BQ.%26aulast%3DNelson%26aufirst%3DF.%26aulast%3DLe%26aufirst%3DV.%26aulast%3DGrimwood%26aufirst%3DS%26aulast%3DChristoffersen%26aufirst%3DC.%26aulast%3DBanerjee%26aufirst%3DS.%26aulast%3DCorrigan%26aufirst%3DB.%26aulast%3DKocan%26aufirst%3DG.%26aulast%3DGeoghegan%26aufirst%3DK.%26aulast%3DCarrieri%26aufirst%3DC.%26aulast%3DRaha%26aufirst%3DN.%26aulast%3DVerhoest%26aufirst%3DP.%26aulast%3DSoares%26aufirst%3DH.%26atitle%3DPF-04447943%252C%2520a%2520Novel%2520PDE9A%2520Inhibitor%252C%2520Increases%2520cGMP%2520Levels%2520in%2520Cerebrospinal%2520Fluid%253A%2520Translation%2520from%2520Non-Clinical%2520Species%2520to%2520Healthy%2520Human%2520Volunteers%26jtitle%3DAlzheimer%25E2%2580%2599s%2520Dementia%26date%3D2009%26volume%3D5%26spage%3DP330%26epage%3DP331" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 51 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Yinuo Wu, Quan Wang, Mei-Yan Jiang, Yi-You Huang, Ziran Zhu, Chuan Han, Yi-Jing Tian, Bei Zhang, <span class="NLM_string-name hlFld-ContribAuthor">Hai-Bin Luo</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of Potent Phosphodiesterase-9 Inhibitors for the Treatment of Hepatic Fibrosis. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>64 </em>
                                    (13)
                                     , 9537-9549. <a href="https://doi.org/10.1021/acs.jmedchem.1c00862" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.1c00862</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.1c00862&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.1c00862%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252BPotent%252BPhosphodiesterase-9%252BInhibitors%252Bfor%252Bthe%252BTreatment%252Bof%252BHepatic%252BFibrosis%26aulast%3DWu%26aufirst%3DYinuo%26date%3D2021%26date%3D2021%26date%3D2021%26date%3D12052021%26date%3D18062021%26volume%3D64%26issue%3D13%26spage%3D9537%26epage%3D9549" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Obdulia Rabal, Juan A. Sánchez-Arias, Mar Cuadrado-Tejedor, Irene de Miguel, Marta Pérez-González, Carolina García-Barroso, Ana Ugarte, Ander Estella-Hermoso de Mendoza, Elena Sáez, Maria Espelosin, Susana Ursua, Haizhong Tan, Wei Wu, Musheng Xu, Antonio Pineda-Lucena, Ana Garcia-Osta, <span class="NLM_string-name hlFld-ContribAuthor">Julen Oyarzabal</span>. </span><span class="cited-content_cbyCitation_article-title">Multitarget Approach for the Treatment of Alzheimer’s Disease: Inhibition of Phosphodiesterase 9 (PDE9) and Histone Deacetylases (HDACs) Covering Diverse Selectivity Profiles. </span><span class="cited-content_cbyCitation_journal-name">ACS Chemical Neuroscience</span><span> <strong>2019,</strong> <em>10 </em>
                                    (9)
                                     , 4076-4101. <a href="https://doi.org/10.1021/acschemneuro.9b00303" title="DOI URL">https://doi.org/10.1021/acschemneuro.9b00303</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acschemneuro.9b00303&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facschemneuro.9b00303%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Chemical%2520Neuroscience%26atitle%3DMultitarget%252BApproach%252Bfor%252Bthe%252BTreatment%252Bof%252BAlzheimer%2525E2%252580%252599s%252BDisease%25253A%252BInhibition%252Bof%252BPhosphodiesterase%252B9%252B%252528PDE9%252529%252Band%252BHistone%252BDeacetylases%252B%252528HDACs%252529%252BCovering%252BDiverse%252BSelectivity%252BProfiles%26aulast%3DRabal%26aufirst%3DObdulia%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D24052019%26date%3D23082019%26date%3D04092019%26date%3D23082019%26volume%3D10%26issue%3D9%26spage%3D4076%26epage%3D4101" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Yinuo Wu, Qian Zhou, Tianhua Zhang, Zhe Li, Yi-Ping Chen, Pei Zhang, Yan-Fa Yu, Haiju Geng, Yi-Jing Tian, Chen Zhang, Yu Wang, Jian-Wen Chen, Yan Chen, <span class="NLM_string-name hlFld-ContribAuthor">Hai-Bin Luo</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of Potent, Selective, and Orally Bioavailable Inhibitors against Phosphodiesterase-9, a Novel Target for the Treatment of Vascular Dementia. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2019,</strong> <em>62 </em>
                                    (8)
                                     , 4218-4224. <a href="https://doi.org/10.1021/acs.jmedchem.8b01041" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.8b01041</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.8b01041&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.8b01041%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252BPotent%25252C%252BSelective%25252C%252Band%252BOrally%252BBioavailable%252BInhibitors%252Bagainst%252BPhosphodiesterase-9%25252C%252Ba%252BNovel%252BTarget%252Bfor%252Bthe%252BTreatment%252Bof%252BVascular%252BDementia%26aulast%3DWu%26aufirst%3DYinuo%26date%3D2019%26date%3D2019%26date%3D2018%26date%3D30062018%26date%3D03042019%26date%3D27032019%26volume%3D62%26issue%3D8%26spage%3D4218%26epage%3D4224" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Yinuo Wu, Zhe Li, Yi-You Huang, Deyan Wu, <span class="NLM_string-name hlFld-ContribAuthor">Hai-Bin Luo</span>. </span><span class="cited-content_cbyCitation_article-title">Novel Phosphodiesterase Inhibitors for Cognitive Improvement in Alzheimer’s Disease. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2018,</strong> <em>61 </em>
                                    (13)
                                     , 5467-5483. <a href="https://doi.org/10.1021/acs.jmedchem.7b01370" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.7b01370</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.7b01370&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.7b01370%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DNovel%252BPhosphodiesterase%252BInhibitors%252Bfor%252BCognitive%252BImprovement%252Bin%252BAlzheimer%2525E2%252580%252599s%252BDisease%26aulast%3DWu%26aufirst%3DYinuo%26date%3D2018%26date%3D2018%26date%3D2017%26date%3D15092017%26date%3D05022018%26date%3D24012018%26volume%3D61%26issue%3D13%26spage%3D5467%26epage%3D5483" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Austin Horton, Kevin Nash, Ethel Tackie-Yarboi, Alexander Kostrevski, Adam Novak, Aparna Raghavan, Jatin Tulsulkar, Qasim Alhadidi, Nathan Wamer, Bryn Langenderfer, Kalee Royster, Maxwell Ducharme, Katelyn Hagood, Megan Post, Zahoor A. Shah, <span class="NLM_string-name hlFld-ContribAuthor">Isaac T. Schiefer</span>. </span><span class="cited-content_cbyCitation_article-title">Furoxans (Oxadiazole-4N-oxides) with Attenuated Reactivity are Neuroprotective, Cross the Blood Brain Barrier, and Improve Passive Avoidance Memory. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2018,</strong> <em>61 </em>
                                    (10)
                                     , 4593-4607. <a href="https://doi.org/10.1021/acs.jmedchem.8b00389" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.8b00389</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.8b00389&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.8b00389%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DFuroxans%252B%252528Oxadiazole-4N-oxides%252529%252Bwith%252BAttenuated%252BReactivity%252Bare%252BNeuroprotective%25252C%252BCross%252Bthe%252BBlood%252BBrain%252BBarrier%25252C%252Band%252BImprove%252BPassive%252BAvoidance%252BMemory%26aulast%3DHorton%26aufirst%3DAustin%26date%3D2018%26date%3D2018%26date%3D2018%26date%3D09032018%26date%3D07052018%26date%3D23042018%26volume%3D61%26issue%3D10%26spage%3D4593%26epage%3D4607" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Paulina  Gonzalez</span>, <span class="hlFld-ContribAuthor ">Kristof  Pota</span>, <span class="hlFld-ContribAuthor ">Lara Su  Turan</span>, <span class="hlFld-ContribAuthor ">Viviana C. P.  da Costa</span>, <span class="hlFld-ContribAuthor ">Giridhar  Akkaraju</span>, and <span class="hlFld-ContribAuthor ">Kayla N.  Green</span>  . </span><span class="cited-content_cbyCitation_article-title">Synthesis, Characterization, and Activity of a Triazine Bridged Antioxidant Small Molecule. </span><span class="cited-content_cbyCitation_journal-name">ACS Chemical Neuroscience</span><span> <strong>2017,</strong> <em>8 </em>
                                    (11)
                                     , 2414-2423. <a href="https://doi.org/10.1021/acschemneuro.7b00184" title="DOI URL">https://doi.org/10.1021/acschemneuro.7b00184</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acschemneuro.7b00184&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facschemneuro.7b00184%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Chemical%2520Neuroscience%26atitle%3DSynthesis%25252C%252BCharacterization%25252C%252Band%252BActivity%252Bof%252Ba%252BTriazine%252BBridged%252BAntioxidant%252BSmall%252BMolecule%26aulast%3DGonzalez%26aufirst%3DPaulina%26date%3D2017%26date%3D2017%26date%3D2017%26date%3D2017%26date%3D18052017%26date%3D02082017%26date%3D22082017%26date%3D15112017%26date%3D03082017%26volume%3D8%26issue%3D11%26spage%3D2414%26epage%3D2423" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Satoshi  Mikami</span>, <span class="hlFld-ContribAuthor ">Shigekazu  Sasaki</span>, <span class="hlFld-ContribAuthor ">Yasutomi  Asano</span>, <span class="hlFld-ContribAuthor ">Osamu  Ujikawa</span>, <span class="hlFld-ContribAuthor ">Shoji  Fukumoto</span>, <span class="hlFld-ContribAuthor ">Kosuke  Nakashima</span>, <span class="hlFld-ContribAuthor ">Hideyuki  Oki</span>, <span class="hlFld-ContribAuthor ">Naomi  Kamiguchi</span>, <span class="hlFld-ContribAuthor ">Haruka  Imada</span>, <span class="hlFld-ContribAuthor ">Hiroki  Iwashita</span>, and <span class="hlFld-ContribAuthor ">Takahiko  Taniguchi</span>  . </span><span class="cited-content_cbyCitation_article-title">Discovery of an Orally Bioavailable, Brain-Penetrating, in Vivo Active Phosphodiesterase 2A Inhibitor Lead Series for the Treatment of Cognitive Disorders. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2017,</strong> <em>60 </em>
                                    (18)
                                     , 7658-7676. <a href="https://doi.org/10.1021/acs.jmedchem.7b00709" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.7b00709</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.7b00709&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.7b00709%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252Ban%252BOrally%252BBioavailable%25252C%252BBrain-Penetrating%25252C%252Bin%252BVivo%252BActive%252BPhosphodiesterase%252B2A%252BInhibitor%252BLead%252BSeries%252Bfor%252Bthe%252BTreatment%252Bof%252BCognitive%252BDisorders%26aulast%3DMikami%26aufirst%3DSatoshi%26date%3D2017%26date%3D2017%26date%3D2017%26date%3D17052017%26date%3D11092017%26date%3D28092017%26date%3D31072017%26volume%3D60%26issue%3D18%26spage%3D7658%26epage%3D7676" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Christopher J.  Helal</span>, <span class="hlFld-ContribAuthor ">Eric P.  Arnold</span>, <span class="hlFld-ContribAuthor ">Tracey L.  Boyden</span>, <span class="hlFld-ContribAuthor ">Cheng  Chang</span>, <span class="hlFld-ContribAuthor ">Thomas A.  Chappie</span>, <span class="hlFld-ContribAuthor ">Kimberly F.  Fennell</span>, <span class="hlFld-ContribAuthor ">Michael D.  Forman</span>, <span class="hlFld-ContribAuthor ">Mihaly  Hajos</span>, <span class="hlFld-ContribAuthor ">John F.  Harms</span>, <span class="hlFld-ContribAuthor ">William E.  Hoffman</span>, <span class="hlFld-ContribAuthor ">John M.  Humphrey</span>, <span class="hlFld-ContribAuthor ">Zhijun  Kang</span>, <span class="hlFld-ContribAuthor ">Robin J.  Kleiman</span>, <span class="hlFld-ContribAuthor ">Bethany L.  Kormos</span>, <span class="hlFld-ContribAuthor ">Che-Wah  Lee</span>, <span class="hlFld-ContribAuthor ">Jiemin  Lu</span>, <span class="hlFld-ContribAuthor ">Noha  Maklad</span>, <span class="hlFld-ContribAuthor ">Laura  McDowell</span>, <span class="hlFld-ContribAuthor ">Scot  Mente</span>, <span class="hlFld-ContribAuthor ">Rebecca E.  O’Connor</span>, <span class="hlFld-ContribAuthor ">Jayvardhan  Pandit</span>, <span class="hlFld-ContribAuthor ">Mary  Piotrowski</span>, <span class="hlFld-ContribAuthor ">Anne W.  Schmidt</span>, <span class="hlFld-ContribAuthor ">Christopher J.  Schmidt</span>, <span class="hlFld-ContribAuthor ">Hirokazu  Ueno</span>, <span class="hlFld-ContribAuthor ">Patrick R.  Verhoest</span>, and <span class="hlFld-ContribAuthor ">Edward X.  Yang</span>  . </span><span class="cited-content_cbyCitation_article-title">Application of Structure-Based Design and Parallel Chemistry to Identify a Potent, Selective, and Brain Penetrant Phosphodiesterase 2A Inhibitor. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2017,</strong> <em>60 </em>
                                    (13)
                                     , 5673-5698. <a href="https://doi.org/10.1021/acs.jmedchem.7b00397" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.7b00397</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.7b00397&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.7b00397%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DApplication%252Bof%252BStructure-Based%252BDesign%252Band%252BParallel%252BChemistry%252Bto%252BIdentify%252Ba%252BPotent%25252C%252BSelective%25252C%252Band%252BBrain%252BPenetrant%252BPhosphodiesterase%252B2A%252BInhibitor%26aulast%3DHelal%26aufirst%3DChristopher%2BJ.%26date%3D2017%26date%3D2017%26date%3D2017%26date%3D14032017%26date%3D16062017%26date%3D13072017%26date%3D02062017%26volume%3D60%26issue%3D13%26spage%3D5673%26epage%3D5698" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Brian  Dyck</span>, <span class="hlFld-ContribAuthor ">Bryan  Branstetter</span>, <span class="hlFld-ContribAuthor ">Tawfik  Gharbaoui</span>, <span class="hlFld-ContribAuthor ">Andrew R.  Hudson</span>, <span class="hlFld-ContribAuthor ">J. Guy  Breitenbucher</span>, <span class="hlFld-ContribAuthor ">Laurent  Gomez</span>, <span class="hlFld-ContribAuthor ">Iriny  Botrous</span>, <span class="hlFld-ContribAuthor ">Tami  Marrone</span>, <span class="hlFld-ContribAuthor ">Richard  Barido</span>, <span class="hlFld-ContribAuthor ">Charles K.  Allerston</span>, <span class="hlFld-ContribAuthor ">E. Peder  Cedervall</span>, <span class="hlFld-ContribAuthor ">Rui  Xu</span>, <span class="hlFld-ContribAuthor ">Vandana  Sridhar</span>, <span class="hlFld-ContribAuthor ">Ryan  Barker</span>, <span class="hlFld-ContribAuthor ">Kathleen  Aertgeerts</span>, <span class="hlFld-ContribAuthor ">Kara  Schmelzer</span>, <span class="hlFld-ContribAuthor ">David  Neul</span>, <span class="hlFld-ContribAuthor ">Dong  Lee</span>, <span class="hlFld-ContribAuthor ">Mark Eben  Massari</span>, <span class="hlFld-ContribAuthor ">Carsten B.  Andersen</span>, <span class="hlFld-ContribAuthor ">Kristen  Sebring</span>, <span class="hlFld-ContribAuthor ">Xianbo  Zhou</span>, <span class="hlFld-ContribAuthor ">Robert  Petroski</span>, <span class="hlFld-ContribAuthor ">James  Limberis</span>, <span class="hlFld-ContribAuthor ">Martin  Augustin</span>, <span class="hlFld-ContribAuthor ">Lawrence E.  Chun</span>, <span class="hlFld-ContribAuthor ">Thomas E.  Edwards</span>, <span class="hlFld-ContribAuthor ">Marco  Peters</span>, and <span class="hlFld-ContribAuthor ">Ali  Tabatabaei</span>  . </span><span class="cited-content_cbyCitation_article-title">Discovery of Selective Phosphodiesterase 1 Inhibitors with Memory Enhancing Properties. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2017,</strong> <em>60 </em>
                                    (8)
                                     , 3472-3483. <a href="https://doi.org/10.1021/acs.jmedchem.7b00302" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.7b00302</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.7b00302&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.7b00302%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252BSelective%252BPhosphodiesterase%252B1%252BInhibitors%252Bwith%252BMemory%252BEnhancing%252BProperties%26aulast%3DDyck%26aufirst%3DBrian%26date%3D2017%26date%3D2017%26date%3D2017%26date%3D22022017%26date%3D13042017%26date%3D27042017%26volume%3D60%26issue%3D8%26spage%3D3472%26epage%3D3483" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yong-xian  Shao</span>, <span class="hlFld-ContribAuthor ">Manna  Huang</span>, <span class="hlFld-ContribAuthor ">Wenjun  Cui</span>, <span class="hlFld-ContribAuthor ">Ling-Jun  Feng</span>, <span class="hlFld-ContribAuthor ">Yinuo  Wu</span>, <span class="hlFld-ContribAuthor ">Yinghong  Cai</span>, <span class="hlFld-ContribAuthor ">Zhe  Li</span>, <span class="hlFld-ContribAuthor ">Xinhai  Zhu</span>, <span class="hlFld-ContribAuthor ">Peiqing  Liu</span>, <span class="hlFld-ContribAuthor ">Yiqian  Wan</span>, <span class="hlFld-ContribAuthor ">Hengming  Ke</span>, and <span class="hlFld-ContribAuthor ">Hai-Bin  Luo</span>  . </span><span class="cited-content_cbyCitation_article-title">Discovery of a Phosphodiesterase 9A Inhibitor as a Potential Hypoglycemic Agent. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2014,</strong> <em>57 </em>
                                    (24)
                                     , 10304-10313. <a href="https://doi.org/10.1021/jm500836h" title="DOI URL">https://doi.org/10.1021/jm500836h</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm500836h&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm500836h%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252Ba%252BPhosphodiesterase%252B9A%252BInhibitor%252Bas%252Ba%252BPotential%252BHypoglycemic%252BAgent%26aulast%3DShao%26aufirst%3DYong-xian%26date%3D2014%26date%3D2014%26date%3D2014%26date%3D01062014%26date%3D08122014%26date%3D26122014%26date%3D28112014%26volume%3D57%26issue%3D24%26spage%3D10304%26epage%3D10313" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Fei  Meng</span>, <span class="hlFld-ContribAuthor ">Jing  Hou</span>, <span class="hlFld-ContribAuthor ">Yong-Xian  Shao</span>, <span class="hlFld-ContribAuthor ">Pei-Ying  Wu</span>, <span class="hlFld-ContribAuthor ">Manna  Huang</span>, <span class="hlFld-ContribAuthor ">Xinhai  Zhu</span>, <span class="hlFld-ContribAuthor ">Yonghong  Cai</span>, <span class="hlFld-ContribAuthor ">Zhe  Li</span>, <span class="hlFld-ContribAuthor ">Jie  Xu</span>, <span class="hlFld-ContribAuthor ">Peiqing  Liu</span>, <span class="hlFld-ContribAuthor ">Hai-Bin  Luo</span>, <span class="hlFld-ContribAuthor ">Yiqian  Wan</span>, and <span class="hlFld-ContribAuthor ">Hengming  Ke</span>  . </span><span class="cited-content_cbyCitation_article-title">Structure-Based Discovery of Highly Selective Phosphodiesterase-9A Inhibitors and Implications for Inhibitor Design. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2012,</strong> <em>55 </em>
                                    (19)
                                     , 8549-8558. <a href="https://doi.org/10.1021/jm301189c" title="DOI URL">https://doi.org/10.1021/jm301189c</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm301189c&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm301189c%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DStructure-Based%252BDiscovery%252Bof%252BHighly%252BSelective%252BPhosphodiesterase-9A%252BInhibitors%252Band%252BImplications%252Bfor%252BInhibitor%252BDesign%26aulast%3DMeng%26aufirst%3DFei%26date%3D2012%26date%3D2012%26date%3D2012%26date%3D13082012%26date%3D01102012%26date%3D11102012%26date%3D17092012%26volume%3D55%26issue%3D19%26spage%3D8549%26epage%3D8558" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Nivedita  Singh</span>, <span class="hlFld-ContribAuthor ">Akhtar Hussain  Malik</span>, <span class="hlFld-ContribAuthor ">Parameswar Krishnan  Iyer</span>, <span class="hlFld-ContribAuthor ">Sanjukta  Patra</span>. </span><span class="cited-content_cbyCitation_article-title">Diversifying the xanthine scaffold for potential phosphodiesterase 9A inhibitors: synthesis and validation. </span><span class="cited-content_cbyCitation_journal-name">Medicinal Chemistry Research</span><span> <strong>2021,</strong> <em>30 </em>
                                    (6)
                                     , 1199-1219. <a href="https://doi.org/10.1007/s00044-021-02722-9" title="DOI URL">https://doi.org/10.1007/s00044-021-02722-9</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s00044-021-02722-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs00044-021-02722-9%26sid%3Dliteratum%253Aachs%26jtitle%3DMedicinal%2520Chemistry%2520Research%26atitle%3DDiversifying%252Bthe%252Bxanthine%252Bscaffold%252Bfor%252Bpotential%252Bphosphodiesterase%252B9A%252Binhibitors%25253A%252Bsynthesis%252Band%252Bvalidation%26aulast%3DSingh%26aufirst%3DNivedita%26date%3D2021%26date%3D2021%26volume%3D30%26issue%3D6%26spage%3D1199%26epage%3D1219" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Dakshinamurthy  Sivakumar</span>, <span class="hlFld-ContribAuthor ">Sathishkumar  Mudedla</span>, <span class="hlFld-ContribAuthor ">Seonghun  Jang</span>, <span class="hlFld-ContribAuthor ">Hyunjun  Kim</span>, <span class="hlFld-ContribAuthor ">Hyunjin  Park</span>, <span class="hlFld-ContribAuthor ">Yonwon  Choi</span>, <span class="hlFld-ContribAuthor ">Joongyo  Oh</span>, <span class="hlFld-ContribAuthor ">Sangwook  Wu</span>. </span><span class="cited-content_cbyCitation_article-title">Computational Study on Selective PDE9 Inhibitors on PDE9-Mg/Mg, PDE9-Zn/Mg, and PDE9-Zn/Zn Systems. </span><span class="cited-content_cbyCitation_journal-name">Biomolecules</span><span> <strong>2021,</strong> <em>11 </em>
                                    (5)
                                     , 709. <a href="https://doi.org/10.3390/biom11050709" title="DOI URL">https://doi.org/10.3390/biom11050709</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/biom11050709&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fbiom11050709%26sid%3Dliteratum%253Aachs%26jtitle%3DBiomolecules%26atitle%3DComputational%252BStudy%252Bon%252BSelective%252BPDE9%252BInhibitors%252Bon%252BPDE9-Mg%25252FMg%25252C%252BPDE9-Zn%25252FMg%25252C%252Band%252BPDE9-Zn%25252FZn%252BSystems%26aulast%3DSivakumar%26aufirst%3DDakshinamurthy%26date%3D2021%26date%3D2021%26volume%3D11%26issue%3D5%26spage%3D709" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xuefei  Li</span>, <span class="hlFld-ContribAuthor ">Yanbo  Yu</span>, <span class="hlFld-ContribAuthor ">Zhude  Tu</span>. </span><span class="cited-content_cbyCitation_article-title">Pyrazole Scaffold Synthesis, Functionalization, and Applications in Alzheimer’s Disease and Parkinson’s Disease Treatment (2011–2020). </span><span class="cited-content_cbyCitation_journal-name">Molecules</span><span> <strong>2021,</strong> <em>26 </em>
                                    (5)
                                     , 1202. <a href="https://doi.org/10.3390/molecules26051202" title="DOI URL">https://doi.org/10.3390/molecules26051202</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/molecules26051202&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fmolecules26051202%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecules%26atitle%3DPyrazole%252BScaffold%252BSynthesis%25252C%252BFunctionalization%25252C%252Band%252BApplications%252Bin%252BAlzheimer%2525E2%252580%252599s%252BDisease%252Band%252BParkinson%2525E2%252580%252599s%252BDisease%252BTreatment%252B%2525282011%2525E2%252580%2525932020%252529%26aulast%3DLi%26aufirst%3DXuefei%26date%3D2021%26date%3D2021%26volume%3D26%26issue%3D5%26spage%3D1202" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Dean  Paes</span>, <span class="hlFld-ContribAuthor ">Keqiang  Xie</span>, <span class="hlFld-ContribAuthor ">Damian G.  Wheeler</span>, <span class="hlFld-ContribAuthor ">Douglas  Zook</span>, <span class="hlFld-ContribAuthor ">Jos  Prickaerts</span>, <span class="hlFld-ContribAuthor ">Marco  Peters</span>. </span><span class="cited-content_cbyCitation_article-title">Inhibition of PDE2 and PDE4 synergistically improves memory consolidation processes. </span><span class="cited-content_cbyCitation_journal-name">Neuropharmacology</span><span> <strong>2021,</strong> <em>184 </em>, 108414. <a href="https://doi.org/10.1016/j.neuropharm.2020.108414" title="DOI URL">https://doi.org/10.1016/j.neuropharm.2020.108414</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.neuropharm.2020.108414&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.neuropharm.2020.108414%26sid%3Dliteratum%253Aachs%26jtitle%3DNeuropharmacology%26atitle%3DInhibition%252Bof%252BPDE2%252Band%252BPDE4%252Bsynergistically%252Bimproves%252Bmemory%252Bconsolidation%252Bprocesses%26aulast%3DPaes%26aufirst%3DDean%26date%3D2021%26volume%3D184%26spage%3D108414" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Eddie L  Myers</span>. </span><span class="cited-content_cbyCitation_article-title">Bicyclic 5–6 Systems: Other Four Heteroatoms 2:2. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2021,</strong>,<a href="https://doi.org/10.1016/B978-0-12-818655-8.00056-1" title="DOI URL">https://doi.org/10.1016/B978-0-12-818655-8.00056-1</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/B978-0-12-818655-8.00056-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2FB978-0-12-818655-8.00056-1%26sid%3Dliteratum%253Aachs%26atitle%3DBicyclic%252B5%2525E2%252580%2525936%252BSystems%25253A%252BOther%252BFour%252BHeteroatoms%252B2%25253A2%26aulast%3DMyers%26aufirst%3DEddie%2BL%26date%3D2021%26pub%3DElsevier%26atitle%3DReference%252BModule%252Bin%252BChemistry%25252C%252BMolecular%252BSciences%252Band%252BChemical%252BEngineering%26date%3D2021%26volume%3D22" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Mayasah Y.  Al-Nema</span>, <span class="hlFld-ContribAuthor ">Anand  Gaurav</span>. </span><span class="cited-content_cbyCitation_article-title">Phosphodiesterase as a Target for Cognition Enhancement in Schizophrenia. </span><span class="cited-content_cbyCitation_journal-name">Current Topics in Medicinal Chemistry</span><span> <strong>2020,</strong> <em>20 </em>
                                    (26)
                                     , 2404-2421. <a href="https://doi.org/10.2174/1568026620666200613202641" title="DOI URL">https://doi.org/10.2174/1568026620666200613202641</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.2174/1568026620666200613202641&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.2174%2F1568026620666200613202641%26sid%3Dliteratum%253Aachs%26jtitle%3DCurrent%2520Topics%2520in%2520Medicinal%2520Chemistry%26atitle%3DPhosphodiesterase%252Bas%252Ba%252BTarget%252Bfor%252BCognition%252BEnhancement%252Bin%252BSchizophrenia%26aulast%3DAl-Nema%26aufirst%3DMayasah%2BY.%26date%3D2020%26volume%3D20%26issue%3D26%26spage%3D2404%26epage%3D2421" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Pei  Zhang</span>, <span class="hlFld-ContribAuthor ">Mei-Yan  Jiang</span>, <span class="hlFld-ContribAuthor ">Mei-Ling  Le</span>, <span class="hlFld-ContribAuthor ">Bei  Zhang</span>, <span class="hlFld-ContribAuthor ">Qian  Zhou</span>, <span class="hlFld-ContribAuthor ">Yinuo  Wu</span>, <span class="hlFld-ContribAuthor ">Chen  Zhang</span>, <span class="hlFld-ContribAuthor ">Hai-Bin  Luo</span>. </span><span class="cited-content_cbyCitation_article-title">Design, synthesis and evaluation of pyrazolopyrimidinone derivatives as novel PDE9A inhibitors for treatment of Alzheimer’s disease. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2020,</strong> <em>30 </em>
                                    (14)
                                     , 127254. <a href="https://doi.org/10.1016/j.bmcl.2020.127254" title="DOI URL">https://doi.org/10.1016/j.bmcl.2020.127254</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2020.127254&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2020.127254%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DDesign%25252C%252Bsynthesis%252Band%252Bevaluation%252Bof%252Bpyrazolopyrimidinone%252Bderivatives%252Bas%252Bnovel%252BPDE9A%252Binhibitors%252Bfor%252Btreatment%252Bof%252BAlzheimer%2525E2%252580%252599s%252Bdisease%26aulast%3DZhang%26aufirst%3DPei%26date%3D2020%26volume%3D30%26issue%3D14%26spage%3D127254" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Shreaya  Chakroborty</span>, <span class="hlFld-ContribAuthor ">Fredric P.  Manfredsson</span>, <span class="hlFld-ContribAuthor ">Alexander M.  Dec</span>, <span class="hlFld-ContribAuthor ">Peter W.  Campbell</span>, <span class="hlFld-ContribAuthor ">Grace E.  Stutzmann</span>, <span class="hlFld-ContribAuthor ">Vahri  Beaumont</span>, <span class="hlFld-ContribAuthor ">Anthony R.  West</span>. </span><span class="cited-content_cbyCitation_article-title">Phosphodiesterase 9A Inhibition Facilitates Corticostriatal Transmission in Wild-Type and Transgenic Rats That Model Huntington’s Disease. </span><span class="cited-content_cbyCitation_journal-name">Frontiers in Neuroscience</span><span> <strong>2020,</strong> <em>14 </em><a href="https://doi.org/10.3389/fnins.2020.00466" title="DOI URL">https://doi.org/10.3389/fnins.2020.00466</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3389/fnins.2020.00466&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3389%2Ffnins.2020.00466%26sid%3Dliteratum%253Aachs%26jtitle%3DFrontiers%2520in%2520Neuroscience%26atitle%3DPhosphodiesterase%252B9A%252BInhibition%252BFacilitates%252BCorticostriatal%252BTransmission%252Bin%252BWild-Type%252Band%252BTransgenic%252BRats%252BThat%252BModel%252BHuntington%2525E2%252580%252599s%252BDisease%26aulast%3DChakroborty%26aufirst%3DShreaya%26date%3D2020%26date%3D2020%26volume%3D14" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Kevin D.  Hesp</span>, <span class="hlFld-ContribAuthor ">Jun  Xiao</span>, <span class="hlFld-ContribAuthor ">Graham M.  West</span>. </span><span class="cited-content_cbyCitation_article-title">Late-stage synthesis and application of photoreactive probes derived from direct benzoylation of heteroaromatic C–H bonds. </span><span class="cited-content_cbyCitation_journal-name">Organic & Biomolecular Chemistry</span><span> <strong>2020,</strong> <em>18 </em>
                                    (19)
                                     , 3669-3673. <a href="https://doi.org/10.1039/D0OB00336K" title="DOI URL">https://doi.org/10.1039/D0OB00336K</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/D0OB00336K&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FD0OB00336K%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520%2526%2520Biomolecular%2520Chemistry%26atitle%3DLate-stage%252Bsynthesis%252Band%252Bapplication%252Bof%252Bphotoreactive%252Bprobes%252Bderived%252Bfrom%252Bdirect%252Bbenzoylation%252Bof%252Bheteroaromatic%252BC%2525E2%252580%252593H%252Bbonds%26aulast%3DHesp%26aufirst%3DKevin%2BD.%26date%3D2020%26date%3D2020%26volume%3D18%26issue%3D19%26spage%3D3669%26epage%3D3673" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">John F.  Harms</span>, <span class="hlFld-ContribAuthor ">Frank S.  Menniti</span>, <span class="hlFld-ContribAuthor ">Christopher J.  Schmidt</span>. </span><span class="cited-content_cbyCitation_article-title">Phosphodiesterase 9A in Brain Regulates cGMP Signaling Independent of Nitric-Oxide. </span><span class="cited-content_cbyCitation_journal-name">Frontiers in Neuroscience</span><span> <strong>2019,</strong> <em>13 </em><a href="https://doi.org/10.3389/fnins.2019.00837" title="DOI URL">https://doi.org/10.3389/fnins.2019.00837</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3389/fnins.2019.00837&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3389%2Ffnins.2019.00837%26sid%3Dliteratum%253Aachs%26jtitle%3DFrontiers%2520in%2520Neuroscience%26atitle%3DPhosphodiesterase%252B9A%252Bin%252BBrain%252BRegulates%252BcGMP%252BSignaling%252BIndependent%252Bof%252BNitric-Oxide%26aulast%3DHarms%26aufirst%3DJohn%2BF.%26date%3D2019%26date%3D2019%26volume%3D13" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">G. Lakshma  Reddy</span>, <span class="hlFld-ContribAuthor ">Mohd. Ishaq  Dar</span>, <span class="hlFld-ContribAuthor ">Abhinandan D.  Hudwekar</span>, <span class="hlFld-ContribAuthor ">Priya  Mahajan</span>, <span class="hlFld-ContribAuthor ">Amit  Nargotra</span>, <span class="hlFld-ContribAuthor ">Adil Manzoor  Baba</span>, <span class="hlFld-ContribAuthor ">Utpal  Nandi</span>, <span class="hlFld-ContribAuthor ">Priya  Wazir</span>, <span class="hlFld-ContribAuthor ">Gurdarshan  Singh</span>, <span class="hlFld-ContribAuthor ">Ram A.  Vishwakarma</span>, <span class="hlFld-ContribAuthor ">Sajad Hussain  Syed</span>, <span class="hlFld-ContribAuthor ">Sanghapal D.  Sawant</span>. </span><span class="cited-content_cbyCitation_article-title">Design, synthesis and biological evaluation of pyrazolopyrimidinone based potent and selective PDE5 inhibitors for treatment of erectile dysfunction. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic Chemistry</span><span> <strong>2019,</strong> <em>89 </em>, 103022. <a href="https://doi.org/10.1016/j.bioorg.2019.103022" title="DOI URL">https://doi.org/10.1016/j.bioorg.2019.103022</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bioorg.2019.103022&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bioorg.2019.103022%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520Chemistry%26atitle%3DDesign%25252C%252Bsynthesis%252Band%252Bbiological%252Bevaluation%252Bof%252Bpyrazolopyrimidinone%252Bbased%252Bpotent%252Band%252Bselective%252BPDE5%252Binhibitors%252Bfor%252Btreatment%252Bof%252Berectile%252Bdysfunction%26aulast%3DReddy%26aufirst%3DG.%2BLakshma%26date%3D2019%26volume%3D89%26spage%3D103022" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Robert J.  Charnigo</span>, <span class="hlFld-ContribAuthor ">David  Beidler</span>, <span class="hlFld-ContribAuthor ">Denis  Rybin</span>, <span class="hlFld-ContribAuthor ">Debra D.  Pittman</span>, <span class="hlFld-ContribAuthor ">Beesan  Tan</span>, <span class="hlFld-ContribAuthor ">Jo  Howard</span>, <span class="hlFld-ContribAuthor ">Alan D.  Michelson</span>, <span class="hlFld-ContribAuthor ">Andrew L.  Frelinger</span>, <span class="hlFld-ContribAuthor ">Nicholas  Clarke</span>. </span><span class="cited-content_cbyCitation_article-title">PF
              ‐04447943, a Phosphodiesterase 9A Inhibitor, in Stable Sickle Cell Disease Patients: A Phase Ib Randomized, Placebo‐Controlled Study. </span><span class="cited-content_cbyCitation_journal-name">Clinical and Translational Science</span><span> <strong>2019,</strong> <em>12 </em>
                                    (2)
                                     , 180-188. <a href="https://doi.org/10.1111/cts.12604" title="DOI URL">https://doi.org/10.1111/cts.12604</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1111/cts.12604&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1111%2Fcts.12604%26sid%3Dliteratum%253Aachs%26jtitle%3DClinical%2520and%2520Translational%2520Science%26atitle%3DPF%252B%2525E2%252580%25259004447943%25252C%252Ba%252BPhosphodiesterase%252B9A%252BInhibitor%25252C%252Bin%252BStable%252BSickle%252BCell%252BDisease%252BPatients%25253A%252BA%252BPhase%252BIb%252BRandomized%25252C%252BPlacebo%2525E2%252580%252590Controlled%252BStudy%26aulast%3DCharnigo%26aufirst%3DRobert%2BJ.%26date%3D2019%26date%3D2018%26volume%3D12%26issue%3D2%26spage%3D180%26epage%3D188" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xian-Feng  Huang</span>, <span class="hlFld-ContribAuthor ">Wen-Tao  Jiang</span>, <span class="hlFld-ContribAuthor ">Li  Liu</span>, <span class="hlFld-ContribAuthor ">Fang-Chen  Song</span>, <span class="hlFld-ContribAuthor ">Xia  Zhu</span>, <span class="hlFld-ContribAuthor ">Gui-Lan  Shi</span>, <span class="hlFld-ContribAuthor ">Shu-Ming  Ding</span>, <span class="hlFld-ContribAuthor ">Heng-Ming  Ke</span>, <span class="hlFld-ContribAuthor ">Wei  Wang</span>, <span class="hlFld-ContribAuthor ">James M.  O'Donnell</span>, <span class="hlFld-ContribAuthor ">Han-Ting  Zhang</span>, <span class="hlFld-ContribAuthor ">Hai-Bin  Luo</span>, <span class="hlFld-ContribAuthor ">Yi-Qian  Wan</span>, <span class="hlFld-ContribAuthor ">Guo-Qiang  Song</span>, <span class="hlFld-ContribAuthor ">Ying  Xu</span>. </span><span class="cited-content_cbyCitation_article-title">A novel PDE9 inhibitor WYQ-C36D ameliorates corticosterone-induced neurotoxicity and depression-like behaviors by cGMP-CREB-related signaling. </span><span class="cited-content_cbyCitation_journal-name">CNS Neuroscience & Therapeutics</span><span> <strong>2018,</strong> <em>24 </em>
                                    (10)
                                     , 889-896. <a href="https://doi.org/10.1111/cns.12864" title="DOI URL">https://doi.org/10.1111/cns.12864</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1111/cns.12864&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1111%2Fcns.12864%26sid%3Dliteratum%253Aachs%26jtitle%3DCNS%2520Neuroscience%2520%2526%2520Therapeutics%26atitle%3DA%252Bnovel%252BPDE9%252Binhibitor%252BWYQ-C36D%252Bameliorates%252Bcorticosterone-induced%252Bneurotoxicity%252Band%252Bdepression-like%252Bbehaviors%252Bby%252BcGMP-CREB-related%252Bsignaling%26aulast%3DHuang%26aufirst%3DXian-Feng%26date%3D2018%26date%3D2018%26volume%3D24%26issue%3D10%26spage%3D889%26epage%3D896" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Christopher J.  Helal</span>, <span class="hlFld-ContribAuthor ">Alessandra  Bartolozzi</span>, <span class="hlFld-ContribAuthor ">Steven D.  Goble</span>, <span class="hlFld-ContribAuthor ">Neelakanda S.  Mani</span>, <span class="hlFld-ContribAuthor ">Angel  Guzman-Perez</span>, <span class="hlFld-ContribAuthor ">Ajay K.  Ohri</span>, <span class="hlFld-ContribAuthor ">Zhi-Cai  Shi</span>, <span class="hlFld-ContribAuthor ">Chakrapani  Subramanyam</span>. </span><span class="cited-content_cbyCitation_article-title">Increased building block access through collaboration. </span><span class="cited-content_cbyCitation_journal-name">Drug Discovery Today</span><span> <strong>2018,</strong> <em>23 </em>
                                    (8)
                                     , 1458-1462. <a href="https://doi.org/10.1016/j.drudis.2018.03.001" title="DOI URL">https://doi.org/10.1016/j.drudis.2018.03.001</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.drudis.2018.03.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.drudis.2018.03.001%26sid%3Dliteratum%253Aachs%26jtitle%3DDrug%2520Discovery%2520Today%26atitle%3DIncreased%252Bbuilding%252Bblock%252Baccess%252Bthrough%252Bcollaboration%26aulast%3DHelal%26aufirst%3DChristopher%2BJ.%26date%3D2018%26volume%3D23%26issue%3D8%26spage%3D1458%26epage%3D1462" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jessica A.  Wales</span>, <span class="hlFld-ContribAuthor ">Cheng-Yu  Chen</span>, <span class="hlFld-ContribAuthor ">Linda  Breci</span>, <span class="hlFld-ContribAuthor ">Andrzej  Weichsel</span>, <span class="hlFld-ContribAuthor ">Sylvie G.  Bernier</span>, <span class="hlFld-ContribAuthor ">James E.  Sheppeck</span>, <span class="hlFld-ContribAuthor ">Robert  Solinga</span>, <span class="hlFld-ContribAuthor ">Takashi  Nakai</span>, <span class="hlFld-ContribAuthor ">Paul A.  Renhowe</span>, <span class="hlFld-ContribAuthor ">Joon  Jung</span>, <span class="hlFld-ContribAuthor ">William R.  Montfort</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of stimulator binding to a conserved pocket in the heme domain of soluble guanylyl cyclase. </span><span class="cited-content_cbyCitation_journal-name">Journal of Biological Chemistry</span><span> <strong>2018,</strong> <em>293 </em>
                                    (5)
                                     , 1850-1864. <a href="https://doi.org/10.1074/jbc.RA117.000457" title="DOI URL">https://doi.org/10.1074/jbc.RA117.000457</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1074/jbc.RA117.000457&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1074%2Fjbc.RA117.000457%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Biological%2520Chemistry%26atitle%3DDiscovery%252Bof%252Bstimulator%252Bbinding%252Bto%252Ba%252Bconserved%252Bpocket%252Bin%252Bthe%252Bheme%252Bdomain%252Bof%252Bsoluble%252Bguanylyl%252Bcyclase%26aulast%3DWales%26aufirst%3DJessica%2BA.%26date%3D2018%26volume%3D293%26issue%3D5%26spage%3D1850%26epage%3D1864" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ana Marta  de Matos</span>, <span class="hlFld-ContribAuthor ">Maria Paula  de Macedo</span>, <span class="hlFld-ContribAuthor ">Amélia Pilar  Rauter</span>. </span><span class="cited-content_cbyCitation_article-title">Bridging Type 2 Diabetes and Alzheimer's Disease: Assembling the Puzzle Pieces in the Quest for the Molecules With Therapeutic and Preventive Potential. </span><span class="cited-content_cbyCitation_journal-name">Medicinal Research Reviews</span><span> <strong>2018,</strong> <em>38 </em>
                                    (1)
                                     , 261-324. <a href="https://doi.org/10.1002/med.21440" title="DOI URL">https://doi.org/10.1002/med.21440</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/med.21440&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fmed.21440%26sid%3Dliteratum%253Aachs%26jtitle%3DMedicinal%2520Research%2520Reviews%26atitle%3DBridging%252BType%252B2%252BDiabetes%252Band%252BAlzheimer%252527s%252BDisease%25253A%252BAssembling%252Bthe%252BPuzzle%252BPieces%252Bin%252Bthe%252BQuest%252Bfor%252Bthe%252BMolecules%252BWith%252BTherapeutic%252Band%252BPreventive%252BPotential%26aulast%3Dde%2BMatos%26aufirst%3DAna%2BMarta%26date%3D2018%26date%3D2017%26volume%3D38%26issue%3D1%26spage%3D261%26epage%3D324" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Kasper  Fjelbye</span>, <span class="hlFld-ContribAuthor ">Mauro  Marigo</span>, <span class="hlFld-ContribAuthor ">Rasmus P.  Clausen</span>, <span class="hlFld-ContribAuthor ">Erling B.  Jørgensen</span>, <span class="hlFld-ContribAuthor ">Claus T.  Christoffersen</span>, <span class="hlFld-ContribAuthor ">Karsten  Juhl</span>. </span><span class="cited-content_cbyCitation_article-title">Elucidation of fluorine's impact on p
              K
              a
              and
              in vitro
              Pgp-mediated efflux for a series of PDE9 inhibitors. </span><span class="cited-content_cbyCitation_journal-name">MedChemComm</span><span> <strong>2018,</strong> <em>9 </em>
                                    (5)
                                     , 893-896. <a href="https://doi.org/10.1039/C8MD00114F" title="DOI URL">https://doi.org/10.1039/C8MD00114F</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C8MD00114F&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC8MD00114F%26sid%3Dliteratum%253Aachs%26jtitle%3DMedChemComm%26atitle%3DElucidation%252Bof%252Bfluorine%252527s%252Bimpact%252Bon%252Bp%252BK%252Ba%252Band%252Bin%252Bvitro%252BPgp-mediated%252Befflux%252Bfor%252Ba%252Bseries%252Bof%252BPDE9%252Binhibitors%26aulast%3DFjelbye%26aufirst%3DKasper%26date%3D2018%26date%3D2018%26volume%3D9%26issue%3D5%26spage%3D893%26epage%3D896" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Chen  Zhang</span>, <span class="hlFld-ContribAuthor ">Qian  Zhou</span>, <span class="hlFld-ContribAuthor ">Xu-Nian  Wu</span>, <span class="hlFld-ContribAuthor ">Ya-Dan  Huang</span>, <span class="hlFld-ContribAuthor ">Jie  Zhou</span>, <span class="hlFld-ContribAuthor ">Zengwei  Lai</span>, <span class="hlFld-ContribAuthor ">Yinuo  Wu</span>, <span class="hlFld-ContribAuthor ">Hai-Bin  Luo</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of novel PDE9A inhibitors with antioxidant activities for treatment of Alzheimer’s disease. </span><span class="cited-content_cbyCitation_journal-name">Journal of Enzyme Inhibition and Medicinal Chemistry</span><span> <strong>2018,</strong> <em>33 </em>
                                    (1)
                                     , 260-270. <a href="https://doi.org/10.1080/14756366.2017.1412315" title="DOI URL">https://doi.org/10.1080/14756366.2017.1412315</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/14756366.2017.1412315&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F14756366.2017.1412315%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Enzyme%2520Inhibition%2520and%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252Bnovel%252BPDE9A%252Binhibitors%252Bwith%252Bantioxidant%252Bactivities%252Bfor%252Btreatment%252Bof%252BAlzheimer%2525E2%252580%252599s%252Bdisease%26aulast%3DZhang%26aufirst%3DChen%26date%3D2018%26date%3D2017%26volume%3D33%26issue%3D1%26spage%3D260%26epage%3D270" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Pan-xia  Wang</span>, <span class="hlFld-ContribAuthor ">Zhuo-ming  Li</span>, <span class="hlFld-ContribAuthor ">Si-dong  Cai</span>, <span class="hlFld-ContribAuthor ">Jing-yan  Li</span>, <span class="hlFld-ContribAuthor ">Ping  He</span>, <span class="hlFld-ContribAuthor ">Yi  Huang</span>, <span class="hlFld-ContribAuthor ">Guo-shuai  Feng</span>, <span class="hlFld-ContribAuthor ">Hai-bin  Luo</span>, <span class="hlFld-ContribAuthor ">Shao-rui  Chen</span>, <span class="hlFld-ContribAuthor ">Pei-qing  Liu</span>. </span><span class="cited-content_cbyCitation_article-title">C33(S), a novel PDE9A inhibitor, protects against rat cardiac hypertrophy through upregulating cGMP signaling. </span><span class="cited-content_cbyCitation_journal-name">Acta Pharmacologica Sinica</span><span> <strong>2017,</strong> <em>38 </em>
                                    (9)
                                     , 1257-1268. <a href="https://doi.org/10.1038/aps.2017.38" title="DOI URL">https://doi.org/10.1038/aps.2017.38</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/aps.2017.38&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Faps.2017.38%26sid%3Dliteratum%253Aachs%26jtitle%3DActa%2520Pharmacologica%2520Sinica%26atitle%3DC33%252528S%252529%25252C%252Ba%252Bnovel%252BPDE9A%252Binhibitor%25252C%252Bprotects%252Bagainst%252Brat%252Bcardiac%252Bhypertrophy%252Bthrough%252Bupregulating%252BcGMP%252Bsignaling%26aulast%3DWang%26aufirst%3DPan-xia%26date%3D2017%26date%3D2017%26volume%3D38%26issue%3D9%26spage%3D1257%26epage%3D1268" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ramin  Ghorbani-Vaghei</span>, <span class="hlFld-ContribAuthor ">Vida  Izadkhah</span>, <span class="hlFld-ContribAuthor ">Jafar  Mahmoodi</span>. </span><span class="cited-content_cbyCitation_article-title">One-pot synthesis of pyran derivatives using silica-coated magnetic nanoparticles functionalized with piperidinium benzene-1,3-disulfonate as a new efficient reusable catalyst. </span><span class="cited-content_cbyCitation_journal-name">Research on Chemical Intermediates</span><span> <strong>2017,</strong> <em>43 </em>
                                    (4)
                                     , 2299-2314. <a href="https://doi.org/10.1007/s11164-016-2762-x" title="DOI URL">https://doi.org/10.1007/s11164-016-2762-x</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s11164-016-2762-x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs11164-016-2762-x%26sid%3Dliteratum%253Aachs%26jtitle%3DResearch%2520on%2520Chemical%2520Intermediates%26atitle%3DOne-pot%252Bsynthesis%252Bof%252Bpyran%252Bderivatives%252Busing%252Bsilica-coated%252Bmagnetic%252Bnanoparticles%252Bfunctionalized%252Bwith%252Bpiperidinium%252Bbenzene-1%25252C3-disulfonate%252Bas%252Ba%252Bnew%252Befficient%252Breusable%252Bcatalyst%26aulast%3DGhorbani-Vaghei%26aufirst%3DRamin%26date%3D2017%26date%3D2016%26volume%3D43%26issue%3D4%26spage%3D2299%26epage%3D2314" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Eric  Knott</span>, <span class="hlFld-ContribAuthor ">Mazen  Assi</span>, <span class="hlFld-ContribAuthor ">Sudheendra  Rao</span>, <span class="hlFld-ContribAuthor ">Mousumi  Ghosh</span>, <span class="hlFld-ContribAuthor ">Damien  Pearse</span>. </span><span class="cited-content_cbyCitation_article-title">Phosphodiesterase Inhibitors as a Therapeutic Approach to Neuroprotection and Repair. </span><span class="cited-content_cbyCitation_journal-name">International Journal of Molecular Sciences</span><span> <strong>2017,</strong> <em>18 </em>
                                    (4)
                                     , 696. <a href="https://doi.org/10.3390/ijms18040696" title="DOI URL">https://doi.org/10.3390/ijms18040696</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/ijms18040696&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fijms18040696%26sid%3Dliteratum%253Aachs%26jtitle%3DInternational%2520Journal%2520of%2520Molecular%2520Sciences%26atitle%3DPhosphodiesterase%252BInhibitors%252Bas%252Ba%252BTherapeutic%252BApproach%252Bto%252BNeuroprotection%252Band%252BRepair%26aulast%3DKnott%26aufirst%3DEric%26date%3D2017%26date%3D2017%26volume%3D18%26issue%3D4%26spage%3D696" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ryan T.  Cameron</span>, <span class="hlFld-ContribAuthor ">Ellanor  Whiteley</span>, <span class="hlFld-ContribAuthor ">Jon P.  Day</span>, <span class="hlFld-ContribAuthor ">Anna I.  Parachikova</span>, <span class="hlFld-ContribAuthor ">George S.  Baillie</span>. </span><span class="cited-content_cbyCitation_article-title">Selective inhibition of phosphodiesterases 4, 5 and 9 induces HSP20 phosphorylation and attenuates amyloid beta 1-42-mediated cytotoxicity. </span><span class="cited-content_cbyCitation_journal-name">FEBS Open Bio</span><span> <strong>2017,</strong> <em>7 </em>
                                    (1)
                                     , 64-73. <a href="https://doi.org/10.1002/2211-5463.12156" title="DOI URL">https://doi.org/10.1002/2211-5463.12156</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/2211-5463.12156&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2F2211-5463.12156%26sid%3Dliteratum%253Aachs%26jtitle%3DFEBS%2520Open%2520Bio%26atitle%3DSelective%252Binhibition%252Bof%252Bphosphodiesterases%252B4%25252C%252B5%252Band%252B9%252Binduces%252BHSP20%252Bphosphorylation%252Band%252Battenuates%252Bamyloid%252Bbeta%252B1-42-mediated%252Bcytotoxicity%26aulast%3DCameron%26aufirst%3DRyan%2BT.%26date%3D2017%26date%3D2016%26volume%3D7%26issue%3D1%26spage%3D64%26epage%3D73" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">J.  Kehler</span>. </span><span class="cited-content_cbyCitation_article-title">Targeting Phosphodiesterases in the CNS. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2017,</strong>,, 384-407. <a href="https://doi.org/10.1016/B978-0-12-409547-2.12445-X" title="DOI URL">https://doi.org/10.1016/B978-0-12-409547-2.12445-X</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/B978-0-12-409547-2.12445-X&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2FB978-0-12-409547-2.12445-X%26sid%3Dliteratum%253Aachs%26atitle%3DTargeting%252BPhosphodiesterases%252Bin%252Bthe%252BCNS%26aulast%3DKehler%26aufirst%3DJ.%26date%3D2017%26spage%3D384%26epage%3D407%26pub%3DElsevier%26atitle%3DComprehensive%252BMedicinal%252BChemistry%252BIII%26date%3D2017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Tao  Su</span>, <span class="hlFld-ContribAuthor ">Tianhua  Zhang</span>, <span class="hlFld-ContribAuthor ">Shishun  Xie</span>, <span class="hlFld-ContribAuthor ">Jun  Yan</span>, <span class="hlFld-ContribAuthor ">Yinuo  Wu</span>, <span class="hlFld-ContribAuthor ">Xingshu  Li</span>, <span class="hlFld-ContribAuthor ">Ling  Huang</span>, <span class="hlFld-ContribAuthor ">Hai-Bin  Luo</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of novel PDE9 inhibitors capable of inhibiting Aβ aggregation as potential candidates for the treatment of Alzheimer’s disease. </span><span class="cited-content_cbyCitation_journal-name">Scientific Reports</span><span> <strong>2016,</strong> <em>6 </em>
                                    (1)
                                     <a href="https://doi.org/10.1038/srep21826" title="DOI URL">https://doi.org/10.1038/srep21826</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/srep21826&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fsrep21826%26sid%3Dliteratum%253Aachs%26jtitle%3DScientific%2520Reports%26atitle%3DDiscovery%252Bof%252Bnovel%252BPDE9%252Binhibitors%252Bcapable%252Bof%252Binhibiting%252BA%2525CE%2525B2%252Baggregation%252Bas%252Bpotential%252Bcandidates%252Bfor%252Bthe%252Btreatment%252Bof%252BAlzheimer%2525E2%252580%252599s%252Bdisease%26aulast%3DSu%26aufirst%3DTao%26date%3D2016%26date%3D2016%26volume%3D6%26issue%3D1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Manna  Huang</span>, <span class="hlFld-ContribAuthor ">Yongxian  Shao</span>, <span class="hlFld-ContribAuthor ">Jianying  Hou</span>, <span class="hlFld-ContribAuthor ">Wenjun  Cui</span>, <span class="hlFld-ContribAuthor ">Beibei  Liang</span>, <span class="hlFld-ContribAuthor ">Yingchun  Huang</span>, <span class="hlFld-ContribAuthor ">Zhe  Li</span>, <span class="hlFld-ContribAuthor ">Yinuo  Wu</span>, <span class="hlFld-ContribAuthor ">Xinhai  Zhu</span>, <span class="hlFld-ContribAuthor ">Peiqing  Liu</span>, <span class="hlFld-ContribAuthor ">Yiqian  Wan</span>, <span class="hlFld-ContribAuthor ">Hengming  Ke</span>, <span class="hlFld-ContribAuthor ">Hai-Bin  Luo</span>. </span><span class="cited-content_cbyCitation_article-title">Structural Asymmetry of Phosphodiesterase-9A and a Unique Pocket for Selective Binding of a Potent Enantiomeric Inhibitor. </span><span class="cited-content_cbyCitation_journal-name">Molecular Pharmacology</span><span> <strong>2015,</strong> <em>88 </em>
                                    (5)
                                     , 836-845. <a href="https://doi.org/10.1124/mol.115.099747" title="DOI URL">https://doi.org/10.1124/mol.115.099747</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1124/mol.115.099747&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1124%2Fmol.115.099747%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecular%2520Pharmacology%26atitle%3DStructural%252BAsymmetry%252Bof%252BPhosphodiesterase-9A%252Band%252Ba%252BUnique%252BPocket%252Bfor%252BSelective%252BBinding%252Bof%252Ba%252BPotent%252BEnantiomeric%252BInhibitor%26aulast%3DHuang%26aufirst%3DManna%26date%3D2015%26date%3D2015%26volume%3D88%26issue%3D5%26spage%3D836%26epage%3D845" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Tomoya  Shiro</span>, <span class="hlFld-ContribAuthor ">Takayuki  Fukaya</span>, <span class="hlFld-ContribAuthor ">Masanori  Tobe</span>. </span><span class="cited-content_cbyCitation_article-title">The chemistry and biological activity of heterocycle-fused quinolinone derivatives: A review. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2015,</strong> <em>97 </em>, 397-408. <a href="https://doi.org/10.1016/j.ejmech.2014.12.004" title="DOI URL">https://doi.org/10.1016/j.ejmech.2014.12.004</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2014.12.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2014.12.004%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DThe%252Bchemistry%252Band%252Bbiological%252Bactivity%252Bof%252Bheterocycle-fused%252Bquinolinone%252Bderivatives%25253A%252BA%252Breview%26aulast%3DShiro%26aufirst%3DTomoya%26date%3D2015%26volume%3D97%26spage%3D397%26epage%3D408" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Dong I.  Lee</span>, <span class="hlFld-ContribAuthor ">Guangshuo  Zhu</span>, <span class="hlFld-ContribAuthor ">Takashi  Sasaki</span>, <span class="hlFld-ContribAuthor ">Gun-Sik  Cho</span>, <span class="hlFld-ContribAuthor ">Nazha  Hamdani</span>, <span class="hlFld-ContribAuthor ">Ronald  Holewinski</span>, <span class="hlFld-ContribAuthor ">Su-Hyun  Jo</span>, <span class="hlFld-ContribAuthor ">Thomas  Danner</span>, <span class="hlFld-ContribAuthor ">Manling  Zhang</span>, <span class="hlFld-ContribAuthor ">Peter P.  Rainer</span>, <span class="hlFld-ContribAuthor ">Djahida  Bedja</span>, <span class="hlFld-ContribAuthor ">Jonathan A.  Kirk</span>, <span class="hlFld-ContribAuthor ">Mark J.  Ranek</span>, <span class="hlFld-ContribAuthor ">Wolfgang R.  Dostmann</span>, <span class="hlFld-ContribAuthor ">Chulan  Kwon</span>, <span class="hlFld-ContribAuthor ">Kenneth B.  Margulies</span>, <span class="hlFld-ContribAuthor ">Jennifer E.  Van Eyk</span>, <span class="hlFld-ContribAuthor ">Walter J.  Paulus</span>, <span class="hlFld-ContribAuthor ">Eiki  Takimoto</span>, <span class="hlFld-ContribAuthor ">David A.  Kass</span>. </span><span class="cited-content_cbyCitation_article-title">Phosphodiesterase 9A controls nitric-oxide-independent cGMP and hypertrophic heart disease. </span><span class="cited-content_cbyCitation_journal-name">Nature</span><span> <strong>2015,</strong> <em>519 </em>
                                    (7544)
                                     , 472-476. <a href="https://doi.org/10.1038/nature14332" title="DOI URL">https://doi.org/10.1038/nature14332</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/nature14332&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fnature14332%26sid%3Dliteratum%253Aachs%26jtitle%3DNature%26atitle%3DPhosphodiesterase%252B9A%252Bcontrols%252Bnitric-oxide-independent%252BcGMP%252Band%252Bhypertrophic%252Bheart%252Bdisease%26aulast%3DLee%26aufirst%3DDong%2BI.%26date%3D2015%26date%3D2015%26volume%3D519%26issue%3D7544%26spage%3D472%26epage%3D476" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Qinglei  Chong</span>, <span class="hlFld-ContribAuthor ">Chunxiang  Wang</span>, <span class="hlFld-ContribAuthor ">Dongping  Wang</span>, <span class="hlFld-ContribAuthor ">Haolong  Wang</span>, <span class="hlFld-ContribAuthor ">Fan  Wu</span>, <span class="hlFld-ContribAuthor ">Xiaoyi  Xin</span>, <span class="hlFld-ContribAuthor ">Boshun  Wan</span>. </span><span class="cited-content_cbyCitation_article-title">DABCO-catalyzed synthesis of 3-bromo-/3-iodo-2H-pyrans from propargyl alcohols, dialkyl acetylene dicarboxylates, and N-bromo-/N-iodosuccinimides. </span><span class="cited-content_cbyCitation_journal-name">Tetrahedron Letters</span><span> <strong>2015,</strong> <em>56 </em>
                                    (2)
                                     , 401-403. <a href="https://doi.org/10.1016/j.tetlet.2014.11.111" title="DOI URL">https://doi.org/10.1016/j.tetlet.2014.11.111</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.tetlet.2014.11.111&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.tetlet.2014.11.111%26sid%3Dliteratum%253Aachs%26jtitle%3DTetrahedron%2520Letters%26atitle%3DDABCO-catalyzed%252Bsynthesis%252Bof%252B3-bromo-%25252F3-iodo-2H-pyrans%252Bfrom%252Bpropargyl%252Balcohols%25252C%252Bdialkyl%252Bacetylene%252Bdicarboxylates%25252C%252Band%252BN-bromo-%25252FN-iodosuccinimides%26aulast%3DChong%26aufirst%3DQinglei%26date%3D2015%26volume%3D56%26issue%3D2%26spage%3D401%26epage%3D403" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Zhe  Li</span>, <span class="hlFld-ContribAuthor ">Xiao  Lu</span>, <span class="hlFld-ContribAuthor ">Ling-Jun  Feng</span>, <span class="hlFld-ContribAuthor ">Ying  Gu</span>, <span class="hlFld-ContribAuthor ">Xingshu  Li</span>, <span class="hlFld-ContribAuthor ">Yinuo  Wu</span>, <span class="hlFld-ContribAuthor ">Hai-Bin  Luo</span>. </span><span class="cited-content_cbyCitation_article-title">Molecular dynamics-based discovery of novel phosphodiesterase-9A inhibitors with non-pyrazolopyrimidinone scaffolds. </span><span class="cited-content_cbyCitation_journal-name">Molecular BioSystems</span><span> <strong>2015,</strong> <em>11 </em>
                                    (1)
                                     , 115-125. <a href="https://doi.org/10.1039/C4MB00389F" title="DOI URL">https://doi.org/10.1039/C4MB00389F</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C4MB00389F&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC4MB00389F%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecular%2520BioSystems%26atitle%3DMolecular%252Bdynamics-based%252Bdiscovery%252Bof%252Bnovel%252Bphosphodiesterase-9A%252Binhibitors%252Bwith%252Bnon-pyrazolopyrimidinone%252Bscaffolds%26aulast%3DLi%26aufirst%3DZhe%26date%3D2015%26date%3D2015%26volume%3D11%26issue%3D1%26spage%3D115%26epage%3D125" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Meng  Li</span>, <span class="hlFld-ContribAuthor ">Bao-Xiang  Zhao</span>. </span><span class="cited-content_cbyCitation_article-title">Progress of the synthesis of condensed pyrazole derivatives (from 2010 to mid-2013). </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2014,</strong> <em>85 </em>, 311-340. <a href="https://doi.org/10.1016/j.ejmech.2014.07.102" title="DOI URL">https://doi.org/10.1016/j.ejmech.2014.07.102</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2014.07.102&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2014.07.102%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DProgress%252Bof%252Bthe%252Bsynthesis%252Bof%252Bcondensed%252Bpyrazole%252Bderivatives%252B%252528from%252B2010%252Bto%252Bmid-2013%252529%26aulast%3DLi%26aufirst%3DMeng%26date%3D2014%26volume%3D85%26spage%3D311%26epage%3D340" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Nivedita  Singh</span>, <span class="hlFld-ContribAuthor ">Sanjukta  Patra</span>. </span><span class="cited-content_cbyCitation_article-title">Phosphodiesterase 9: Insights from protein structure and role in therapeutics. </span><span class="cited-content_cbyCitation_journal-name">Life Sciences</span><span> <strong>2014,</strong> <em>106 </em>
                                    (1-2)
                                     , 1-11. <a href="https://doi.org/10.1016/j.lfs.2014.04.007" title="DOI URL">https://doi.org/10.1016/j.lfs.2014.04.007</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.lfs.2014.04.007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.lfs.2014.04.007%26sid%3Dliteratum%253Aachs%26jtitle%3DLife%2520Sciences%26atitle%3DPhosphodiesterase%252B9%25253A%252BInsights%252Bfrom%252Bprotein%252Bstructure%252Band%252Brole%252Bin%252Btherapeutics%26aulast%3DSingh%26aufirst%3DNivedita%26date%3D2014%26volume%3D106%26issue%3D1-2%26spage%3D1%26epage%3D11" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jayvardhan  Pandit</span>. </span><span class="cited-content_cbyCitation_article-title">PDE4: New Structural Insights into the Regulatory Mechanism and Implications for the Design of Selective Inhibitors. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2014,</strong>,, 29-44. <a href="https://doi.org/10.1002/9783527682348.ch03" title="DOI URL">https://doi.org/10.1002/9783527682348.ch03</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/9783527682348.ch03&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2F9783527682348.ch03%26sid%3Dliteratum%253Aachs%26atitle%3DPDE4%25253A%252BNew%252BStructural%252BInsights%252Binto%252Bthe%252BRegulatory%252BMechanism%252Band%252BImplications%252Bfor%252Bthe%252BDesign%252Bof%252BSelective%252BInhibitors%26aulast%3DPandit%26aufirst%3DJayvardhan%26date%3D2014%26date%3D2014%26spage%3D29%26epage%3D44%26pub%3DWiley%26atitle%3DPhosphodiesterases%252Band%252BTheir%252BInhibitors%26aulast%3DLiras%26aufirst%3DSpiros%26date%3D2014%26date%3D2014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Hengming  Ke</span>, <span class="hlFld-ContribAuthor ">Yousheng  Wang</span>, <span class="hlFld-ContribAuthor ">Yiqian  Wan</span>, <span class="hlFld-ContribAuthor ">Hai‐Bin  Luo</span>. </span><span class="cited-content_cbyCitation_article-title">Crystal Structures of Phosphodiesterase 9A and Insight into Inhibitor Discovery. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2014,</strong>,, 105-116. <a href="https://doi.org/10.1002/9783527682348.ch07" title="DOI URL">https://doi.org/10.1002/9783527682348.ch07</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/9783527682348.ch07&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2F9783527682348.ch07%26sid%3Dliteratum%253Aachs%26atitle%3DCrystal%252BStructures%252Bof%252BPhosphodiesterase%252B9A%252Band%252BInsight%252Binto%252BInhibitor%252BDiscovery%26aulast%3DKe%26aufirst%3DHengming%26date%3D2014%26date%3D2014%26spage%3D105%26epage%3D116%26pub%3DWiley%26atitle%3DPhosphodiesterases%252Band%252BTheir%252BInhibitors%26aulast%3DLiras%26aufirst%3DSpiros%26date%3D2014%26date%3D2014%26volume%3D68" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Michelle M.  Claffey</span>, <span class="hlFld-ContribAuthor ">Christopher J.  Helal</span>, <span class="hlFld-ContribAuthor ">Xinjun  Hou</span>. </span><span class="cited-content_cbyCitation_article-title">PDEs as CNS Targets: PDE9 Inhibitors for Cognitive Deficit Diseases. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2014,</strong>,, 117-140. <a href="https://doi.org/10.1002/9783527682348.ch08" title="DOI URL">https://doi.org/10.1002/9783527682348.ch08</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/9783527682348.ch08&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2F9783527682348.ch08%26sid%3Dliteratum%253Aachs%26atitle%3DPDEs%252Bas%252BCNS%252BTargets%25253A%252BPDE9%252BInhibitors%252Bfor%252BCognitive%252BDeficit%252BDiseases%26aulast%3DClaffey%26aufirst%3DMichelle%2BM.%26date%3D2014%26date%3D2014%26spage%3D117%26epage%3D140%26pub%3DWiley%26atitle%3DPhosphodiesterases%252Band%252BTheir%252BInhibitors%26aulast%3DLiras%26aufirst%3DSpiros%26date%3D2014%26date%3D2014%26volume%3D68" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Frank S.  Menniti</span>, <span class="hlFld-ContribAuthor ">Niels  Plath</span>, <span class="hlFld-ContribAuthor ">Niels  Svenstrup</span>, <span class="hlFld-ContribAuthor ">Christopher J.  Schmidt</span>. </span><span class="cited-content_cbyCitation_article-title">Pharmacological Manipulation of Cyclic Nucleotide Phosphodiesterase Signaling for The Treatment of Neurological and Psychiatric Disorders In The Brain. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2014,</strong>,, 77-114. <a href="https://doi.org/10.1002/9781118836507.ch04" title="DOI URL">https://doi.org/10.1002/9781118836507.ch04</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/9781118836507.ch04&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2F9781118836507.ch04%26sid%3Dliteratum%253Aachs%26atitle%3DPharmacological%252BManipulation%252Bof%252BCyclic%252BNucleotide%252BPhosphodiesterase%252BSignaling%252Bfor%252BThe%252BTreatment%252Bof%252BNeurological%252Band%252BPsychiatric%252BDisorders%252BIn%252BThe%252BBrain%26aulast%3DMenniti%26aufirst%3DFrank%2BS.%26date%3D2014%26date%3D2014%26spage%3D77%26epage%3D114%26pub%3DJohn%2520Wiley%2520%2526%2520Sons%252C%2520Inc%26atitle%3DCyclic-Nucleotide%252BPhosphodiesterases%252BIn%252BThe%252BCentral%252BNervous%252BSystem%26aulast%3DBrandon%26aufirst%3DNicholas%2BJ.%26date%3D2014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">David P.  Rotella</span>. </span><span class="cited-content_cbyCitation_article-title">Recent Results In Phosphodiesterase Inhibitor Development and CNS Applications. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2014,</strong>,, 115-144. <a href="https://doi.org/10.1002/9781118836507.ch05" title="DOI URL">https://doi.org/10.1002/9781118836507.ch05</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/9781118836507.ch05&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2F9781118836507.ch05%26sid%3Dliteratum%253Aachs%26atitle%3DRecent%252BResults%252BIn%252BPhosphodiesterase%252BInhibitor%252BDevelopment%252Band%252BCNS%252BApplications%26aulast%3DRotella%26aufirst%3DDavid%2BP.%26date%3D2014%26date%3D2014%26spage%3D115%26epage%3D144%26pub%3DJohn%2520Wiley%2520%2526%2520Sons%252C%2520Inc%26atitle%3DCyclic-Nucleotide%252BPhosphodiesterases%252BIn%252BThe%252BCentral%252BNervous%252BSystem%26aulast%3DBrandon%26aufirst%3DNicholas%2BJ.%26date%3D2014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Gretchen L.  Snyder</span>, <span class="hlFld-ContribAuthor ">Joseph P.  Hendrick</span>, <span class="hlFld-ContribAuthor ">Akinori  Nishi</span>. </span><span class="cited-content_cbyCitation_article-title">The Role of Phosphodiesterases in Dopamine Systems governing Motivated Behavior. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2014,</strong>,, 303-352. <a href="https://doi.org/10.1002/9781118836507.ch12" title="DOI URL">https://doi.org/10.1002/9781118836507.ch12</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/9781118836507.ch12&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2F9781118836507.ch12%26sid%3Dliteratum%253Aachs%26atitle%3DThe%252BRole%252Bof%252BPhosphodiesterases%252Bin%252BDopamine%252BSystems%252Bgoverning%252BMotivated%252BBehavior%26aulast%3DSnyder%26aufirst%3DGretchen%2BL.%26date%3D2014%26date%3D2014%26spage%3D303%26epage%3D352%26pub%3DJohn%2520Wiley%2520%2526%2520Sons%252C%2520Inc%26atitle%3DCyclic-Nucleotide%252BPhosphodiesterases%252BIn%252BThe%252BCentral%252BNervous%252BSystem%26aulast%3DBrandon%26aufirst%3DNicholas%2BJ.%26date%3D2014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jamison B.  Tuttle</span>, <span class="hlFld-ContribAuthor ">Bethany L.  Kormos</span>. </span><span class="cited-content_cbyCitation_article-title">The Use of PDE10A and PDE9 Inhibitors for Treating Schizophrenia. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2014,</strong>,, 255-316. <a href="https://doi.org/10.1007/7355_2014_54" title="DOI URL">https://doi.org/10.1007/7355_2014_54</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/7355_2014_54&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2F7355_2014_54%26sid%3Dliteratum%253Aachs%26atitle%3DThe%252BUse%252Bof%252BPDE10A%252Band%252BPDE9%252BInhibitors%252Bfor%252BTreating%252BSchizophrenia%26aulast%3DTuttle%26aufirst%3DJamison%2BB.%26date%3D2014%26date%3D2014%26spage%3D255%26epage%3D316%26pub%3DSpringer%2520International%2520Publishing%26atitle%3DSmall%252BMolecule%252BTherapeutics%252Bfor%252BSchizophrenia%26aulast%3DCelanire%26aufirst%3DSylvain%26date%3D2015%26volume%3D13" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Qin  Zhihui</span>. </span><span class="cited-content_cbyCitation_article-title">Modulating nitric oxide signaling in the CNS for Alzheimer’s disease therapy. </span><span class="cited-content_cbyCitation_journal-name">Future Medicinal Chemistry</span><span> <strong>2013,</strong> <em>5 </em>
                                    (12)
                                     , 1451-1468. <a href="https://doi.org/10.4155/fmc.13.111" title="DOI URL">https://doi.org/10.4155/fmc.13.111</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.4155/fmc.13.111&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.4155%2Ffmc.13.111%26sid%3Dliteratum%253Aachs%26jtitle%3DFuture%2520Medicinal%2520Chemistry%26atitle%3DModulating%252Bnitric%252Boxide%252Bsignaling%252Bin%252Bthe%252BCNS%252Bfor%252BAlzheimer%2525E2%252580%252599s%252Bdisease%252Btherapy%26aulast%3DZhihui%26aufirst%3DQin%26date%3D2013%26volume%3D5%26issue%3D12%26spage%3D1451%26epage%3D1468" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Morten  Jørgensen</span>, <span class="hlFld-ContribAuthor ">Jan  Kehler</span>, <span class="hlFld-ContribAuthor ">Morten  Langgård</span>, <span class="hlFld-ContribAuthor ">Niels  Svenstrup</span>, <span class="hlFld-ContribAuthor ">Lena  Tagmose</span>. </span><span class="cited-content_cbyCitation_article-title">Selective Inhibitors of PDE2, PDE9, and PDE10. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2013,</strong>,, 37-55. <a href="https://doi.org/10.1016/B978-0-12-417150-3.00004-1" title="DOI URL">https://doi.org/10.1016/B978-0-12-417150-3.00004-1</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/B978-0-12-417150-3.00004-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2FB978-0-12-417150-3.00004-1%26sid%3Dliteratum%253Aachs%26atitle%3DSelective%252BInhibitors%252Bof%252BPDE2%25252C%252BPDE9%25252C%252Band%252BPDE10%26aulast%3DJ%25C3%25B8rgensen%26aufirst%3DMorten%26date%3D2013%26spage%3D37%26epage%3D55%26pub%3DElsevier%26date%3D2013%26volume%3D48" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="f_tgr1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-21/jm3007799/production/images/medium/jm-2012-007799_0007.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-21/jm3007799/production/images/large/jm-2012-007799_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm3007799&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-21/jm3007799/production/images/medium/jm-2012-007799_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-21/jm3007799/production/images/large/jm-2012-007799_0009.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Development of in vivo active lead <b>2</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-21/jm3007799/production/images/large/jm-2012-007799_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm3007799&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-21/jm3007799/production/images/medium/jm-2012-007799_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-21/jm3007799/production/images/large/jm-2012-007799_0004.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. PDE9A inhibitor <b>1</b> (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3JSI">3JSI</a>) bound and structural differences with PDE1C (pink).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-21/jm3007799/production/images/large/jm-2012-007799_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm3007799&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-21/jm3007799/production/images/medium/jm-2012-007799_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-21/jm3007799/production/images/large/jm-2012-007799_0012.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 1. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-21/jm3007799/production/images/large/jm-2012-007799_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm3007799&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>(a) Step 1: 2-(ethoxymethylene)malononitrile (1 equiv), triethylamine (4 equiv), ethanol (0.3 M), reflux 2 h. Step 2: 35% aq H<sub>2</sub>O<sub>2</sub>, aq ammonia, ethanol, 48 h. Step 3: pyrolidine ester (2 equiv), THF (0.1 M), 1.0 M <i>t</i>-BuOK (in THF, 2 equiv), reflux 16 h. Step 4: PdOH<sub>2</sub> (10%), conc HCl (1 equiv), methanol, 40 psi of H<sub>2</sub> 18 h. Step 5: reductive amination, aldehyde, 1,2-dichloroethane, sodium triacetoxyborohydride, 50 °C, 18 h; or alkylation, 2-(chloromethyl)pyrimidine–HCl, cesium carbonate, iron triflate, DMF, 60 °C, 24 h.</p></p></figure><figure data-id="fig3" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-21/jm3007799/production/images/medium/jm-2012-007799_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-21/jm3007799/production/images/large/jm-2012-007799_0005.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. The methyl group on the pyrrolidine does not completely fill the lipophilic pocket of PDE9A (circled area) (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3JSW">3JSW</a>).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-21/jm3007799/production/images/large/jm-2012-007799_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm3007799&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-21/jm3007799/production/images/medium/jm-2012-007799_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-21/jm3007799/production/images/large/jm-2012-007799_0006.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. X-ray crystral structure of PDE9A inhibitor <b>20</b> (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4E90">4E90</a>) bound in PDE9A making key interaction with the phenylalanine and tyrosine to provide selectivity over PDE1C.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-21/jm3007799/production/images/large/jm-2012-007799_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm3007799&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i27">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_13068" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_13068" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 30 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group">Schmidt, C. J.</span><span> </span><span class="NLM_article-title">Phosphodiesterase Inhibitors as Potential Cognition Enhancing Agents</span> <span class="citation_source-journal">Curr. Top. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">222</span><span class="NLM_x">–</span> <span class="NLM_lpage">230</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Fjm3007799&amp;key=10.2174%2F156802610790411009" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Fjm3007799&amp;key=20166957" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Fjm3007799&amp;key=1%3ACAS%3A528%3ADC%252BC3cXjtFajsrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2010&pages=222-230&author=C.+J.+Schmidt&title=Phosphodiesterase+Inhibitors+as+Potential+Cognition+Enhancing+Agents"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Phosphodiesterase inhibitors as potential cognition enhancing agents</span></div><div class="casAuthors">Schmidt, Christopher J.</div><div class="citationInfo"><span class="NLM_cas:title">Current Topics in Medicinal Chemistry (Sharjah, United Arab Emirates)</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">222-230</span>CODEN:
                <span class="NLM_cas:coden">CTMCCL</span>;
        ISSN:<span class="NLM_cas:issn">1568-0266</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  As might be predicted for an organ designed for cell to cell communication, cyclic nucleotide signaling in the brain is highly organized and regulated.  Augmentation of cyclic nucleotide signaling by means of phosphodiesterase inhibition appears to be a viable and tractable means of enhancing neuronal communication.  Of the various CNS disorders that have been considered as target indications for phosphodiesterase inhibitors, no condition has received more attention than cognitive dysfunction.  This review provides a background for understanding the expanding literature in this field as well as a brief update on the rationale driving the search for selective inhibitors of targets such as PDE1B, PDE2, PDE5 and PDE9.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqBVYtnViej97Vg90H21EOLACvtfcHk0lgCHcuA1UyjlA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXjtFajsrY%253D&md5=47e8397d9f69207c27940575411bbe12</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.2174%2F156802610790411009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F156802610790411009%26sid%3Dliteratum%253Aachs%26aulast%3DSchmidt%26aufirst%3DC.%2BJ.%26atitle%3DPhosphodiesterase%2520Inhibitors%2520as%2520Potential%2520Cognition%2520Enhancing%2520Agents%26jtitle%3DCurr.%2520Top.%2520Med.%2520Chem.%26date%3D2010%26volume%3D10%26spage%3D222%26epage%3D230" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group">Beavo, J. A.</span><span> </span><span class="NLM_article-title">Cyclic Nucleotide Phosphodiesterases: Functional Implications of Multiple Isoforms</span> <span class="citation_source-journal">Phys. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">75</span><span class="NLM_x">, </span> <span class="NLM_fpage">725</span><span class="NLM_x">–</span> <span class="NLM_lpage">748</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=75&publication_year=1995&pages=725-748&author=J.+A.+Beavo&title=Cyclic+Nucleotide+Phosphodiesterases%3A+Functional+Implications+of+Multiple+Isoforms"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBeavo%26aufirst%3DJ.%2BA.%26atitle%3DCyclic%2520Nucleotide%2520Phosphodiesterases%253A%2520Functional%2520Implications%2520of%2520Multiple%2520Isoforms%26jtitle%3DPhys.%2520Rev.%26date%3D1995%26volume%3D75%26spage%3D725%26epage%3D748" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group">Setter, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iltz, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fincham, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Campbell, R. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baker, D. E.</span><span> </span><span class="NLM_article-title">Phosphodiesterase 5 Inhibitors for Erectile Dysfunction</span> <span class="citation_source-journal">Ann. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">39</span><span class="NLM_x">, </span> <span class="NLM_fpage">1286</span><span class="NLM_x">–</span> <span class="NLM_lpage">1295</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Fjm3007799&amp;key=10.1345%2Faph.1E487" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Fjm3007799&amp;key=1%3ACAS%3A528%3ADC%252BD2MXms12gsrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=39&publication_year=2005&pages=1286-1295&author=S.+M.+Setterauthor=J.+L.+Iltzauthor=J.+E.+Finchamauthor=R.+K.+Campbellauthor=D.+E.+Baker&title=Phosphodiesterase+5+Inhibitors+for+Erectile+Dysfunction"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Phosphodiesterase 5 inhibitors for erectile dysfunction</span></div><div class="casAuthors">Setter, Stephen M.; Iltz, Jason L.; Fincham, Jack E.; Campbell, R. Keith; Baker, Danial E.</div><div class="citationInfo"><span class="NLM_cas:title">Annals of Pharmacotherapy</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">39</span>
        (<span class="NLM_cas:issue">7/8</span>),
    <span class="NLM_cas:pages">1286-1295</span>CODEN:
                <span class="NLM_cas:coden">APHRER</span>;
        ISSN:<span class="NLM_cas:issn">1060-0280</span>.
    
            (<span class="NLM_cas:orgname">Harvey Whitney Books Co.</span>)
        </div><div class="casAbstract">Objective: To review the pharmacol. and clin. trial data of the Food and Drug Administration-approved phosphodiesterase 5 (PDE5) inhibitors for the treatment of erectile dysfunction (ED).  Data Sources: Primary research and review articles were identified through a search of ScienceDirect, PubMed/MEDLINE, and International Pharmaceutical Abstrs. (1990-August 2004).  The following search terms were used in the Medicine Dentistry and Pharmacol., Toxicol., and Pharmaceutical Sciences subcategories: phosphodiesterase 5 inhibitor, PDE5 inhibitor, erectile dysfunction, sildenafil, vardenafil, tadalafil, prostatectomy, and diabetes.  Web of Science (1990-August 2004) was used to search for addnl. abstrs. using the same search terms as above.  The package inserts for sildenafil, vardenafil, and tadalafil were also consulted.  Study Selection And Data Extn.: All identified research, review articles, and abstrs. were assessed for relevance, and all relevant information was included.  Priority was given to the primary medical literature and clin. trial reports.  Data Synthesis: ED is a common disorder in males with increased prevalence assocd. with age and presence of cardiovascular disease, prostatectomy, or diabetes mellitus.  Sildenafil, vardenafil, and tadalafil are selective PDE5 inhibitors currently available for treatment of ED.  Their pharmacol. and pharmacokinetics vary slightly, but with potentially important clin. differences in duration of activity; all have similar clin. efficacy and adverse effect profiles in patients with ED of various causes.  Conclusions: Sildenafil, vardenafil, and tadalafil are safe and effective PDE5 inhibitors for the treatment of ED.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqYGVq6PfMu3LVg90H21EOLACvtfcHk0lgCHcuA1UyjlA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXms12gsrk%253D&md5=ba8f6a681eee4e96832e4e98df7be0c3</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1345%2Faph.1E487&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1345%252Faph.1E487%26sid%3Dliteratum%253Aachs%26aulast%3DSetter%26aufirst%3DS.%2BM.%26aulast%3DIltz%26aufirst%3DJ.%2BL.%26aulast%3DFincham%26aufirst%3DJ.%2BE.%26aulast%3DCampbell%26aufirst%3DR.%2BK.%26aulast%3DBaker%26aufirst%3DD.%2BE.%26atitle%3DPhosphodiesterase%25205%2520Inhibitors%2520for%2520Erectile%2520Dysfunction%26jtitle%3DAnn.%2520Pharmacol.%26date%3D2005%26volume%3D39%26spage%3D1286%26epage%3D1295" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group">Zewail, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Newar, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vrtovec, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eastwood, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Biswajit, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Delgado, R. M.</span><span> </span><span class="NLM_article-title">Intravenous Milrinone in Treatment of Advanced Congestive Heart Failure</span> <span class="citation_source-journal">Tex. Heart Inst. J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">30</span><span class="NLM_x">, </span> <span class="NLM_fpage">109</span><span class="NLM_x">–</span> <span class="NLM_lpage">113</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Fjm3007799&amp;key=12809251" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Fjm3007799&amp;key=1%3ACAS%3A280%3ADC%252BD3s3otFyjtA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=2003&pages=109-113&author=A.+M.+Zewailauthor=M.+Newarauthor=B.+Vrtovecauthor=C.+Eastwoodauthor=K.+Biswajitauthor=R.+M.+Delgado&title=Intravenous+Milrinone+in+Treatment+of+Advanced+Congestive+Heart+Failure"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Intravenous milrinone in treatment of advanced congestive heart failure</span></div><div class="casAuthors">Zewail Aly M; Nawar Mohammad; Vrtovec Bojan; Eastwood Cathy; Kar M N Biswajit; Delgado Reynolds M 3rd</div><div class="citationInfo"><span class="NLM_cas:title">Texas Heart Institute journal / from the Texas Heart Institute of St. Luke's Episcopal Hospital, Texas Children's Hospital</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">30</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">109-13</span>
        ISSN:<span class="NLM_cas:issn">0730-2347</span>.
    </div><div class="casAbstract">Phosphodiesterase inhibitors such as milrinone can relieve symptoms and improve hemodynamics in patients with advanced congestive heart failure.  We retrospectively evaluated the hemodynamic and clinical outcomes of long-term combination therapy with intravenous milrinone and oral beta-blockers in 65 patients with severe congestive heart failure (New York Heart Association class IV function and ejection fraction <25%) refractory to oral medical therapy.  Fifty-one patients successfully began beta-blocker therapy while on intravenous milrinone.  Oral medical therapy was maximized when possible.  The mean duration of milrinone treatment in this combination-treatment group was 269 days (range, 14-1,026 days).  Functional class improved from IV to II-III with milrinone therapy.  Twenty-four such patients tolerated beta-blocker up-titration and were successfully weaned from milrinone.  Sixteen patients (31%) died while receiving combination therapy; one died of sudden cardiac death (on treatment day 116); the other 15 died of progressive heart failure or other complications.  Hospital admissions during the previous 6 months and admissions within 6 months after milrinone initiation stayed the same.  Meanwhile, the total number of hospital days decreased from 450 to 380 (a 15.6% reduction), and the mean length of stay decreased by 1.4 days (a 14.7% reduction).  We conclude that 1) milrinone plus beta-blocker combination therapy is an effective treatment for heart failure even with beta-blocker up-titration, 2) weaning from milrinone may be possible once medications are maximized, 3) patients' functional status improves on the combination regimen, and 4) treatment-related sudden death is relatively infrequent during the combination regimen.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSlTNY8KKijnO98rul4nhSdfW6udTcc2ebMs9oevVc7pbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD3s3otFyjtA%253D%253D&md5=a5cdc3c0d36b4b3d13baecf7ac0b7a62</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DZewail%26aufirst%3DA.%2BM.%26aulast%3DNewar%26aufirst%3DM.%26aulast%3DVrtovec%26aufirst%3DB.%26aulast%3DEastwood%26aufirst%3DC.%26aulast%3DBiswajit%26aufirst%3DK.%26aulast%3DDelgado%26aufirst%3DR.%2BM.%26atitle%3DIntravenous%2520Milrinone%2520in%2520Treatment%2520of%2520Advanced%2520Congestive%2520Heart%2520Failure%26jtitle%3DTex.%2520Heart%2520Inst.%2520J.%26date%3D2003%26volume%3D30%26spage%3D109%26epage%3D113" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group">Boswell-Smith, V</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spina, D.</span><span> </span><span class="NLM_article-title">PDE4 Inhibitors as Potential Therapeutic Agents in the Treatment of COPD-Focus on Roflumilast</span> <span class="citation_source-journal">Int. J. Chronic Obstruct. Pulm. Dis.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">121</span><span class="NLM_x">–</span> <span class="NLM_lpage">129</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Fjm3007799&amp;key=18044684" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Fjm3007799&amp;key=1%3ACAS%3A528%3ADC%252BD2sXpsFKgu78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2007&pages=121-129&author=V+Boswell-Smithauthor=D.+Spina&title=PDE4+Inhibitors+as+Potential+Therapeutic+Agents+in+the+Treatment+of+COPD-Focus+on+Roflumilast"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">PDE4 inhibitors as potential therapeutic agents in the treatment of COPD-focus on roflumilast</span></div><div class="casAuthors">Boswell-Smith, Victoria; Spina, Domenico</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Chronic Obstructive Pulmonary Disease</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">121-129</span>CODEN:
                <span class="NLM_cas:coden">IJCOC3</span>;
        ISSN:<span class="NLM_cas:issn">1176-9106</span>.
    
            (<span class="NLM_cas:orgname">Dove Medical Press (NZ) Ltd.</span>)
        </div><div class="casAbstract">A review.  Chronic obstructive pulmonary disease is characterized by a rapid decline in lung function due to small airway fibrosis, mucus hypersecretion and emphysema.  The major causative factor for COPD is cigarette smoking that drives an inflammatory process that gives rise to leukocyte recruitment, imbalance in protease levels and consequently matrix remodeling resulting in small airway fibrosis and loss of alveolar tissue.  Current drug treatment improves symptoms but do not alter the underlying progression of this disease.  The failure of anti-inflammatory drugs like glucocorticosteroids to have a major impact in this disease has hastened the need to develop novel therapeutic strategies.  Phosphodiesterase (PDE)4 inhibitors are novel anti-inflammatory drugs that have recently been show to document clin. efficacy in this disease, although their utility is hampered by class related side-effects of nausea, emesis and diarrhea.  While it is not yet clear whether such drugs will prevent emphysema, this is a distinct possibility provided exptl. observations from preclin. studies translate to man.  This review will discuss the current standing of PDE4 inhibitors like roflumilast as novel treatments for COPD and the potential for developing nonemetic anti-inflammatory drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq2kjDBEjY5yrVg90H21EOLACvtfcHk0lh1dPx9_aEENQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXpsFKgu78%253D&md5=98a80944248eb8649145a33d6229def0</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBoswell-Smith%26aufirst%3DV%26aulast%3DSpina%26aufirst%3DD.%26atitle%3DPDE4%2520Inhibitors%2520as%2520Potential%2520Therapeutic%2520Agents%2520in%2520the%2520Treatment%2520of%2520COPD-Focus%2520on%2520Roflumilast%26jtitle%3DInt.%2520J.%2520Chronic%2520Obstruct.%2520Pulm.%2520Dis.%26date%3D2007%26volume%3D2%26spage%3D121%26epage%3D129" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group">Cote, R. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feng, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Valeriani, B. A.</span><span> </span><span class="NLM_article-title">Relative Potency of Various Classes of Phosphodiesterase (PDE) Inhibitors for Rod and Cone Photoreceptor PDE6</span> <span class="citation_source-journal">Invest. Ophthalmol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">44</span><span class="NLM_x">, </span> <span class="NLM_fpage">1524</span><span class="NLM_x">–</span> <span class="NLM_lpage">1527</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=2003&pages=1524-1527&author=R.+H.+Coteauthor=Q.+Fengauthor=B.+A.+Valeriani&title=Relative+Potency+of+Various+Classes+of+Phosphodiesterase+%28PDE%29+Inhibitors+for+Rod+and+Cone+Photoreceptor+PDE6"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCote%26aufirst%3DR.%2BH.%26aulast%3DFeng%26aufirst%3DQ.%26aulast%3DValeriani%26aufirst%3DB.%2BA.%26atitle%3DRelative%2520Potency%2520of%2520Various%2520Classes%2520of%2520Phosphodiesterase%2520%2528PDE%2529%2520Inhibitors%2520for%2520Rod%2520and%2520Cone%2520Photoreceptor%2520PDE6%26jtitle%3DInvest.%2520Ophthalmol.%26date%3D2003%26volume%3D44%26spage%3D1524%26epage%3D1527" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group">Young, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ward, A.</span><span> </span><span class="NLM_article-title">Milrinone. A Preliminary Review of Its Pharmacological Properties and Therapeutic Use</span> <span class="citation_source-journal">Drugs</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1988</span><span class="NLM_x">, </span> <span class="NLM_volume">36</span><span class="NLM_x">, </span> <span class="NLM_fpage">158</span><span class="NLM_x">–</span> <span class="NLM_lpage">192</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=36&publication_year=1988&pages=158-192&author=R.+A.+Youngauthor=A.+Ward&title=Milrinone.+A+Preliminary+Review+of+Its+Pharmacological+Properties+and+Therapeutic+Use"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DYoung%26aufirst%3DR.%2BA.%26aulast%3DWard%26aufirst%3DA.%26atitle%3DMilrinone.%2520A%2520Preliminary%2520Review%2520of%2520Its%2520Pharmacological%2520Properties%2520and%2520Therapeutic%2520Use%26jtitle%3DDrugs%26date%3D1988%26volume%3D36%26spage%3D158%26epage%3D192" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group">Card, G. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">England, B. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suzuki, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fong, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Powell, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luu, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tabrizizad, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gillete, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ibrahim, P. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Artis, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bollag, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Milburn, M. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schlessinger, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zang, K. Y. J.</span><span> </span><span class="NLM_article-title">Structural Basis for the Activity of Drugs That Inhibit Phosphodiesterases</span> <span class="citation_source-journal">Structure</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">2233</span><span class="NLM_x">–</span> <span class="NLM_lpage">2247</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Fjm3007799&amp;key=10.1016%2Fj.str.2004.10.004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Fjm3007799&amp;key=15576036" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Fjm3007799&amp;key=1%3ACAS%3A528%3ADC%252BD2cXhtVClur3K" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2004&pages=2233-2247&author=G.+L.+Cardauthor=B.+P.+Englandauthor=Y.+Suzukiauthor=D.+Fongauthor=B.+Powellauthor=B.+Leeauthor=C.+Luuauthor=M.+Tabrizizadauthor=S.+Gilleteauthor=P.+N.+Ibrahimauthor=D.+R.+Artisauthor=G.+Bollagauthor=M.+V.+Milburnauthor=S.+Kimauthor=J.+Schlessingerauthor=K.+Y.+J.+Zang&title=Structural+Basis+for+the+Activity+of+Drugs+That+Inhibit+Phosphodiesterases"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Structural Basis for the Activity of Drugs that Inhibit Phosphodiesterases</span></div><div class="casAuthors">Card, Graeme L.; England, Bruce P.; Suzuki, Yoshihisa; Fong, Daniel; Powell, Ben; Lee, Byunghun; Luu, Catherine; Tabrizizad, Maryam; Gillette, Sam; Ibrahim, Prabha N.; Artis, Dean R.; Bollag, Gideon; Milburn, Michael V.; Kim, Sung-Hou; Schlessinger, Joseph; Zhang, Kam Y. J.</div><div class="citationInfo"><span class="NLM_cas:title">Structure (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">2233-2247</span>CODEN:
                <span class="NLM_cas:coden">STRUE6</span>;
        ISSN:<span class="NLM_cas:issn">0969-2126</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Phosphodiesterases (PDEs) comprise a large family of enzymes that catalyze the hydrolysis of cAMP or cGMP and are implicated in various diseases.  The authors describe the high-resoln. crystal structures of the catalytic domains of PDE4B, PDE4D, and PDE5A with ten different inhibitors, including the drug candidates cilomilast and roflumilast, for respiratory diseases.  These cocrystal structures reveal a common scheme of inhibitor binding to the PDEs: (i) a hydrophobic clamp formed by highly conserved hydrophobic residues that sandwich the inhibitor in the active site; (ii) hydrogen bonding to an invariant glutamine that controls the orientation of inhibitor binding.  A scaffold can be readily identified for any given inhibitor based on the formation of these two types of conserved interactions.  These structural insights will enable the design of isoform-selective inhibitors with improved binding affinity and should facilitate the discovery of more potent and selective PDE inhibitors for the treatment of a variety of diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr8l4KWCohSy7Vg90H21EOLACvtfcHk0lh1dPx9_aEENQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXhtVClur3K&md5=0fa91e4b9047e3df3946c526592be396</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1016%2Fj.str.2004.10.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.str.2004.10.004%26sid%3Dliteratum%253Aachs%26aulast%3DCard%26aufirst%3DG.%2BL.%26aulast%3DEngland%26aufirst%3DB.%2BP.%26aulast%3DSuzuki%26aufirst%3DY.%26aulast%3DFong%26aufirst%3DD.%26aulast%3DPowell%26aufirst%3DB.%26aulast%3DLee%26aufirst%3DB.%26aulast%3DLuu%26aufirst%3DC.%26aulast%3DTabrizizad%26aufirst%3DM.%26aulast%3DGillete%26aufirst%3DS.%26aulast%3DIbrahim%26aufirst%3DP.%2BN.%26aulast%3DArtis%26aufirst%3DD.%2BR.%26aulast%3DBollag%26aufirst%3DG.%26aulast%3DMilburn%26aufirst%3DM.%2BV.%26aulast%3DKim%26aufirst%3DS.%26aulast%3DSchlessinger%26aufirst%3DJ.%26aulast%3DZang%26aufirst%3DK.%2BY.%2BJ.%26atitle%3DStructural%2520Basis%2520for%2520the%2520Activity%2520of%2520Drugs%2520That%2520Inhibit%2520Phosphodiesterases%26jtitle%3DStructure%26date%3D2004%26volume%3D12%26spage%3D2233%26epage%3D2247" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group">Menniti, F. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Faraci, S. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schmidt, C. J.</span><span> </span><span class="NLM_article-title">Phosphodiesterases in the CNS: Targets for Drug Development</span> <span class="citation_source-journal">Nat. Rev. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">660</span><span class="NLM_x">–</span> <span class="NLM_lpage">670</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Fjm3007799&amp;key=10.1038%2Fnrd2058" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Fjm3007799&amp;key=16883304" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Fjm3007799&amp;key=1%3ACAS%3A528%3ADC%252BD28XnsFCkurg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2006&pages=660-670&author=F.+S.+Mennitiauthor=S.+W.+Faraciauthor=C.+J.+Schmidt&title=Phosphodiesterases+in+the+CNS%3A+Targets+for+Drug+Development"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Phosphodiesterases in the CNS: targets for drug development</span></div><div class="casAuthors">Menniti, Frank S.; Faraci, W. Stephen; Schmidt, Christopher J.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">660-670</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  The therapeutic and com. success of phosphodiesterase 5 inhibitors such as Viagra, Levitra and Cialis has sparked renewed interest in the phosphodiesterases as drug discovery targets.  Virtually all the phosphodiesterases are expressed in the CNS, making this gene family a particularly attractive source of new targets for the treatment of psychiatric and neurodegenerative disorders.  Significantly, all neurons express multiple phosphodiesterases, which differ in cyclic nucleotide specificity, affinity, regulatory control and subcellular compartmentalization.  Therefore, phosphodiesterase inhibition represents a mechanism through which it could be possible to precisely modulate neuronal activity.  In this article, we review the current state of the art in the burgeoning field of phosphodiesterase pharmacol. in the CNS.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpa2I3t5o1HibVg90H21EOLACvtfcHk0lh1dPx9_aEENQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XnsFCkurg%253D&md5=7c2b421b629efe9ee73999098322e811</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1038%2Fnrd2058&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd2058%26sid%3Dliteratum%253Aachs%26aulast%3DMenniti%26aufirst%3DF.%2BS.%26aulast%3DFaraci%26aufirst%3DS.%2BW.%26aulast%3DSchmidt%26aufirst%3DC.%2BJ.%26atitle%3DPhosphodiesterases%2520in%2520the%2520CNS%253A%2520Targets%2520for%2520Drug%2520Development%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2006%26volume%3D5%26spage%3D660%26epage%3D670" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group">Chappie, T. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Humphrey, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Allen, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Estep, K. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fox, C. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lebel, L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liras, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marr, E. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Menniti, F. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pandit, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schmidt, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tu, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, R. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, F. V.</span><span> </span><span class="NLM_article-title">Discovery of a Series of 6,7-Dimethoxy-4-pyrrolidylquinazoline PDE10A Inhibitors</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x">, </span> <span class="NLM_fpage">182</span><span class="NLM_x">–</span> <span class="NLM_lpage">185</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm060653b" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2007&pages=182-185&author=T.+A.+Chappieauthor=J.+M.+Humphreyauthor=M.+P.+Allenauthor=K.+G.+Estepauthor=C.+B.+Foxauthor=L.+A.+Lebelauthor=S.+Lirasauthor=E.+S.+Marrauthor=F.+S.+Mennitiauthor=J.+Panditauthor=C.+J.+Schmidtauthor=M.+Tuauthor=R.+D.+Williamsauthor=F.+V.+Yang&title=Discovery+of+a+Series+of+6%2C7-Dimethoxy-4-pyrrolidylquinazoline+PDE10A+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1021%2Fjm060653b&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm060653b%26sid%3Dliteratum%253Aachs%26aulast%3DChappie%26aufirst%3DT.%2BA.%26aulast%3DHumphrey%26aufirst%3DJ.%2BM.%26aulast%3DAllen%26aufirst%3DM.%2BP.%26aulast%3DEstep%26aufirst%3DK.%2BG.%26aulast%3DFox%26aufirst%3DC.%2BB.%26aulast%3DLebel%26aufirst%3DL.%2BA.%26aulast%3DLiras%26aufirst%3DS.%26aulast%3DMarr%26aufirst%3DE.%2BS.%26aulast%3DMenniti%26aufirst%3DF.%2BS.%26aulast%3DPandit%26aufirst%3DJ.%26aulast%3DSchmidt%26aufirst%3DC.%2BJ.%26aulast%3DTu%26aufirst%3DM.%26aulast%3DWilliams%26aufirst%3DR.%2BD.%26aulast%3DYang%26aufirst%3DF.%2BV.%26atitle%3DDiscovery%2520of%2520a%2520Series%2520of%25206%252C7-Dimethoxy-4-pyrrolidylquinazoline%2520PDE10A%2520Inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2007%26volume%3D50%26spage%3D182%26epage%3D185" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group">Verhoest, P. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chapin, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Corman, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fonseca, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harms, J. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hou, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marr, E. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Menniti, F. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nelson, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Connor, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pandit, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Proulx-LaFrance, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schmidt, A. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schmidt, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suiciak, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liras, S.</span><span> </span><span class="NLM_article-title">Discovery of a Novel Class of PDE10A Inhibitors and Identification of Clinical Candidate 2-[4-(1-Methyl-4-pyridin-4-yl-1<i>H</i>-pyrazol-3-yl)phenoxylmethyl]quinoline (PF-2545920) for the Treatment of Schizophrenia</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">5188</span><span class="NLM_x">–</span> <span class="NLM_lpage">5196</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm900521k" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=5188-5196&author=P.+R.+Verhoestauthor=D.+S.+Chapinauthor=M.+Cormanauthor=K.+Fonsecaauthor=J.+F.+Harmsauthor=X.+Houauthor=E.+S.+Marrauthor=F.+S.+Mennitiauthor=F.+Nelsonauthor=R.+O%E2%80%99Connorauthor=J.+Panditauthor=C.+Proulx-LaFranceauthor=A.+W.+Schmidtauthor=C.+J.+Schmidtauthor=J.+A.+Suiciakauthor=S.+Liras&title=Discovery+of+a+Novel+Class+of+PDE10A+Inhibitors+and+Identification+of+Clinical+Candidate+2-%5B4-%281-Methyl-4-pyridin-4-yl-1H-pyrazol-3-yl%29phenoxylmethyl%5Dquinoline+%28PF-2545920%29+for+the+Treatment+of+Schizophrenia"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1021%2Fjm900521k&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm900521k%26sid%3Dliteratum%253Aachs%26aulast%3DVerhoest%26aufirst%3DP.%2BR.%26aulast%3DChapin%26aufirst%3DD.%2BS.%26aulast%3DCorman%26aufirst%3DM.%26aulast%3DFonseca%26aufirst%3DK.%26aulast%3DHarms%26aufirst%3DJ.%2BF.%26aulast%3DHou%26aufirst%3DX.%26aulast%3DMarr%26aufirst%3DE.%2BS.%26aulast%3DMenniti%26aufirst%3DF.%2BS.%26aulast%3DNelson%26aufirst%3DF.%26aulast%3DO%25E2%2580%2599Connor%26aufirst%3DR.%26aulast%3DPandit%26aufirst%3DJ.%26aulast%3DProulx-LaFrance%26aufirst%3DC.%26aulast%3DSchmidt%26aufirst%3DA.%2BW.%26aulast%3DSchmidt%26aufirst%3DC.%2BJ.%26aulast%3DSuiciak%26aufirst%3DJ.%2BA.%26aulast%3DLiras%26aufirst%3DS.%26atitle%3DDiscovery%2520of%2520a%2520Novel%2520Class%2520of%2520PDE10A%2520Inhibitors%2520and%2520Identification%2520of%2520Clinical%2520Candidate%25202-%255B4-%25281-Methyl-4-pyridin-4-yl-1H-pyrazol-3-yl%2529phenoxylmethyl%255Dquinoline%2520%2528PF-2545920%2529%2520for%2520the%2520Treatment%2520of%2520Schizophrenia%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26spage%3D5188%26epage%3D5196" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group">Lu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kandel, E., R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hawkins, R. D.</span><span> </span><span class="NLM_article-title">Nitric Oxide Signaling Contributes to Late-Phase LTP and CREB Phosphorylation in the Hippocampus</span> <span class="citation_source-journal">J. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">10250</span><span class="NLM_x">–</span> <span class="NLM_lpage">10261</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Fjm3007799&amp;key=10.1523%2FJNEUROSCI.19-23-10250.1999" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Fjm3007799&amp;key=10575022" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Fjm3007799&amp;key=1%3ACAS%3A528%3ADyaK1MXnslyrt70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=1999&pages=10250-10261&author=Y.+Luauthor=E.%2C+R.+Kandelauthor=R.+D.+Hawkins&title=Nitric+Oxide+Signaling+Contributes+to+Late-Phase+LTP+and+CREB+Phosphorylation+in+the+Hippocampus"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Nitric oxide signaling contributes to late-phase LTP and CREB phosphorylation in the hippocampus</span></div><div class="casAuthors">Lu, Yun-Fei; Kandel, Eric R.; Hawkins, Robert D.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroscience</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">10250-10261</span>CODEN:
                <span class="NLM_cas:coden">JNRSDS</span>;
        ISSN:<span class="NLM_cas:issn">0270-6474</span>.
    
            (<span class="NLM_cas:orgname">Society for Neuroscience</span>)
        </div><div class="casAbstract">Long-term potentiation (LTP) in the hippocampus has an early phase (E-LTP) that can be induced by 1- or 2-train tetanization, lasts ∼1 h, and is cAMP-dependent protein kinase A (PKA)- and protein synthesis-independent and a late phase (L-LTP) that can be induced by 3- or 4-train tetanization, lasts >3 h, and is reduced by inhibitors of PKA and of protein or RNA synthesis.  NO is thought to be involved in E-LTP, but until now there has been no information about the role of the NO-signaling pathway in L-LTP.  Here, the authors examd. this question at the Schaffer collateral-CA1 synapses in slices of mouse hippocampus.  An inhibitor of nitric oxide synthase blocked L-LTP induced by 3-train tetanization and reduced L-LTP induced by 4-train tetanization, whereas an inhibitor of PKA was more effective in blocking 4-train L-LTP than 3-train L-LTP.  Three-train L-LTP was also blocked by inhibitors of guanylyl cyclase or cGMP-dependent protein kinase G (PKG).  Conversely, either NO or cGMP analogs paired with 1-train tetanization produced late-phase potentiation, and the cGMP-induced potentiation was blocked by inhibitors of protein or RNA synthesis and an inhibitor of PKG, but not by an inhibitor of PKA.  To test a possible downstream target of PKG, the authors examd. changes in phospho-CRE-binding protein (phospho-CREB) immunofluorescence in the CA1 cell body area and obtained results similar to those of the electrophysiol. expts.  The results suggested that NO contributes to L-LTP by stimulating guanylyl cyclase and PKG, which acts in parallel with PKA to increase phosphorylation of transcription factor CREB.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqY0i0LYOPf7LVg90H21EOLACvtfcHk0ligcwoWER_Kew"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXnslyrt70%253D&md5=6d09b68560c09b81e38354826f7c21b6</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1523%2FJNEUROSCI.19-23-10250.1999&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1523%252FJNEUROSCI.19-23-10250.1999%26sid%3Dliteratum%253Aachs%26aulast%3DLu%26aufirst%3DY.%26aulast%3DKandel%26aufirst%3DE.%252C%2BR.%26aulast%3DHawkins%26aufirst%3DR.%2BD.%26atitle%3DNitric%2520Oxide%2520Signaling%2520Contributes%2520to%2520Late-Phase%2520LTP%2520and%2520CREB%2520Phosphorylation%2520in%2520the%2520Hippocampus%26jtitle%3DJ.%2520Neurosci.%26date%3D1999%26volume%3D19%26spage%3D10250%26epage%3D10261" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group">Puzzo, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vitolo, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fabrizio, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jacob, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Palmeri, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arancio, O.</span><span> </span><span class="NLM_article-title">Amyloid-beta Peptide Inhibits Activation of the Nitric Oxide/cGMP/cAMP Responsive Element-Binding Protein Pathway during Hippocampal Synaptic Plasticity</span> <span class="citation_source-journal">J. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">25</span><span class="NLM_x">, </span> <span class="NLM_fpage">6887</span><span class="NLM_x">–</span> <span class="NLM_lpage">6897</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Fjm3007799&amp;key=10.1523%2FJNEUROSCI.5291-04.2005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Fjm3007799&amp;key=16033898" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Fjm3007799&amp;key=1%3ACAS%3A528%3ADC%252BD2MXmslClt78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2005&pages=6887-6897&author=D.+Puzzoauthor=O.+Vitoloauthor=T.+Fabrizioauthor=J.+P.+Jacobauthor=A.+Palmeriauthor=O.+Arancio&title=Amyloid-beta+Peptide+Inhibits+Activation+of+the+Nitric+Oxide%2FcGMP%2FcAMP+Responsive+Element-Binding+Protein+Pathway+during+Hippocampal+Synaptic+Plasticity"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Amyloid-β peptide inhibits activation of the nitric oxide/cGMP/cAMP-responsive element-binding protein pathway during hippocampal synaptic plasticity</span></div><div class="casAuthors">Puzzo, Daniela; Vitolo, Ottavio; Trinchese, Fabrizio; Jacob, Joel P.; Palmeri, Agostino; Arancio, Ottavio</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroscience</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">29</span>),
    <span class="NLM_cas:pages">6887-6897</span>CODEN:
                <span class="NLM_cas:coden">JNRSDS</span>;
        ISSN:<span class="NLM_cas:issn">0270-6474</span>.
    
            (<span class="NLM_cas:orgname">Society for Neuroscience</span>)
        </div><div class="casAbstract">Amyloid-β (Aβ), a peptide thought to play a crucial role in Alzheimer's disease (AD), has many targets that, in turn, activate different 2nd-messenger cascades.  Interestingly, Aβ was found to markedly impair hippocampal long-term potentiation (LTP).  To identify a new pathway that might be responsible for such impairment, the authors analyzed the role of the NO/sol. guanylyl cyclase (sGC)/cGMP/cGMP-dependent protein kinase (cGK)/cAMP-responsive element-binding protein (CREB) cascade because of its involvement in LTP.  The use of the NO donor 2-(N,N-dethylamino)-diazenolate-2-oxide diethylammonium salt (DEA/NO), the sGC stimulator 3-(4-amino-5-cyclopropylpyrimidine-2-yl)-1-(2-fluorobenzyl)-1H-pyrazolo[3,4-b]pyridine, or the cGMP-analogs 8-bromo-cGMP and 8-(4-chlorophenylthio)-cGMP reversed the Aβ-induced impairment of CA1-LTP through cGK activation.  Furthermore, these compds. reestablished the enhancement of CREB phosphorylation occurring during LTP in slices exposed to Aβ.  We also found that Aβ blocks the increase in cGMP immunoreactivity occurring immediately after LTP and that DEA/NO counteracts the effect of Aβ.  These results strongly suggest that, when modulating hippocampal synaptic plasticity, Aβ downregulates the NO/cGMP/cGK/CREB pathway; thus, enhancement of the NO/cGMP signaling may provide a novel approach to the treatment of AD and other neurodegenerative diseases with elevated prodn. of Aβ.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpT_M3WUlYelLVg90H21EOLACvtfcHk0lix61_pK34fWA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXmslClt78%253D&md5=448717d56147ceb9665d8c1ce8136c98</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1523%2FJNEUROSCI.5291-04.2005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1523%252FJNEUROSCI.5291-04.2005%26sid%3Dliteratum%253Aachs%26aulast%3DPuzzo%26aufirst%3DD.%26aulast%3DVitolo%26aufirst%3DO.%26aulast%3DFabrizio%26aufirst%3DT.%26aulast%3DJacob%26aufirst%3DJ.%2BP.%26aulast%3DPalmeri%26aufirst%3DA.%26aulast%3DArancio%26aufirst%3DO.%26atitle%3DAmyloid-beta%2520Peptide%2520Inhibits%2520Activation%2520of%2520the%2520Nitric%2520Oxide%252FcGMP%252FcAMP%2520Responsive%2520Element-Binding%2520Protein%2520Pathway%2520during%2520Hippocampal%2520Synaptic%2520Plasticity%26jtitle%3DJ.%2520Neurosci.%26date%3D2005%26volume%3D25%26spage%3D6887%26epage%3D6897" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group">Fisher, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, J. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pillar, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Denis, S. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheng, J. B.</span><span> </span><span class="NLM_article-title">Isolation and Characterization of PDE9A, a Novel Human cGMP-Specific Phosphodiesterase</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">25</span><span class="NLM_x">, </span> <span class="NLM_fpage">15559</span><span class="NLM_x">–</span> <span class="NLM_lpage">15564</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=1998&pages=15559-15564&author=D.+A.+Fisherauthor=J.+F.+Smithauthor=J.+S.+Pillarauthor=S.+H.+Denisauthor=J.+B.+Cheng&title=Isolation+and+Characterization+of+PDE9A%2C+a+Novel+Human+cGMP-Specific+Phosphodiesterase"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFisher%26aufirst%3DD.%2BA.%26aulast%3DSmith%26aufirst%3DJ.%2BF.%26aulast%3DPillar%26aufirst%3DJ.%2BS.%26aulast%3DDenis%26aufirst%3DS.%2BH.%26aulast%3DCheng%26aufirst%3DJ.%2BB.%26atitle%3DIsolation%2520and%2520Characterization%2520of%2520PDE9A%252C%2520a%2520Novel%2520Human%2520cGMP-Specific%2520Phosphodiesterase%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1998%26volume%3D25%26spage%3D15559%26epage%3D15564" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group">Andreeva, S. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dikkes, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Epstein, P. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosenberg, P. A.</span><span> </span><span class="NLM_article-title">Expression of cGMP-Specific Phosphodiesterase 9A mRNA in the Rat Brain</span> <span class="citation_source-journal">J. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">9068</span><span class="NLM_x">–</span> <span class="NLM_lpage">9076</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2001&pages=9068-9076&author=S.+G.+Andreevaauthor=P.+Dikkesauthor=P.+M.+Epsteinauthor=P.+A.+Rosenberg&title=Expression+of+cGMP-Specific+Phosphodiesterase+9A+mRNA+in+the+Rat+Brain"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAndreeva%26aufirst%3DS.%2BG.%26aulast%3DDikkes%26aufirst%3DP.%26aulast%3DEpstein%26aufirst%3DP.%2BM.%26aulast%3DRosenberg%26aufirst%3DP.%2BA.%26atitle%3DExpression%2520of%2520cGMP-Specific%2520Phosphodiesterase%25209A%2520mRNA%2520in%2520the%2520Rat%2520Brain%26jtitle%3DJ.%2520Neurosci.%26date%3D2001%26volume%3D15%26spage%3D9068%26epage%3D9076" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group">Van Der Staay, F. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rutten, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barfacker, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DeVry, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Erb, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schroder, H. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hendrix, M.</span><span> </span><span class="NLM_article-title">The Novel Selective PDE9 Inhibitor BAY 73-6691 Improves Learning and Memory in Rodents</span> <span class="citation_source-journal">Neuropharmacology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">908</span><span class="NLM_x">–</span> <span class="NLM_lpage">918</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2008&pages=908-918&author=F.+J.+Van+Der+Staayauthor=K.+Ruttenauthor=L.+Barfackerauthor=J.+DeVryauthor=C.+Erbauthor=H.+H.+Schroderauthor=M.+Hendrix&title=The+Novel+Selective+PDE9+Inhibitor+BAY+73-6691+Improves+Learning+and+Memory+in+Rodents"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DVan%2BDer%2BStaay%26aufirst%3DF.%2BJ.%26aulast%3DRutten%26aufirst%3DK.%26aulast%3DBarfacker%26aufirst%3DL.%26aulast%3DDeVry%26aufirst%3DJ.%26aulast%3DErb%26aufirst%3DC.%26aulast%3DSchroder%26aufirst%3DH.%2BH.%26aulast%3DHendrix%26aufirst%3DM.%26atitle%3DThe%2520Novel%2520Selective%2520PDE9%2520Inhibitor%2520BAY%252073-6691%2520Improves%2520Learning%2520and%2520Memory%2520in%2520Rodents%26jtitle%3DNeuropharmacology%26date%3D2008%26volume%3D55%26spage%3D908%26epage%3D918" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group">Verhoest, P. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Proulx-Lafrance, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Corman, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chenard, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Helal, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hou, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kleiman, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marr, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Menniti, F. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schmidt, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vanase-Frawley, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schmidt, A. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, R. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nelson, F. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fonseca, K. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liras, S.</span><span> </span><span class="NLM_article-title">Identification of a Brain Penetrant PDE9A Inhibitor Utilizing Prospective Design and Chemical Enablement as a Rapid Lead Optimization Strategy</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">7946</span><span class="NLM_x">–</span> <span class="NLM_lpage">7949</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm9015334" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Fjm3007799&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhsValtbzI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=7946-7949&author=P.+R.+Verhoestauthor=C.+Proulx-Lafranceauthor=M.+Cormanauthor=L.+Chenardauthor=C.+J.+Helalauthor=X.+Houauthor=R.+Kleimanauthor=S.+Liuauthor=E.+Marrauthor=F.+S.+Mennitiauthor=C.+J.+Schmidtauthor=M.+Vanase-Frawleyauthor=A.+W.+Schmidtauthor=R.+D.+Williamsauthor=F.+R.+Nelsonauthor=K.+R.+Fonsecaauthor=S.+Liras&title=Identification+of+a+Brain+Penetrant+PDE9A+Inhibitor+Utilizing+Prospective+Design+and+Chemical+Enablement+as+a+Rapid+Lead+Optimization+Strategy"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of a Brain Penetrant PDE9A Inhibitor Utilizing Prospective Design and Chemical Enablement as a Rapid Lead Optimization Strategy</span></div><div class="casAuthors">Verhoest, Patrick R.; Proulx-Lafrance, Caroline; Corman, Michael; Chenard, Lois; Helal, Christopher J.; Hou, Xinjun; Kleiman, Robin; Liu, Shenping; Marr, Eric; Menniti, Frank S.; Schmidt, Christopher J.; Vanase-Frawley, Michelle; Schmidt, Anne W.; Williams, Robert D.; Nelson, Frederick R.; Fonseca, Kari R.; Liras, Spiros</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">52</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">7946-7949</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A novel series of selective, brain penetrant PDE9A inhibitors I (R1 = i-Pr, i-Bu, cyclopentyl, R2 = Ph; R1 = cyclopentyl, R2 = 3-MeC6H4, 2-pyridyl, 6-quinoxalinyl, etc.) has been identified that are capable of producing in vivo elevations of brain cGMP.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGou_Q49qDJV3bVg90H21EOLACvtfcHk0lix61_pK34fWA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhsValtbzI&md5=4e1a67684031737596a83d1feb4bee08</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1021%2Fjm9015334&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm9015334%26sid%3Dliteratum%253Aachs%26aulast%3DVerhoest%26aufirst%3DP.%2BR.%26aulast%3DProulx-Lafrance%26aufirst%3DC.%26aulast%3DCorman%26aufirst%3DM.%26aulast%3DChenard%26aufirst%3DL.%26aulast%3DHelal%26aufirst%3DC.%2BJ.%26aulast%3DHou%26aufirst%3DX.%26aulast%3DKleiman%26aufirst%3DR.%26aulast%3DLiu%26aufirst%3DS.%26aulast%3DMarr%26aufirst%3DE.%26aulast%3DMenniti%26aufirst%3DF.%2BS.%26aulast%3DSchmidt%26aufirst%3DC.%2BJ.%26aulast%3DVanase-Frawley%26aufirst%3DM.%26aulast%3DSchmidt%26aufirst%3DA.%2BW.%26aulast%3DWilliams%26aufirst%3DR.%2BD.%26aulast%3DNelson%26aufirst%3DF.%2BR.%26aulast%3DFonseca%26aufirst%3DK.%2BR.%26aulast%3DLiras%26aufirst%3DS.%26atitle%3DIdentification%2520of%2520a%2520Brain%2520Penetrant%2520PDE9A%2520Inhibitor%2520Utilizing%2520Prospective%2520Design%2520and%2520Chemical%2520Enablement%2520as%2520a%2520Rapid%2520Lead%2520Optimization%2520Strategy%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26spage%3D7946%26epage%3D7949" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group">Whalen, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gobey, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Janiszewski, J. A.</span><span> </span><span class="NLM_article-title">Centralized Approach to Tandem Mass Spectrometry Method Development for High-Throughput ADME Screening</span> <span class="citation_source-journal">Rapid Commun. Mass Spectrom.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">1497</span><span class="NLM_x">–</span> <span class="NLM_lpage">1503</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Fjm3007799&amp;key=10.1002%2Frcm.2469" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Fjm3007799&amp;key=16628559" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Fjm3007799&amp;key=1%3ACAS%3A528%3ADC%252BD28XltVartLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2006&pages=1497-1503&author=K.+Whalenauthor=J.+Gobeyauthor=J.+A.+Janiszewski&title=Centralized+Approach+to+Tandem+Mass+Spectrometry+Method+Development+for+High-Throughput+ADME+Screening"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">A centralized approach to tandem mass spectrometry method development for high-throughput ADME screening</span></div><div class="casAuthors">Whalen, Kevin; Gobey, Jason; Janiszewski, John</div><div class="citationInfo"><span class="NLM_cas:title">Rapid Communications in Mass Spectrometry</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1497-1503</span>CODEN:
                <span class="NLM_cas:coden">RCMSEF</span>;
        ISSN:<span class="NLM_cas:issn">0951-4198</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons Ltd.</span>)
        </div><div class="casAbstract">A centralized approach to acquisition and dissemination of tandem mass spectrometry (MS/MS) conditions within an ADME-screening bioanal. mass spectrometry group was developed.  The method development process uses 2 automated software products (Autoscan and Automaton) specifically designed for mass spectrometers manufd. by MDS Sciex.  Both provide the ability to quickly det. selected reaction monitoring (SRM) transitions for hundreds of compds. per day.  Autoscan dets. optimal polarity and collision energy (CE).  Automaton also dets. the optimal declustering potential (DP) as well as the CE.  The resulting optimized conditions are loaded into a central database for access by LC/MS/MS bioanal. workstations in the group.  The effect of DP and CE on the sensitivity was studied.  Optimization of DP improved signal response ∼27% on av.  For ∼10% of compds., signal enhancement was >50% compared to the generic setting.  A generic setting of DP = 25 V can be used for the majority of ADME-screening applications.  Optimization of CE can have a much larger impact on signal intensity and a min. of 3 CE settings should be tested.  CE values of 1, 30 and 45 V provide adequate coverage for most small mol. drug discovery analytes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpjYhEOAvOWB7Vg90H21EOLACvtfcHk0lhQfFRRkZ91GA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XltVartLk%253D&md5=6e57b4b490527b98931bc58aa871d48c</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1002%2Frcm.2469&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Frcm.2469%26sid%3Dliteratum%253Aachs%26aulast%3DWhalen%26aufirst%3DK.%26aulast%3DGobey%26aufirst%3DJ.%26aulast%3DJaniszewski%26aufirst%3DJ.%2BA.%26atitle%3DCentralized%2520Approach%2520to%2520Tandem%2520Mass%2520Spectrometry%2520Method%2520Development%2520for%2520High-Throughput%2520ADME%2520Screening%26jtitle%3DRapid%2520Commun.%2520Mass%2520Spectrom.%26date%3D2006%26volume%3D20%26spage%3D1497%26epage%3D1503" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group">Kuntz, I. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sharp, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kollman, P. A.</span><span> </span><span class="NLM_article-title">The Maximal Affinity of Ligands</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U.S.A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">96</span><span class="NLM_x">, </span> <span class="NLM_fpage">9997</span><span class="NLM_x">–</span> <span class="NLM_lpage">10002</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Fjm3007799&amp;key=10.1073%2Fpnas.96.18.9997" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Fjm3007799&amp;key=10468550" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Fjm3007799&amp;key=1%3ACAS%3A528%3ADyaK1MXlvFehu7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=96&publication_year=1999&pages=9997-10002&author=I.+D.+Kuntzauthor=K.+Chenauthor=K.+A.+Sharpauthor=P.+A.+Kollman&title=The+Maximal+Affinity+of+Ligands"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">The maximal affinity of ligands</span></div><div class="casAuthors">Kuntz, I. D.; Chen, K.; Sharp, K. A.; Kollman, P. A.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">96</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">9997-10002</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">We explore the question of what are the best ligands for macromol. targets.  A survey of exptl. data on a large no. of the strongest-binding ligands indicates that the free energy of binding increases with the no. of nonhydrogen atoms with an initial slope of ≈-1.5 kcal/mol (1 cal = 4.18 J) per atom.  For ligands that contain more than 15 nonhydrogen atoms, the free energy of binding increases very little with relative mol. mass.  This nonlinearity is largely ascribed to nonthermodynamic factors.  An anal. of the dominant interactions suggests that van der Waals interactions and hydrophobic effects provide a reasonable basis for understanding binding affinities across the entire set of ligands.  Interesting outliers that bind unusually strongly on a per atom basis include metal ions, covalently attached ligands, and a few well known complexes such as biotin-avidin.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq0L6KZhR0TxbVg90H21EOLACvtfcHk0lhQfFRRkZ91GA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXlvFehu7s%253D&md5=46fe894b016f3041831a2f0b71f812b1</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1073%2Fpnas.96.18.9997&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.96.18.9997%26sid%3Dliteratum%253Aachs%26aulast%3DKuntz%26aufirst%3DI.%2BD.%26aulast%3DChen%26aufirst%3DK.%26aulast%3DSharp%26aufirst%3DK.%2BA.%26aulast%3DKollman%26aufirst%3DP.%2BA.%26atitle%3DThe%2520Maximal%2520Affinity%2520of%2520Ligands%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D1999%26volume%3D96%26spage%3D9997%26epage%3D10002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group">Wager, T. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chandrasekaran, R. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hou, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Troutman, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Verhoest, P. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Villalobos, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Will, Y.</span><span> </span><span class="NLM_article-title">Defining Desirable Central Nervous System Drug Space through the Alignment of Molecular Properties, in Vitro ADME, and Safety Attributes</span> <span class="citation_source-journal">ACS Chem. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">1</span><span class="NLM_x">, </span> <span class="NLM_fpage">420</span><span class="NLM_x">–</span> <span class="NLM_lpage">434</span></span><div class="citationLinks">[<a href="/doi/10.1021/cn100007x" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Fjm3007799&amp;key=1%3ACAS%3A528%3ADC%252BC3cXjvVaqtbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2010&pages=420-434&author=T.+T.+Wagerauthor=R.+Y.+Chandrasekaranauthor=X.+Houauthor=M.+D.+Troutmanauthor=P.+R.+Verhoestauthor=A.+Villalobosauthor=Y.+Will&title=Defining+Desirable+Central+Nervous+System+Drug+Space+through+the+Alignment+of+Molecular+Properties%2C+in+Vitro+ADME%2C+and+Safety+Attributes"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Defining Desirable Central Nervous System Drug Space through the Alignment of Molecular Properties, in Vitro ADME, and Safety Attributes</span></div><div class="casAuthors">Wager, Travis T.; Chandrasekaran, Ramalakshmi Y.; Hou, Xinjun; Troutman, Matthew D.; Verhoest, Patrick R.; Villalobos, Anabella; Will, Yvonne</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Neuroscience</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">420-434</span>CODEN:
                <span class="NLM_cas:coden">ACNCDM</span>;
        ISSN:<span class="NLM_cas:issn">1948-7193</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">As part of our effort to increase survival of drug candidates and to move our medicinal chem. design to higher probability space for success in the Neuroscience therapeutic area, we embarked on a detailed study of the property space for a collection of central nervous system (CNS) mols.  We carried out a thorough anal. of properties for 119 marketed CNS drugs and a set of 108 Pfizer CNS candidates.  In particular, we focused on understanding the relationships between physicochem. properties, in vitro ADME (absorption, distribution, metab., and elimination) attributes, primary pharmacol. binding efficiencies, and in vitro safety data for these two sets of compds.  This scholarship provides guidance for the design of CNS mols. in a property space with increased probability of success and may lead to the identification of druglike candidates with favorable safety profiles that can successfully test hypotheses in the clinic.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqvEMBo2f34BrVg90H21EOLACvtfcHk0lhQfFRRkZ91GA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXjvVaqtbk%253D&md5=85716be86290fd85e93c6b8d5621683c</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1021%2Fcn100007x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcn100007x%26sid%3Dliteratum%253Aachs%26aulast%3DWager%26aufirst%3DT.%2BT.%26aulast%3DChandrasekaran%26aufirst%3DR.%2BY.%26aulast%3DHou%26aufirst%3DX.%26aulast%3DTroutman%26aufirst%3DM.%2BD.%26aulast%3DVerhoest%26aufirst%3DP.%2BR.%26aulast%3DVillalobos%26aufirst%3DA.%26aulast%3DWill%26aufirst%3DY.%26atitle%3DDefining%2520Desirable%2520Central%2520Nervous%2520System%2520Drug%2520Space%2520through%2520the%2520Alignment%2520of%2520Molecular%2520Properties%252C%2520in%2520Vitro%2520ADME%252C%2520and%2520Safety%2520Attributes%26jtitle%3DACS%2520Chem.%2520Neurosci.%26date%3D2010%26volume%3D1%26spage%3D420%26epage%3D434" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group">Feng, B</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mills, J. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davidson, R. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mireles, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Janiszewski, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Troutman, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Morais, S. M.</span><span> </span><span class="NLM_article-title">In Vitro P-Glycoprotein Assays To Predict the in Vivo Interactions of P-Glycoprotein with Drugs in the Central Nervous System</span> <span class="citation_source-journal">Drug Metab. Dispos.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">36</span><span class="NLM_x">, </span> <span class="NLM_fpage">268</span><span class="NLM_x">–</span> <span class="NLM_lpage">275</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Fjm3007799&amp;key=10.1124%2Fdmd.107.017434" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Fjm3007799&amp;key=17962372" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Fjm3007799&amp;key=1%3ACAS%3A528%3ADC%252BD1cXht1yktbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=36&publication_year=2008&pages=268-275&author=B+Fengauthor=J.+B.+Millsauthor=R.+E.+Davidsonauthor=R.+J.+Mirelesauthor=J.+S.+Janiszewskiauthor=M.+D.+Troutmanauthor=S.+M.+de+Morais&title=In+Vitro+P-Glycoprotein+Assays+To+Predict+the+in+Vivo+Interactions+of+P-Glycoprotein+with+Drugs+in+the+Central+Nervous+System"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">In vitro P-glycoprotein assays to predict the in vivo interactions of P-glycoprotein with drugs in the central nervous system</span></div><div class="casAuthors">Feng, Bo; Mills, Jessica B.; Davidson, Ralph E.; Mireles, Rouchelle J.; Janiszewski, John S.; Troutman, Matthew D.; de Morais, Sonia M.</div><div class="citationInfo"><span class="NLM_cas:title">Drug Metabolism and Disposition</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">36</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">268-275</span>CODEN:
                <span class="NLM_cas:coden">DMDSAI</span>;
        ISSN:<span class="NLM_cas:issn">0090-9556</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Thirty-one structurally diverse marketed central nervous system (CNS)-active drugs, one active metabolite, and seven non-CNS-active compds. were tested in three P-glycoprotein (P-gp) in vitro assays: transwell assays using MDCK, human MDR1-MDCK, and mouse Mdr1a-MDCK cells, ATPase, and calcein AM inhibition.  Addnl., the permeability for these compds. was measured in two in vitro models: parallel artificial membrane permeation assay and apical-to-basolateral apparent permeability in MDCK.  The exposure of the same set of compds. in brain and plasma was measured in P-gp knockout (KO) and wild-type (WT) mice after s.c. administration.  One drug and its metabolite, risperidone and 9-hydroxyrisperidone, of the 32 CNS compds., and 6 of the 7 non-CNS drugs were detd. to have pos. efflux using ratio of ratios in MDR1-MDCK vs. MDCK transwell assays.  Data from transwell studies correlated well with the brain-to-plasma area under the curve ratios between P-gp KO and WT mice for the 32 CNS compds.  In addn., 3300 Pfizer compds. were tested in MDR1-MDCK and Mdr1a-MDCK transwell assays, with a good correlation (R2 = 0.92) between the efflux ratios in human MDR1-MDCK and mouse Mdr1a-MDCK cells.  Permeability data showed that the majority of the 32 CNS compds. have moderate to high passive permeability.  This work has demonstrated that in vitro transporter assays help in understanding the role of P-gp-mediated efflux activity in detg. the disposition of CNS drugs in vivo, and the transwell assay is a valuable in vitro assay to evaluate human P-gp interaction with compds. for assessing brain penetration of new chem. entities to treat CNS disorders.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqsQyRSOySyGLVg90H21EOLACvtfcHk0lhQfFRRkZ91GA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXht1yktbc%253D&md5=bbf8b6969bd6d6b3d741b6ef9e7853f3</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1124%2Fdmd.107.017434&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fdmd.107.017434%26sid%3Dliteratum%253Aachs%26aulast%3DFeng%26aufirst%3DB%26aulast%3DMills%26aufirst%3DJ.%2BB.%26aulast%3DDavidson%26aufirst%3DR.%2BE.%26aulast%3DMireles%26aufirst%3DR.%2BJ.%26aulast%3DJaniszewski%26aufirst%3DJ.%2BS.%26aulast%3DTroutman%26aufirst%3DM.%2BD.%26aulast%3Dde%2BMorais%26aufirst%3DS.%2BM.%26atitle%3DIn%2520Vitro%2520P-Glycoprotein%2520Assays%2520To%2520Predict%2520the%2520in%2520Vivo%2520Interactions%2520of%2520P-Glycoprotein%2520with%2520Drugs%2520in%2520the%2520Central%2520Nervous%2520System%26jtitle%3DDrug%2520Metab.%2520Dispos.%26date%3D2008%26volume%3D36%26spage%3D268%26epage%3D275" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group">Obach, R. S.</span><span> </span><span class="NLM_article-title">Prediction of Human Clearance of Twenty-Nine Drugs from Hepatic Microsomal Intrinsic Clearance Data: An Examination of in Vitro Half-Life Approach and Nonspecific Binding to Microsomes</span> <span class="citation_source-journal">Drug. Metab. Dispos.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">27</span><span class="NLM_x">, </span> <span class="NLM_fpage">1350</span><span class="NLM_x">–</span> <span class="NLM_lpage">1359</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Fjm3007799&amp;key=10534321" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Fjm3007799&amp;key=1%3ACAS%3A528%3ADyaK1MXntFSht7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=1999&pages=1350-1359&author=R.+S.+Obach&title=Prediction+of+Human+Clearance+of+Twenty-Nine+Drugs+from+Hepatic+Microsomal+Intrinsic+Clearance+Data%3A+An+Examination+of+in+Vitro+Half-Life+Approach+and+Nonspecific+Binding+to+Microsomes"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Prediction of human clearance of twenty-nine drugs from hepatic microsomal intrinsic clearance data: an examination of in vitro half-life approach and nonspecific binding to microsomes</span></div><div class="casAuthors">Obach, R. Scott</div><div class="citationInfo"><span class="NLM_cas:title">Drug Metabolism and Disposition</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1350-1359</span>CODEN:
                <span class="NLM_cas:coden">DMDSAI</span>;
        ISSN:<span class="NLM_cas:issn">0090-9556</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Twenty-nine drugs of disparate structures and physicochem. properties were used in an examn. of the capability of human liver microsomal lability data ("in vitro T1/2" approach) to be useful in the prediction of human clearance.  Addnl., the potential importance of nonspecific binding to microsomes in the in vitro incubation milieu for the accurate prediction of human clearance was investigated.  The compds. examd. demonstrated a wide range of microsomal metabolic labilities with scaled intrinsic clearance values ranging from less than 0.5 mL/min/kg to 189 mL/min/kg.  Microsomal binding was detd. at microsomal protein concns. used in the lability incubations.  For the 29 compds. studied, unbound fractions in microsomes ranged from 0.11 to 1.0.  Generally, basic compds. demonstrated the greatest extent of binding and neutral and acidic compds. the least extent of binding.  In the projection of human clearance values, basic and neutral compds. were well predicted when all binding considerations (blood and microsome) were disregarded, however, including both binding considerations also yielded reasonable predictions.  Including only blood binding yielded very poor projections of human clearance for these two types of compds.  However, for acidic compds., disregarding all binding considerations yielded poor predictions of human clearance.  It was generally most difficult to accurately predict clearance for this class of compds.; however the accuracy was best when all binding considerations were included.  Overall, inclusion of both blood and microsome binding values gave the best agreement between in vivo clearance values and clearance values projected from in vitro intrinsic clearance data.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpWp2hUTOxyubVg90H21EOLACvtfcHk0ljKI6-Ks7y7Rw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXntFSht7c%253D&md5=7804cd4dfb131caac45aff9b7a1df901</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DObach%26aufirst%3DR.%2BS.%26atitle%3DPrediction%2520of%2520Human%2520Clearance%2520of%2520Twenty-Nine%2520Drugs%2520from%2520Hepatic%2520Microsomal%2520Intrinsic%2520Clearance%2520Data%253A%2520An%2520Examination%2520of%2520in%2520Vitro%2520Half-Life%2520Approach%2520and%2520Nonspecific%2520Binding%2520to%2520Microsomes%26jtitle%3DDrug.%2520Metab.%2520Dispos.%26date%3D1999%26volume%3D27%26spage%3D1350%26epage%3D1359" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group">Obach, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baxter, J. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liston, T. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Silber, B. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, B. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">MacIntyre, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rance, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wastall, P.</span><span> </span><span class="NLM_article-title">The Prediction of Human Pharmacokinetic Parameters from Preclinical and in Vitro Metabolism Data</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">283</span><span class="NLM_x">, </span> <span class="NLM_fpage">46</span><span class="NLM_x">–</span> <span class="NLM_lpage">58</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Fjm3007799&amp;key=9336307" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Fjm3007799&amp;key=1%3ACAS%3A528%3ADyaK2sXmslCltr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=283&publication_year=1997&pages=46-58&author=S.+R.+Obachauthor=J.+G.+Baxterauthor=T.+E.+Listonauthor=B.+M.+Silberauthor=B.+C.+Jonesauthor=F.+MacIntyreauthor=D.+J.+Ranceauthor=P.+Wastall&title=The+Prediction+of+Human+Pharmacokinetic+Parameters+from+Preclinical+and+in+Vitro+Metabolism+Data"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">The prediction of human pharmacokinetic parameters from preclinical and in vitro metabolism data</span></div><div class="casAuthors">Obach, R. Scott; Baxter, James G.; Liston, Theodore E.; Silber, B. Michael; Jones, Barry C.; Macintyre, Flona; Rance, David J.; Wastall, Philip</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">283</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">46-58</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">Williams & Wilkins</span>)
        </div><div class="casAbstract">A review with 35 refs.  We describe a comprehensive retrospective anal. in which the abilities of several methods by which human pharmacokinetic parameters are predicted from preclin. pharmacokinetic data and/or in vitro metab. data were assessed.  The prediction methods examd. included both methods from the scientific literature as well as some described in this report for the first time.  Four methods were examd. for their ability to predict human vol. of distribution.  Three were highly predictive, yielding, on av., predictions that were within 60% to 90% of actual values.  Twelve methods were assessed for their utility in predicting clearance.  The most successful allometric scaling method yielded clearance predictions that were, on av., within 80% of actual values.  The best methods in which in vitro metab. data from human liver microsomes were scaled to in vivo clearance values yielded predicted clearance values that were, on av., within 70% to 80% of actual values.  Human t1/2 was predicted by combining predictions of human vol. of distribution and clearance.  The best t1/2 prediction methods successfully assigned compds. to appropriate dosing regimen categories (e.g., once daily, twice daily and so forth) 70% to 80% of the time.  In addn., correlations between human t1/2 and t1/2 values from preclin. species were also generally successful (72-87%) when used to predict human dosing regimens.  In summary, this retrospective anal. has identified several approaches by which human pharmacokinetic data can be predicted from preclin. data.  Such approaches should find utility in the drug discovery and development processes in the identification and selection of compds. that will possess appropriate pharmacokinetic characteristics in humans for progression to clin. trials.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGppAngniZ4izLVg90H21EOLACvtfcHk0ljKI6-Ks7y7Rw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXmslCltr0%253D&md5=68d1910d925e26ec4a8ef23043ffb1ed</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DObach%26aufirst%3DS.%2BR.%26aulast%3DBaxter%26aufirst%3DJ.%2BG.%26aulast%3DListon%26aufirst%3DT.%2BE.%26aulast%3DSilber%26aufirst%3DB.%2BM.%26aulast%3DJones%26aufirst%3DB.%2BC.%26aulast%3DMacIntyre%26aufirst%3DF.%26aulast%3DRance%26aufirst%3DD.%2BJ.%26aulast%3DWastall%26aufirst%3DP.%26atitle%3DThe%2520Prediction%2520of%2520Human%2520Pharmacokinetic%2520Parameters%2520from%2520Preclinical%2520and%2520in%2520Vitro%2520Metabolism%2520Data%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D1997%26volume%3D283%26spage%3D46%26epage%3D58" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group">Kleiman, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chapin, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Christoffersen, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Freeman, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fonseca, K. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Geoghegan, K. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grimwood, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guanowsky, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hajos, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harms, J. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Helal, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoffman, W. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kocan, G. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Majchrzak, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McGinnis, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McLean, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Menniti, F. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nelson, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roof, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schmidt, A. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seymour, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stephenson, D. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tingley, F. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vanase-Frawley, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Verhoest, P. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schmidt, C. J.</span><span> </span><span class="NLM_article-title">Phosphodiesterase 9A Regulates Central cGMP and Modulates Responses to Cholinergic and Monoaminergic Perturbation in Vivo</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">341</span><span class="NLM_x">, </span> <span class="NLM_fpage">1</span><span class="NLM_x">–</span> <span class="NLM_lpage">14</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Fjm3007799&amp;key=10.1124%2Fjpet.111.191353" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=341&publication_year=2012&pages=1-14&author=R.+J.+Kleimanauthor=D.+S.+Chapinauthor=C.+Christoffersenauthor=J.+Freemanauthor=K.+R.+Fonsecaauthor=K.+F.+Geogheganauthor=S.+Grimwoodauthor=V.+Guanowskyauthor=M.+Hajosauthor=J.+F.+Harmsauthor=C.+J.+Helalauthor=W.+E.+Hoffmanauthor=G.+P.+Kocanauthor=M.+Majchrzakauthor=D.+McGinnisauthor=S.+McLeanauthor=F.+S.+Mennitiauthor=F.+Nelsonauthor=R.+Roofauthor=A.+W.+Schmidtauthor=P.+A.+Seymourauthor=D.+T.+Stephensonauthor=F.+D.+Tingleyauthor=M.+Vanase-Frawleyauthor=P.+R.+Verhoestauthor=C.+J.+Schmidt&title=Phosphodiesterase+9A+Regulates+Central+cGMP+and+Modulates+Responses+to+Cholinergic+and+Monoaminergic+Perturbation+in+Vivo"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1124%2Fjpet.111.191353&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.111.191353%26sid%3Dliteratum%253Aachs%26aulast%3DKleiman%26aufirst%3DR.%2BJ.%26aulast%3DChapin%26aufirst%3DD.%2BS.%26aulast%3DChristoffersen%26aufirst%3DC.%26aulast%3DFreeman%26aufirst%3DJ.%26aulast%3DFonseca%26aufirst%3DK.%2BR.%26aulast%3DGeoghegan%26aufirst%3DK.%2BF.%26aulast%3DGrimwood%26aufirst%3DS.%26aulast%3DGuanowsky%26aufirst%3DV.%26aulast%3DHajos%26aufirst%3DM.%26aulast%3DHarms%26aufirst%3DJ.%2BF.%26aulast%3DHelal%26aufirst%3DC.%2BJ.%26aulast%3DHoffman%26aufirst%3DW.%2BE.%26aulast%3DKocan%26aufirst%3DG.%2BP.%26aulast%3DMajchrzak%26aufirst%3DM.%26aulast%3DMcGinnis%26aufirst%3DD.%26aulast%3DMcLean%26aufirst%3DS.%26aulast%3DMenniti%26aufirst%3DF.%2BS.%26aulast%3DNelson%26aufirst%3DF.%26aulast%3DRoof%26aufirst%3DR.%26aulast%3DSchmidt%26aufirst%3DA.%2BW.%26aulast%3DSeymour%26aufirst%3DP.%2BA.%26aulast%3DStephenson%26aufirst%3DD.%2BT.%26aulast%3DTingley%26aufirst%3DF.%2BD.%26aulast%3DVanase-Frawley%26aufirst%3DM.%26aulast%3DVerhoest%26aufirst%3DP.%2BR.%26aulast%3DSchmidt%26aufirst%3DC.%2BJ.%26atitle%3DPhosphodiesterase%25209A%2520Regulates%2520Central%2520cGMP%2520and%2520Modulates%2520Responses%2520to%2520Cholinergic%2520and%2520Monoaminergic%2520Perturbation%2520in%2520Vivo%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2012%26volume%3D341%26spage%3D1%26epage%3D14" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group">Vardigan, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Convero, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hutson, P. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Uslaner, J. M.</span><span> </span><span class="NLM_article-title">Selective Phosphodiesterase 9 Inhibitor PF-04447943 Attenuates a Scapolamine-Induced Deficits in a Novel Rodent Attenuation Task</span> <span class="citation_source-journal">J. Neurogenet.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">25</span><span class="NLM_x">, </span> <span class="NLM_fpage">120</span><span class="NLM_x">–</span> <span class="NLM_lpage">126</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Fjm3007799&amp;key=10.3109%2F01677063.2011.630494" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Fjm3007799&amp;key=22070409" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Fjm3007799&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhsV2hs7bF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2011&pages=120-126&author=J.+D.+Vardiganauthor=A.+Converoauthor=P.+H.+Hutsonauthor=J.+M.+Uslaner&title=Selective+Phosphodiesterase+9+Inhibitor+PF-04447943+Attenuates+a+Scapolamine-Induced+Deficits+in+a+Novel+Rodent+Attenuation+Task"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">The Selective Phosphodiesterase 9 (PDE9) Inhibitor PF-04447943 Attenuates a Scopolamine-Induced Deficit in a Novel Rodent Attention Task</span></div><div class="casAuthors">Vardigan, Joshua D.; Converso, Antonella; Hutson, Pete H.; Uslaner, Jason M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neurogenetics</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">120-126</span>CODEN:
                <span class="NLM_cas:coden">JLNEDK</span>;
        ISSN:<span class="NLM_cas:issn">0167-7063</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">Numerous changes occur during aging and Alzheimer's disease (AD) progression, including a decline in cholinergic functioning and cognition, as well as alterations in gene expression and activity in the nitric oxide/cyclic guanosine monophosphate (NO/cGMP) pathway.  Donepezil, the current std. of care for Alzheimer's disease, improves cholinergic functioning and has demonstrated effects on multiple domains of cognition, including memory and attention in both preclin. species and patients.  We previously found that increasing activation of the NO/cGMP pathway via phosphodiesterase 9 (PDE9) inhibition also improves memory in rodents and suggested that PDE9 might be a promising target for novel treatments for AD.  Here we investigated whether PDE9 inhibition also enhances attention using a novel attention task in rats.  We validated this task using several pharmacol. manipulations and showed that the selective PDE9 inhibitor PF-04447943 produced effects similar to those of donepezil.  These data confirm and extend the hypothesis that PDE9 inhibition might serve as a novel treatment for AD and age-related cognitive decline.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqJa-1clww9LrVg90H21EOLACvtfcHk0lgsvLie975Xcg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhsV2hs7bF&md5=1d03e024134e690d1765bd4ee8576aad</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.3109%2F01677063.2011.630494&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3109%252F01677063.2011.630494%26sid%3Dliteratum%253Aachs%26aulast%3DVardigan%26aufirst%3DJ.%2BD.%26aulast%3DConvero%26aufirst%3DA.%26aulast%3DHutson%26aufirst%3DP.%2BH.%26aulast%3DUslaner%26aufirst%3DJ.%2BM.%26atitle%3DSelective%2520Phosphodiesterase%25209%2520Inhibitor%2520PF-04447943%2520Attenuates%2520a%2520Scapolamine-Induced%2520Deficits%2520in%2520a%2520Novel%2520Rodent%2520Attenuation%2520Task%26jtitle%3DJ.%2520Neurogenet.%26date%3D2011%26volume%3D25%26spage%3D120%26epage%3D126" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group">Hutson, P. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Finger, E. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Magliaro, B. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Converso, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sanderson, P. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mullins, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hyde, L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eschle, B. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Turnbull, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sloan, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guzzi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rindgen, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mazzola, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vivian, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eddins, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Uslaner, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bednar, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gambone, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Le-Mari, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marino, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sachs, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parmentier-Batteur, S.</span><span> </span><span class="NLM_article-title">The Selective Phosphodiesterase 9 (PDE9) Inhibitor PF-04447943 (6-[(3<i>S</i>,4<i>S</i>)-4-methyl-1-(pyrimidin-2-ylmethyl)pyrrolidin-3-yl]-1-(tetrahydro-2<i>H</i>-pyran-4-yl)-1,5-dihydro-4<i>H</i>-pyrazolo[3,4-<i>d</i>]pyrimidin-4-one) Enhances Synaptic Plasticity and Cognitive Function in Rodents</span> <span class="citation_source-journal">Neuropharmacology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">61</span><span class="NLM_x">, </span> <span class="NLM_fpage">665</span><span class="NLM_x">–</span> <span class="NLM_lpage">667</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2011&pages=665-667&author=P.+H.+Hutsonauthor=E.+N.+Fingerauthor=B.+C.+Magliaroauthor=S.+M.+Smithauthor=A.+Conversoauthor=P.+E.+Sandersonauthor=D.+Mullinsauthor=L.+A.+Hydeauthor=B.+K.+Eschleauthor=Z.+Turnbullauthor=H.+Sloanauthor=M.+Guzziauthor=X.+Zhangauthor=A.+Wangauthor=D.+Rindgenauthor=R.+Mazzolaauthor=J.+A.+Vivianauthor=D.+Eddinsauthor=J.+M.+Uslanerauthor=R.+Bednarauthor=C.+Gamboneauthor=W.+Le-Mariauthor=M.+J.+Marinoauthor=N.+Sachsauthor=G.+Xuauthor=S.+Parmentier-Batteur&title=The+Selective+Phosphodiesterase+9+%28PDE9%29+Inhibitor+PF-04447943+%286-%5B%283S%2C4S%29-4-methyl-1-%28pyrimidin-2-ylmethyl%29pyrrolidin-3-yl%5D-1-%28tetrahydro-2H-pyran-4-yl%29-1%2C5-dihydro-4H-pyrazolo%5B3%2C4-d%5Dpyrimidin-4-one%29+Enhances+Synaptic+Plasticity+and+Cognitive+Function+in+Rodents"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHutson%26aufirst%3DP.%2BH.%26aulast%3DFinger%26aufirst%3DE.%2BN.%26aulast%3DMagliaro%26aufirst%3DB.%2BC.%26aulast%3DSmith%26aufirst%3DS.%2BM.%26aulast%3DConverso%26aufirst%3DA.%26aulast%3DSanderson%26aufirst%3DP.%2BE.%26aulast%3DMullins%26aufirst%3DD.%26aulast%3DHyde%26aufirst%3DL.%2BA.%26aulast%3DEschle%26aufirst%3DB.%2BK.%26aulast%3DTurnbull%26aufirst%3DZ.%26aulast%3DSloan%26aufirst%3DH.%26aulast%3DGuzzi%26aufirst%3DM.%26aulast%3DZhang%26aufirst%3DX.%26aulast%3DWang%26aufirst%3DA.%26aulast%3DRindgen%26aufirst%3DD.%26aulast%3DMazzola%26aufirst%3DR.%26aulast%3DVivian%26aufirst%3DJ.%2BA.%26aulast%3DEddins%26aufirst%3DD.%26aulast%3DUslaner%26aufirst%3DJ.%2BM.%26aulast%3DBednar%26aufirst%3DR.%26aulast%3DGambone%26aufirst%3DC.%26aulast%3DLe-Mari%26aufirst%3DW.%26aulast%3DMarino%26aufirst%3DM.%2BJ.%26aulast%3DSachs%26aufirst%3DN.%26aulast%3DXu%26aufirst%3DG.%26aulast%3DParmentier-Batteur%26aufirst%3DS.%26atitle%3DThe%2520Selective%2520Phosphodiesterase%25209%2520%2528PDE9%2529%2520Inhibitor%2520PF-04447943%2520%25286-%255B%25283S%252C4S%2529-4-methyl-1-%2528pyrimidin-2-ylmethyl%2529pyrrolidin-3-yl%255D-1-%2528tetrahydro-2H-pyran-4-yl%2529-1%252C5-dihydro-4H-pyrazolo%255B3%252C4-d%255Dpyrimidin-4-one%2529%2520Enhances%2520Synaptic%2520Plasticity%2520and%2520Cognitive%2520Function%2520in%2520Rodents%26jtitle%3DNeuropharmacology%26date%3D2011%26volume%3D61%26spage%3D665%26epage%3D667" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group">Kleiman, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lanz, T. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Finley, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bove, S. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Majchrzak, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Becker, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carvajal-Gonzales, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuhn, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wood, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mariga, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nelson, F. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Verhoest, P. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seymour, P. A</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stephenson, D. T.</span><span> </span><span class="NLM_article-title">Dendritic Spine Density Deficits in the Hippocampal CA1 Region of Young Tg2576 Mice Are Ameliorated with the PDE9A Inhibitor PF-04447943</span> <span class="citation_source-journal">Alzheimer’s Dementia</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">S563</span><span class="NLM_x">–</span> <span class="NLM_lpage">S564</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2010&pages=S563-S564&author=R.+J.+Kleimanauthor=T.+A.+Lanzauthor=J.+E.+Finleyauthor=S.+E.+Boveauthor=M.+J.+Majchrzakauthor=S.+L.+Beckerauthor=S.+Carvajal-Gonzalesauthor=A.+M.+Kuhnauthor=K.+M.+Woodauthor=A.+Marigaauthor=F.+R.+Nelsonauthor=P.+R.+Verhoestauthor=P.+A+Seymourauthor=D.+T.+Stephenson&title=Dendritic+Spine+Density+Deficits+in+the+Hippocampal+CA1+Region+of+Young+Tg2576+Mice+Are+Ameliorated+with+the+PDE9A+Inhibitor+PF-04447943"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKleiman%26aufirst%3DR.%2BJ.%26aulast%3DLanz%26aufirst%3DT.%2BA.%26aulast%3DFinley%26aufirst%3DJ.%2BE.%26aulast%3DBove%26aufirst%3DS.%2BE.%26aulast%3DMajchrzak%26aufirst%3DM.%2BJ.%26aulast%3DBecker%26aufirst%3DS.%2BL.%26aulast%3DCarvajal-Gonzales%26aufirst%3DS.%26aulast%3DKuhn%26aufirst%3DA.%2BM.%26aulast%3DWood%26aufirst%3DK.%2BM.%26aulast%3DMariga%26aufirst%3DA.%26aulast%3DNelson%26aufirst%3DF.%2BR.%26aulast%3DVerhoest%26aufirst%3DP.%2BR.%26aulast%3DSeymour%26aufirst%3DP.%2BA%26aulast%3DStephenson%26aufirst%3DD.%2BT.%26atitle%3DDendritic%2520Spine%2520Density%2520Deficits%2520in%2520the%2520Hippocampal%2520CA1%2520Region%2520of%2520Young%2520Tg2576%2520Mice%2520Are%2520Ameliorated%2520with%2520the%2520PDE9A%2520Inhibitor%2520PF-04447943%26jtitle%3DAlzheimer%25E2%2580%2599s%2520Dementia%26date%3D2010%26volume%3D6%26spage%3DS563%26epage%3DS564" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group">Wager, T. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hou, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Verhoest, P. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Villalobos, A.</span><span> </span><span class="NLM_article-title">Moving beyond Rules: The Development of a Central Nervous System Multiparameter Optimization (CNS MPO) Approach To Enable Alignment of Druglike Properties</span> <span class="citation_source-journal">ACS Chem. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">1</span><span class="NLM_x">, </span> <span class="NLM_fpage">435</span><span class="NLM_x">–</span> <span class="NLM_lpage">449</span></span><div class="citationLinks">[<a href="/doi/10.1021/cn100008c" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Fjm3007799&amp;key=1%3ACAS%3A528%3ADC%252BC3cXjvVejtr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2010&pages=435-449&author=T.+T.+Wagerauthor=X.+Houauthor=P.+R.+Verhoestauthor=A.+Villalobos&title=Moving+beyond+Rules%3A+The+Development+of+a+Central+Nervous+System+Multiparameter+Optimization+%28CNS+MPO%29+Approach+To+Enable+Alignment+of+Druglike+Properties"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Moving beyond Rules: The Development of a Central Nervous System Multiparameter Optimization (CNS MPO) Approach To Enable Alignment of Druglike Properties</span></div><div class="casAuthors">Wager, Travis T.; Hou, Xinjun; Verhoest, Patrick R.; Villalobos, Anabella</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Neuroscience</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">435-449</span>CODEN:
                <span class="NLM_cas:coden">ACNCDM</span>;
        ISSN:<span class="NLM_cas:issn">1948-7193</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The interplay among commonly used physicochem. properties in drug design was examd. and utilized to create a prospective design tool focused on the alignment of key druglike attributes.  Using a set of six physicochem. parameters ((a) lipophilicity, calcd. partition coeff. (ClogP); (b) calcd. distribution coeff. at pH = 7.4 (ClogD); (c) mol. wt. (MW); (d) topol. polar surface area (TPSA); (e) no. of hydrogen bond donors (HBD); (f) most basic center (pKa)), a druglikeness central nervous system multiparameter optimization (CNS MPO) algorithm was built and applied to a set of marketed CNS drugs (N = 119) and Pfizer CNS candidates (N = 108), as well as to a large diversity set of Pfizer proprietary compds. (N = 11 303).  The novel CNS MPO algorithm showed that 74% of marketed CNS drugs displayed a high CNS MPO score (MPO desirability score ≥ 4, using a scale of 0-6), in comparison to 60% of the Pfizer CNS candidates.  This anal. suggests that this algorithm could potentially be used to identify compds. with a higher probability of successfully testing hypotheses in the clinic.  In addn., a relationship between an increasing CNS MPO score and alignment of key in vitro attributes of drug discovery (favorable permeability, P-glycoprotein (P-gp) efflux, metabolic stability, and safety) was seen in the marketed CNS drug set, the Pfizer candidate set, and the Pfizer proprietary diversity set.  The CNS MPO scoring function offers advantages over hard cutoffs or utilization of single parameters to optimize structure-activity relationships (SAR) by expanding medicinal chem. design space through a holistic assessment approach.  Based on six physicochem. properties commonly used by medicinal chemists, the CNS MPO function may be used prospectively at the design stage to accelerate the identification of compds. with increased probability of success.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqB3Mvkgm_X5bVg90H21EOLACvtfcHk0lgy6fbMIvSUYQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXjvVejtr8%253D&md5=e94998f65a420be6ee4dec4a987cb983</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1021%2Fcn100008c&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcn100008c%26sid%3Dliteratum%253Aachs%26aulast%3DWager%26aufirst%3DT.%2BT.%26aulast%3DHou%26aufirst%3DX.%26aulast%3DVerhoest%26aufirst%3DP.%2BR.%26aulast%3DVillalobos%26aufirst%3DA.%26atitle%3DMoving%2520beyond%2520Rules%253A%2520The%2520Development%2520of%2520a%2520Central%2520Nervous%2520System%2520Multiparameter%2520Optimization%2520%2528CNS%2520MPO%2529%2520Approach%2520To%2520Enable%2520Alignment%2520of%2520Druglike%2520Properties%26jtitle%3DACS%2520Chem.%2520Neurosci.%26date%3D2010%26volume%3D1%26spage%3D435%26epage%3D449" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group">Evans, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nicholas, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Le, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qiu, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martin, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martin, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Styren, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fullerton, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schwam, E.</span><span> </span><span class="NLM_article-title">Safety and Pharmacokinetics of PF-04447943, a PDE9A Inhibitor, in Single and Mulitple Dose Phase 1 Studies in Healthy Volunteers</span> <span class="citation_source-journal">Alzheimer’s Dementia</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">S135</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2010&pages=S135&author=R.+M.+Evansauthor=T.+Nicholasauthor=V.+Leauthor=R.+Qiuauthor=W.+Martinauthor=D.+Martinauthor=S.+Styrenauthor=T.+Fullertonauthor=E.+Schwam&title=Safety+and+Pharmacokinetics+of+PF-04447943%2C+a+PDE9A+Inhibitor%2C+in+Single+and+Mulitple+Dose+Phase+1+Studies+in+Healthy+Volunteers"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DEvans%26aufirst%3DR.%2BM.%26aulast%3DNicholas%26aufirst%3DT.%26aulast%3DLe%26aufirst%3DV.%26aulast%3DQiu%26aufirst%3DR.%26aulast%3DMartin%26aufirst%3DW.%26aulast%3DMartin%26aufirst%3DD.%26aulast%3DStyren%26aufirst%3DS.%26aulast%3DFullerton%26aufirst%3DT.%26aulast%3DSchwam%26aufirst%3DE.%26atitle%3DSafety%2520and%2520Pharmacokinetics%2520of%2520PF-04447943%252C%2520a%2520PDE9A%2520Inhibitor%252C%2520in%2520Single%2520and%2520Mulitple%2520Dose%2520Phase%25201%2520Studies%2520in%2520Healthy%2520Volunteers%26jtitle%3DAlzheimer%25E2%2580%2599s%2520Dementia%26date%3D2010%26volume%3D6%26spage%3DS135" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group">Nicholas, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Evans, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Styren, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qui, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, E. Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nelson, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Le, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grimwood, S</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Christoffersen, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Banerjee, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Corrigan, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kocan, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Geoghegan, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carrieri, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raha, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Verhoest, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Soares, H.</span><span> </span><span class="NLM_article-title">PF-04447943, a Novel PDE9A Inhibitor, Increases cGMP Levels in Cerebrospinal Fluid: Translation from Non-Clinical Species to Healthy Human Volunteers</span> <span class="citation_source-journal">Alzheimer’s Dementia</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">P330</span><span class="NLM_x">–</span> <span class="NLM_lpage">P331</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2009&pages=P330-P331&author=T.+Nicholasauthor=R.+Evansauthor=S.+Styrenauthor=R.+Quiauthor=E.+Q.+Wangauthor=F.+Nelsonauthor=V.+Leauthor=S+Grimwoodauthor=C.+Christoffersenauthor=S.+Banerjeeauthor=B.+Corriganauthor=G.+Kocanauthor=K.+Geogheganauthor=C.+Carrieriauthor=N.+Rahaauthor=P.+Verhoestauthor=H.+Soares&title=PF-04447943%2C+a+Novel+PDE9A+Inhibitor%2C+Increases+cGMP+Levels+in+Cerebrospinal+Fluid%3A+Translation+from+Non-Clinical+Species+to+Healthy+Human+Volunteers"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DNicholas%26aufirst%3DT.%26aulast%3DEvans%26aufirst%3DR.%26aulast%3DStyren%26aufirst%3DS.%26aulast%3DQui%26aufirst%3DR.%26aulast%3DWang%26aufirst%3DE.%2BQ.%26aulast%3DNelson%26aufirst%3DF.%26aulast%3DLe%26aufirst%3DV.%26aulast%3DGrimwood%26aufirst%3DS%26aulast%3DChristoffersen%26aufirst%3DC.%26aulast%3DBanerjee%26aufirst%3DS.%26aulast%3DCorrigan%26aufirst%3DB.%26aulast%3DKocan%26aufirst%3DG.%26aulast%3DGeoghegan%26aufirst%3DK.%26aulast%3DCarrieri%26aufirst%3DC.%26aulast%3DRaha%26aufirst%3DN.%26aulast%3DVerhoest%26aufirst%3DP.%26aulast%3DSoares%26aufirst%3DH.%26atitle%3DPF-04447943%252C%2520a%2520Novel%2520PDE9A%2520Inhibitor%252C%2520Increases%2520cGMP%2520Levels%2520in%2520Cerebrospinal%2520Fluid%253A%2520Translation%2520from%2520Non-Clinical%2520Species%2520to%2520Healthy%2520Human%2520Volunteers%26jtitle%3DAlzheimer%25E2%2580%2599s%2520Dementia%26date%3D2009%26volume%3D5%26spage%3DP330%26epage%3DP331" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><div class="accessionCode mb-5"><div class="toolbar-section accession-codes"><ul><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4E90" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4E90','PDB','4E90'); return false;">PDB: 4E90</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3JSI" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3JSI','PDB','3JSI'); return false;">PDB: 3JSI</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3JSW" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3JSW','PDB','3JSW'); return false;">PDB: 3JSW</a></li></ul></div></div><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i24"><a href="/doi/suppl/10.1021/jm3007799">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_42477"></div></div></div></div></div><hr /></hr><p class="last">Experimental procedures for the enzyme assays and pharmacokinetic experiments. This material is available free of charge via the Internet at <a class="extLink" href="http://pubs.acs.org">http://pubs.acs.org</a>.</p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/jm3007799/suppl_file/jm3007799_si_001.pdf">jm3007799_si_001.pdf (174.01 kb)</a></li></ul></div></div><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Fjm3007799&amp;pbContext=%3Barticle%3Aarticle%3A10.1021%2Fjm3007799%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bwgroup%3Astring%3AACHS+website+Group%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2012.55.issue-21%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/jm3007799" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                5MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"67990c254e443da6","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
